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Abstract 
A high level of sedentary behaviour has recently emerged as a distinct risk factor for a 
number of diseases. On the other hand, a large body of evidence has shown that physical 
activity (PA) can prevent several illnesses. However, there are important issues regarding 
the accurate measurement of SB behaviour and physical activity in observational studies 
which are currently unresolved. Research is particularly needed to investigate the impact of 
characteristics of sedentary behaviour such as type/context, sedentary bout length, breaks in 
sedentary time on metabolic responses and accurate quantification of PA and SB is needed 
to evaluate current and changing physical activity and sedentary behaviour levels on health 
outcomes. 
 
A number of studies have demonstrated that replacing sedentary time with light-intensity 
physical activity such as standing can induce a measurable metabolic benefit. However, it is 
unclear whether these benefits could be stimulated by simply breaking up time spent sitting 
down by standing up, or whether the number of transitions from sitting to standing influences 
metabolic changes over and above the effects of total time spent standing. The first 
experimental study in this thesis demonstrated, in ten overweight/obese men, that prolonged 
standing – where participants alternated 15 minutes of sitting with 15 minutes of standing – 
energy expenditure was 10.7% higher than continuous sitting (p<0.001) over an 8-hour 
observation period.  Intermittent standing – where participants undertook 10, 1.5-minute 
bouts of standing in every half-hour – led to a further increase in energy expenditure of 9.0% 
(p<0.001). Participants oxidised 7.1 g more fat and 7.7 g more carbohydrate with intermittent 
standing compared with prolonged standing, but there was no significant effects of either 
prolonged or intermittent standing breaks on postprandial incremental glucose, insulin or 
triglyceride (TG) responses. 
 
However, the intermittent protocol used in that study was clearly not feasible to implement 
as a practical intervention. Building on these data, the second experimental chapter involved 
breaking up prolonged sedentary time by undertaking sit-to-stand transitions over a short 
period (sitting and standing 10 times over 30 seconds, every 20 minutes) was compared to 
prolonged sitting in fourteen overweight/obese men. The main finding in chapter 4 was that 
 II 
sit/stand trial ‘chair squats’ significantly increased energy expenditure by 16.6% over a 6.5-
hour observation period (p<0.0001). Total carbohydrate oxidation was 33.9% higher in the 
‘sit/stand’ trial than the sitting trial (p = 0.0005).  The difference in total fat oxidation 
between trials over the 6.5-hour observation period was not statistically significant, but 
tended to be 9.7% higher in the ‘sit/stand’ trial, (p = 0.11). Postprandial insulin 
concentrations over the post-breakfast period were 10.9% lower in the ‘sit/stand’ trial than 
the sitting trial (p = 0.047), but no difference in the post-lunch period. Postprandial TG and 
glucose responses were not significantly different between the two trials.   
 
Comprehensive and accurate methods of assessing sedentary time and physical activity are 
essential to further our understanding the links between activity behaviours and disease: 
misclassification due to poor measurement can attenuate the apparent association between 
these behavouirs and health outcomes. The aims of the third experiment chapter were 
therefore to compare thigh and hip positions for accelerometer placement of an ActivPAL 
accelerometer for the measurement of step-based physical activity and to develop an 
algorithm for the estimation of walking or running speed and energy expenditure from 
acceleration outputs from a thigh-based accelerometer. The main finding was that the thigh- 
based ActivPAL were capable of determining stepping activity well at speeds from 2 km.h-
1 upward, whereas the hip-based ActivPAL accelerometer and the hip-based Actigraph 
underestimated steps count at speed below ~ 3-4 km.h-1. There was a strong linear 
relationship between vector magnitude acceleration and speed for both hip and thigh 
positions. The relationship between ActivPAL accelarations and oxygen uptake was very 
strong for both the thigh and hip positions (R2 ≈ 0.90), (R2 ≈ 0.88) respectively. Half of the 
participants (n = 20) were used to derive regression equations for the relationship between 
accelerations and oxygen uptake and these equations were tested in the other half of the cross 
– validation group (n = 20). The result indicated that the linear regression equation to obtain 
oxygen uptake from accelerometer was valid in all ActivPAL positions with standard errors 
of the estimate (SEE) between 3.2 to 3.7 ml.kg-1.min-1. For the hip-based, ActiGraph, the 
regression equations had lower accuratcy with SEE = 4.8 ml.kg.min-1.  To establish whether 
data generated from treadmill-based walking was applicable to free-living walking, the 
relationship between walking or running speed and vector magnitude accelerations was 
compared between the treadmill and overground walking or running on a track.  The 
relationships were virtually identical, which suggests that estimates of oxygen uptake and 
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therefore energy expenditure based on treadmill exercise are likely to be applicable to free-
living conditions.   
 
The combined findings of this thesis suggest that small increments in activity beyond sitting, 
especially standing, could be efficient and feasible behaviours to replace sedentary 
behaviour. Targeting such facets of individuals’ behaviour, particularly obese adults who are 
likely to be the most susceptible to the health risks associated with prolonged sitting. This 
thesis also achieved the initial and crucial steps towards the developing novel algorithms to 
predict additional physiological measurements using accelerometer devices, which with 
future work will allow accelerometers to produce accurate and informative physiological 
measurements to assess physical activity behaviour in free-living conditions. 
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1. Introduction and Literature Review 
 The prevalence of cardiovascular disease 
Cardiovascular diseases (CVDs) are a group of disorders of the heart and blood vessels. 
Coronary heart disease and stroke have emerged as main areas of concern for researchers. 
These conditions arise from  a build-up of fatty deposits inside the arteries precipating an 
increased risk of blood clots on the inner walls of the blood vessels which supply the brain 
and heart (WHO 2011).  Several studies have documented that cardiovascular disease (CVD) 
is one of the major causes of death worldwide, accounting for more than 17.3 million deaths 
per year in 2012 and 2013; this, is expected to rise to more than 23.6 million by 2030 
(Mozaffarian et al. 2016;WHO 2011). In 2014, cardiovascular disease was the cause for a 
second highest cause of all deaths in the UK with 26% of all female deaths and 28% of male 
deaths Table 1-1. There are around 7 million people living with cardiovascular disease in 
the UK: 3.5 million men and 3.5 million women (BHF Heart Statistics 2016). The cost of 
CVD to the UK economy was £29.1 billion in 2004 (Luengo-Fernandez et al. 2006) and in 
England, more than £6.8 billion was spent on treating CVD in 2012/2013 (Bhatnagar et al. 
2015).  Each year around £11 billion is spent on healthcare costs relating to cardiovascular 
disease. Data from several studies suggest that the risk of cardiovascular disease can 
prevented by addressing behavioral risk factors. 
Table 1-1: Deaths by cause and sex, UK 2014 (men, and women) (Bhatnagar et al. 2015). 
Deaths by cause (%) Men Women 
Hypertensive Disease 2,743 (1%) 3,975 (1%) 
Coronary heart disease 41,364 (16%) 27,799 (10%) 
Other heart disease 11,090 (4%) 14,737 (5%) 
Stroke 16,222 (6%) 23,060 (8%) 
All cardiovascular disease 78,240 (28%) 76,399 (26%) 
Cancer 8,666 (32%) 78,916 (27%) 
Respiratory disease 36,344 (14%) 38,938 (14%) 
Diabetes 3,018 (1%) 3,295 (1%) 
Dementia and Alzheimer 19,187 (6%) 38,724 (13%) 
All other causes 53,000 (18%) 55,614 (19%) 
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 Risk factors for cardiovascular disease 
Anumber of factors influence risk of CVD which can be divided into non-modifiable and 
modifiable risk factors. A subset of modifiable risk factors are behavioral risk factors. These 
are described below and in Table 1-2. 
 Non-modifiable risk factors 
Family history, sex, ethnicity and age are factors which cannot be modified. The risk of CVD 
increases approximately by 3-fold with each decade of life (Finegold et al. 2013). Patients 
with a family history of coronary artery disease have a higher prevalence of CVD (45% 
higher odds with sibling history) and stroke (50% higher odds with history in a first-degree 
relative) (Mozaffarian et al. 2016). Men have higher risk of CVD than premenopausal 
women, but after menopause the protection associated with being female is attenuated 
(Edmunds and Lip 2000) . Individual of South Asians or Afro-Caribbean or African-
American ethnicity are at increased risk of CVD mortality than White Europeans (Cappuccio 
1997). In addition, the risk of stroke is higher than White Europeans in Blacks, some 
Hispanic Americans, Chinese, and Japanese populations (Cappuccio 1997). 
 Major modifiable risk factors  
Obesity is an independent risk factor in the incidence and development of cardiovascular 
disease. In Scotland in 2014, 69% of men 61% of women, aged ≥ 16 were overweight (BMI 
≥ 25 kg/m2) and 26% of men and 29% of women were obese (BMI ≥ 30 kg/m2). In the UK 
26% of men and 24% of women are obese (Bhatnagar et al. 2015). A recent individual-
participant-data meta-analysis of data from the Global BMI Mortality Collaboration, 
incorporating over 10 million participants, reported a hazard ratios of 1.42 per 5 kg.m-2 
increase in BMI above 25 kg.m-2 for coronary heart disease and stroke (Global BMI et al. 
2016).  
Diabetes Mellitus (DM) is defined as a metabolic condition in which the pancreas does not 
produce sufficient insulin to regulate blood glucose levels or where the insulin produced is 
unable to work efficiently (WHO. 2015). DM is one of the key factors driving increasing 
rates of CVD, such as CHD and stroke having the condition approximately doubles the risk 
of developing CVD disease (BHF Heart Statistics 2016). According to British Heart 
Foundation 3.5 million adults in the UK have been diagnosed with diabetes, with 10% of 
those diagnosed are living with Type 1 diabetes and 90% with Type 2. In the United States, 
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data from NHANES 2009 to 2012 was reported that 21.1 million adults have diagnosed DM, 
8.1 million adults have undiagnosed DM, and 80.8 million adults (35.3%) have prediabetes 
(eg, fasting blood glucose of 100 to < 126 mg/dL) (Mozaffarian et al. 2016). Obesity is a 
key risk factors for diabetes. Individuals with a BMI of 25kg/m2 have a 5 times greater risk 
for developing diabetes than those with a BMI <20kg/m2 with increments rising up to 93 
times for those with a BMI >35kg/m2 (Astrup and Finer 2000). The two conditions share 
causative factors, but do not necessarily lead to one another. However the development of 
diabetes/insulin resistance in the obese leads to an exponential rise in CV mortality (Astrup 
and Finer 2000).  
High blood pressure is defined as constant systolic and diastolic blood pressure (BP) above 
140/90mmHg (Mackay and Mensah 2004). 30% of adults in the UK have high blood 
pressure and up to half are not receiving treatment (BHF Heart Statistics 2016). Data from 
NHANES 2011 to 2012 observed that 17.2% of US adults are not aware they have 
hypertension. The prevalence of hypertension in men and women ≥ 18 years of age was 
29.7% and 28.5%, respectively (Mozaffarian et al. 2016). Moreover, higher risk has been 
indicated in those aged between 40 and 89 years, as for every 20mmHg systolic or 10mmHg 
diastolic increase in blood pressure is a doubling of stroke ischaemic heart disease mortality 
(Lewington et al. 2002). Unhealthy diet is estimated to be accountable for half of 
hypertension whereas physical inactivity and obesity are both accountable for about 2% each 
(Bhatnagar et al. 2015) 
Cholesterol is a fatty substance transported by in the circulation in particles called 
lipoproteins. While many lipoprotein subclasses exist, broadly speaking low-density 
lipoproteins (LDL) are the most atherogenic lipoprotein species which carry cholesterol from 
the liver to the cells, and high-density lipoprotein (HDL) is responsible for reverse 
cholesterol transport, carrying cholesterol away from the cells and back to the liver to be 
broken down, and are associated with lowering of atherogenic risk (Mackay and Mensah 
2004). High level of cholesterol can led to atherosclerosis, limiting blood flow through the 
arteries and increasing the possibility of heart attack and stroke. High total cholesterol TC, 
low-density lipoprotein LDL-cholesterol and triglyceride levels TG, and low levels of high-
density lipoprotein HDL-cholesterol can increase the risk of coronary heart disease and 
ischaemic stroke. Beyond this, there is a substantial body of evidence that high levels of 
triglyceride, particularly in the postprandial state, is associated with increased CVD risk and 
are mechanistically implicated in the atherosclerotic disease process (Bansal et al. 
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2007;Chapman et al. 2011; Goldberg et al. 2011; Mora et al. 2008; Nordestgaard et al. 
2007). 
 Behavioural modifiable risk factors 
Daily smoking is one of the top three leading risk factors for CVD and contributed to an 
estimated  6.2 million deaths in 2010 (Mozaffarian et al. 2015).  Nearly one in five adults in 
the UK smoke cigarettes which close to 10 million adults, and 20.000 UK deaths from CVD 
disease can be attributes to smoking each year (BHF Heart Statistics 2016). In England in 
2013, an estimated 78,200 deaths among adults aged 35 and around 17% among older were 
attributed to smoking (Bhatnagar et al. 2015).  
A number of dietary factors as associated with CVD risk.  There is evidence that diets high 
in saturated fat intakes are associated with higher CVD risk and replacement of saturated 
with unsaturated fats leads to lower risk (Sacks et al. 2017). Data on the association between 
carbohydrate intake and CVD risk is less clear. Replacing saturated fat with refined 
carbohydrates and sugars does not appear to reduce CVD risk, (Sacks et al. 2017), but diets 
high in complex carbohydrates, particularly low glycaemic index carbohydrates may lead to 
lower CVD risk (Fleming and Godwin 2013). Increasingly, dietary studies are moving 
beyond considering single nutrients and are instead investigating dietary patterns. There is 
increasing evidence that adopting a Mediterranean diet, characterised by high intakes of 
vegetables, legumes, fruit, nuts, grains and fish is associated with lower CVD risk (Sacks et 
al. 2017). A meta-analysis of prospective cohort studies showed that each 2% of calories 
from unsaturated fat was associated with a 23% higher risk of CHD (RR, 1.23; 95% CI, 
1.11–1.37) (Mozaffarian et al. 2016). 
Physical inactivity, defined as an activity level insufficient to meet public health guidelines 
(Department of Health 2011), has been identified as the fourth leading risk factor for 
mortality, CHD  and type 2 diabetes (WHO 2011). Insufficient physical inactivity is 
associated with an increase the risk of all-cause mortality by 20%–30% and also is one of 
the key factors in prediabetes, diabetes and hypertension. 150 minutes of physical activity 
of moderate intensity per week can reduce the risk of Ischemic heart disease and diabetes 
risk by 30%, and 27% respectivly (Al-Nooh et al. 2014). 
Recent evidence indicates that sedentary behaviour, which includes watching TV, overall 
daily sitting time, and time spent sitting in cars is another factor associated with increased 
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risk of cardiovascular disease and all-cause mortality (Owen et al. 2010b). Sedentary 
behaviour is one of the modifiable key factors driving increasing rates of CVD (Bauman et 
al. 2013), and sedentary behaviour in adults has shown reasonable evidence of a causal 
relationship with all-cause mortality (Biddle et al. 2016).  The work in this thesis, and the 
remainder of this chapter will focus mostly on sedentary behaviour and physical inactivity. 
Table 1-2: Risk Factors (Mackay and Mensah 2004). 
Major Modifiable Risk 
Factors 
Behavioural Modifiable 
Risk Factors 
Non-Modifiable Risk 
Factors 
Abnormal blood lipids Tobacco use Heredity or family history 
High blood pressure Unhealthy diets Age 
Diabetes mellitus Physical inactivity Gender 
Obesity Sedentary behaviour Ethnicity or race 
 Physical activity and cardiovascular disease 
Physical activity has been defined as  “any bodily movement produced by skeletal muscles 
that results in energy expenditure above the basal metabolic level” (Vanhees et al. 2012). 
Within this overall definition, light intensity physical activity (LTPA) has been defined as 
those activities that increase energy expenditure at the level of 1.6–2.9 METs (where 1 MET 
is equivalent to resting metabolic rate) such as slow walking (less than 2.0mph) (2.0 METs), 
cooking (2.0 METs), and washing dishes (1.8 METs) and moderate-to-vigorous physical 
activity (MVPA) is defined as activities with an energy expenditure of at least 3 METs (Carr 
and Mahar 2012). A large body of epidemiological evidence has shown that engaging in 
high levels of MVPA is associated with lower risk of a number of adverse health outcomes 
including CVD and diabetes (Hu et al. 1999; Manson et al. 2002; Nocon et al. 2008; 
Wijndaele et al. 2011). According to (WHO 2017),  adults (18-64 years) should accumulate 
at least 150 minutes of moderate-intensity aerobic activity such walking, cycling, or 75 
minutes (1 h and 15 min) of vigorous-intensity aerobic activity such as running, throughout 
the week. Physical activity can reduce the risk of CVD events by 30% to 50% (Mozaffarian 
et al. 2008). Warburton et al (Warburton et al. 2010) undertook a systematic review of 
prospective cohort investigations including over 200 studies of male and female subjects 
from all over the world, between 1985 and 2007. Overall these studies found a 31% reduction 
in all-cause mortality in more active compared with less active individuals and a reduction 
in mortality risk of 45% for fit comparted with unfit individuals. The fit and physically active 
had a 42% lower diabetes risk than their inactive and unfit counterparts.  
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In recent years, there has been growing evidence that other aspects of activity behaviours 
beyond moderate-to-vigorous physical activity are also associated with health outcomes. In 
particular, sedentary behaviour has been highlighted as a behaviour associated with adverse 
health outcomes.  
 The definition of sedentary behaviour, physical inactivity and 
physical activity 
The word ‘sedentary’ comes from the Latin ‘sedere’ (to sit) and can refer to any waking 
sitting or reclining posture, such as watching television, using the computer, driving a car, 
or lying behaviour and other forms of screen based entertainment with low energy 
expenditure at the level of 1.0 – 1.5 metabolic equivalent units (METs) (Thorp et al. 2011; 
Tremblay et al. 2017; Wilmot et al. 2012), with 1MET being equivalent to the amount of 
energy expended during rest (Ainsworth et al. 2000; Jette et al. 1990).  
 Historically, many researchers have typically used the phrase sedentary lifestyle to represent 
people who are physically inactive but more recently sedentary behavior has been defined 
as low energy sitting (or reclining) during waking hours (Mark 2012), thus excluding sleep 
or seated exercise. It is, essentially, ‘sitting time’ rather than ‘lack of exercise’. Thus, it is 
possible for a person to meet PA guidelines and also spend a large proportion of the day 
sedentary. For example if someone does 30 min of MVPA in the evening but sits for the rest 
of the day, they are meeting PA guideline, but also highly sedentary. Figure 1-1 shows the 
continuum of PA and sedentary behavior (Dempsey et al. 2014;Saunders et al. 2014).  There 
is evidence which has shown that being sedentary and being inactive are different constructs 
and have a differential effect on health factors such as cardiovascular disease (CVD), some 
types of cancer, diabetes and all-cause mortality (Hamilton et al. 2008; Lynch 2010; Wilmot 
et al. 2012). Hamilton et al (Hamilton et al. 2007) mentioned that the term sedentary includes 
a sense of “lack of exercise”, and is not limited to the original Latin definition of sitting. This 
has led to the inclusion of standing time with sitting in the classification of sedentary in some 
studies. However, a systematic review undertaken by Thorp et al (Thorp et al. 2011) 
concluded that, standing should not be assigned as “a sedentary activity”, suggesting that the 
term sedentary should be used to refer only both seated and reclining posture. Thus, standing 
activity, even at low energy expenditure, can be defined as non-sedentary (Ainsworth et al. 
2011). The corollary of this is that sedentary behaviour should be studied as a unique 
behavior that is distinct from physical activity (Dempsey et al. 2014; Saunders et al. 2014). 
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However, this view is not unequivocal. Gibbs et al, defined, sedentary behavior by intensity 
only without an additional posture component with sedentary behaviour characterised as any 
waking behaviour or activity at the level of ≤ 1.5 (METs), Here, light activity was defined 
as 1.5 - 2.9 METs, moderate activity as 3.0 - 5.9 METs and vigorous activity as ≥ 6.0 METs. 
Thus the difference between the definitions is that quiet standing would be included as 
sedentary behavior by the intensity definition, but not by the posture and intensity definition. 
Thus, there is debate about which definition should be used and how sedentary behaviour 
should be assessed. (Gibbs et al. 2015). There is also debate on the MET values range that 
should be ascribed to sedentary behavior.  According to Sedentary Behaviour Research 
Network (Sedentary Behaviour Research Network 2012), sedentary behavior defined as 
“any waking behavior characterized by an energy expenditure of ≤ 1.5 METs while in a 
sitting or reclining posture”. On the other hand, Ainsworth has coded MET values from 1.0 
- 2.5 for time spend in sedentary behavior such as that sitting at a desk, sitting in a vehicle, 
watching TV, while, standing activities, which are not categorized as sedentary, are coded 
with a MET value of 1.5 (Ainsworth et al. 2011). Moreover, another sitting activity, for 
example, playing games (often classified as sitting time in self-report questionnaire) 
categorized to have 4.5 MET values (O'Donovan et al. 2012). 
 
Figure 1-1: Continuum of time spent sitting (left side) and in MVPA (right side) as 2 distinct classes of 
behaviour. Plus signs = healthier behaviour pattern, minus signs = riskier behaviour pattern. (Dempsey 
et al. 2014;Saunders et al. 2014).  
 
 The prevalence of sedentary behaviour 
Over the past few decades, the way in which we live our daily lives has changed rapidly.  
Technological advances and societal changes have significantly influenced the way we 
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spend our leisure and work time, resulting in considerable proportions of the day spent 
sedentary. The prevalence of sedentary time has been described in a number of international 
studies. The average weekday time spent sitting in 32 European countries was 309 minutes 
per day, equating to 5-6 hours of sitting per day (Bennie et al. 2013), similarity, the average 
time engaged in sedentary was 300 minutes per day across 20 International countries 
(Bauman et al. 2011). Also, Milton et al (Milton et al. 2015) observed the prevalence of 
sedentary time in 27 European countries and the results indicated that the average daily time 
spent sitting in evaluated countries was 292 minutes per day in 2013. It is important to 
recognise that these studies measured sedentary time from mostly developed countries, the 
outcomes therefore cannot be generalised to lower- income nations. Furthermore, in all 
studies, a self-report questionnaires were used to quantify time spend sitting. However, the 
IPAQ questionnaire have been reported to underestimate sedentary behaviour and has poor 
validity (Atkin et al. 2012). Estimates from objective monitoring of sedentary behaviour in 
the US showed that adults spent 55 % - 57 % of their waking day engaging in sedentary 
pursuits (Healy et al. 2008b;Matthews et al. 2008), which is substantially higher than the 
estimates from self-report. 
Over the past five decades there has been a significant reduction in the proportion of people 
who are employed in physically active occupations and on the other hand there has been a 
growth in the proportion of employees in more sedentary jobs (Church et al. 2011). These 
type of sitting occupations usually involve prolonged bouts of sitting time at an office desk 
or driving a vehicle. A recent study in office workers indicated that individuals  spent a 
greater proportion of time in sedentary behaviour during working hours (68% vs 60%) and 
less time in light-intensity physical activity (28% vs 36%) compared to non-working days. 
Overall, these adults spent up to 71% of their working days sedentary (Clemes et al. 2014a). 
In comparison to the international epidemiological studies mentioned above, researchers 
have demonstated that office workers are sedentary for approximately 10 hours/day (Clemes 
et al. 2016; Clemes et al. 2014a; Clemes et al. 2014b). This shift towards sedentary 
occupations may have serious implications for health and well-being (Morris et al. 1953; 
Paffenbarger, Jr. 2000). 
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 Sedentary behaviours, diabetes, CVD disease, metabolic syndrome 
and all-cause mortality 
 In recent years, there has been a large number of observational studies (including 
prospective cohort studies) investigating the association between sedentary behaviour 
(sitting) and health outcomes. Studies have shown that individuals can spend 50 – 60% their 
waking hours in sedentary activities (Edwardson et al. 2012; Wilmot et al. 2012). Several 
recent reviews have highlighted the health risks linked to this type of conduct, such as 
metabolic syndrome (Edwardson et al. 2012; Wijndaele et al. 2011), type 2 diabetes (Ford 
et al. 2010; Hu et al. 2001; Hu et al. 2003; Zhang et al. 2006), cancer, CVD and all-cause 
mortality (Katzmarzyk et al. 2009; Patel et al. 2010; Stamatakis et al. 2011). A considerable 
number of systematic reviews and meta-analyses have been published summarising the 
available evidence on sedentary behaviour and health outcomes. These studies are 
summarised in Table 1-3. In a meta-analysis including 16 prospective and 2 cross-sectional 
studies, with a total 794,000 participants from all over the world Wilmot et al (Wilmot et al. 
2012) reported that individuals spending the greatest time spent sedentary compared to the 
lowest time spent sedentary had 112% higher relative risk (RR) for diabetes, 147% higher 
risk of cardiovascular disease, 90% higher risk of cardiovascular mortality  and 49% higher  
of all-cause mortality. Similarly, in a meta-analysis of 10 cross-sectional studies with a total 
of 21,393 participants Edwardson and colleagues reported that high levels of sedentary 
behaviour were associated with increased risk of the metabolic syndrome by 73% (OR 1.73, 
95% CI 1.55 – 1.94, p < 0.0001) (Edwardson et al. 2012). Importantly, the results remained 
largely unchanged when only studies which adjusted for physical activity were included (OR 
1.73, 95% CI 1.54 –1.97, p < 0.0001).  
Some meta-analyses considered specific aspects of sedentary behaviour. In a meta-analysis 
including 11 prospective (cohort, case-cohort, and nested case-control) studies and at total 
of 236,700 adults, Grontved and Hu (Grontved and Hu 2011) assessed the association 
between TV viewing and risk of diabetes, fatal or nonfatal CVD, and all-cause mortality, 
showing that watching more than 2 hours of TV per day was associated with a 13% higher 
risk of all-cause mortality, a 15% higher risk of fatal or non-fatal CVD, and a 20% higher 
risk of diabetes. The pooled relative risks of watching TV for 2 hours per day was 1.13; 95% 
CI = 1.07-1.18) P < 0.001 of all-cause mortality, 1.15; 95% CI = 1.06 - 1.23) p< 0.001 of 
fatal or non-fatal cardiovascular disease, and 1.20; 95% CI, 1.14 - 1.27) p< 0.001 of diabetes. 
The absolute risk differences per every 2 hours of TV viewing per day were 176 cases of 
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type 2 diabetes, 38 cases of fatal cardiovascular disease, and 104 deaths for all-cause 
mortality per 100 000 individuals per year. Similarly, Ford and Caspersen  (Ford and 
Caspersen 2012) evaluated the  associations between screen time (TV viewing, watching 
videos and using a computer) and total sedentary time and CVD in a meta-analysis of nine 
prospective studies, with 496,394 participant, aged ≥18 to 90 years. The summary hazard 
ratio for CVD risk per 2-hour increase in sitting time was 1.05 (95% CI 1.01-1.09), in 
contrast the summary hazard ratio for CVD risk per 2-hour increases in TV viewing time 
substantially higher 1.17 (95% CI 1.13-1.20).  Thus, it appears that TV viewing has a 
stronger association with adverse health outcomes than overall sedentary behaviour.  
The study findings suggest that substituting sedentary behaviour with standing or light-
intensity physical activity may reduce the risk of chronic disease and mortality, independent 
of the amount of MVPA undertaken. This implies that reduction of sedentary time may 
impact prevention of these diseases. This research attempts to show that the risk of sedentary 
behavior seems to be independent of physical activity. There is an urgent need to further 
investigate the impact of reducing sedentary time on metabolic syndrome.  
A systematic review done by Thorp et al (Thorp et al. 2011) examined the relationship 
between self-reported and device-based measures of prolonged sitting with diabetes, 
cardiovascular disease, obesity and all-cause mortality in adults across 48 longitudinal 
studies from 1996 to 2011. All of the participants were aged more than 18 years. This study 
measured different types of sitting time, such as, TV screen time only, TV screen time and 
other screen-time behaviour, and TV screen time plus other sedentary behaviour. Sedentary 
behaviour here refers to sitting during commuting, in the place of work and the household 
environment, and during free time. Overall, there seems to be some evidence to indicate that 
prolonged sitting, especially in relation to TV viewing time and other screen-based activities 
with increased snacking behaviour, is positively associated with increased risk health 
outcomes such as obesity, cholesterol/lipids, metabolic syndrome and type 2 diabetes. Sitting 
in front of the TV was strongly associated with the consumption of energy-dense snacks, 
soft drinks and fast food, and was consistently inversely associated with fruit and vegetable 
consumption and also can influence the type of food they desire and consume, resulting in a 
lack of awareness of actual food consumption or overlooking food sign that may lead to 
overconsumption (Pearson and Biddle 2011). 
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A recent meta-analyses on 47 prospective cohort studies was undertaken by Biswas et al 
(Biswas et al. 2015). The aim of this paper was to review recent research into the association 
between sitting time, hospitalizations, all-cause mortality, cardiovascular disease, diabetes, 
and cancer. It was observed that, greater sedentary time was positively associated with an 
increased risk for cardiovascular disease (HR, 1.14 [CI, 1.00 to 1.73]), cardiovascular 
disease mortality (HR, 1.18 [CI, 1.11 to 1.26]), all-cause mortality (HR, 1.24 [95% CI, 1.09 
to 1.41]),  cancer mortality (HR, 1.17 [CI, 1.11 to 1.24]),  cancer (HR, 1.13 [CI, 1.05 to 
1.21]), and type 2 diabetes (HR, 1.91 [CI, 1.64 to 2.22]), but the main statistical impact was 
associated with the risk for type 2 diabetes. Moreover, sitting less than < 8h per day was 
associated with lower risk of potentially preventable hospitalization by 14% (HR, 0.86 [CI, 
0.83 to 0.89]). The multivariate regression model (the technique to estimate a single 
regression model with more than one input variable), was adjusted for age, sex, education, 
marital status, income, geographic remoteness of residence, language, health insurance, 
chronic disease history, previous admission for potentially preventable hospitalization, 
MVPA, and other health behaviors. The most striking result to emerge from the data is that 
prolonged sitting time is independently associated with greater risk for all-cause mortality, 
cardiovascular disease and type 2 diabetes, regardless of PA. However, the risk associated 
with sedentary time was lower among people who participated in higher levels of PA 
compared with lower levels. 
In 2013, Chau et al (Chau et al. 2013) published a paper in which they described the 
relationship between the daily total sitting and all-cause mortality risk in adults using meta-
analysis. Six prospective studies were accepted with 595,086 participants, aged ≥ 18. 
Sedentary behaviour was measured by using self-report or accelerometer. Each additional 
hour of daily sitting in intervals 0-3, > 3-7 and > 7 h/day total sitting time is associated with 
increase the risk of all-cause mortality, the HRs were 1.00 (95% CI: 0.98 - 1.03), 1.02 (95% 
CI: 0.99 - 1.05) and 1.05 (95% CI: 1.02 - 1.08) respectively, adjusted for MVPA. Sitting for 
more than 10 h/day had 34% (HR = 1.34, 95% CI: 1.28 - 1.40) and 52% (HR = 1.52, 95% 
CI: 1.46 - 1.58) increased the risk all-cause mortality with and without adjusting for physical 
activity, respectively. Physical activity partly attenuated the increased risk associations 
between prolonged sitting and all-cause mortality, especially in those who spent the most 
time in sitting. 
Another systematic review was undertaken by Van Uffelen et al. The purpose of this paper 
was to systematically review the recent evidence on association between occupational sitting 
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and BMI (12 studies); cancer (17 studies); cardiovascular disease (8 studies); diabetes 
mellitus (4 studies); and mortality (6 studies). Of the 43 papers identified, 21% were cross-
sectional, 14% were case control and 65% were prospective cohort studies. Only five cross-
sectional studies out of ten confirmed a positive relationship between sitting and BMI, five 
of the 17 studies showed there was a relationship between sitting and higher risk of cancer. 
Moreover, there was association between sitting and increase the risk of CVD in four studies. 
Two prospective and one cross sectional showed a positive association between sitting and 
diabetes. Finally, four prospective studies found a positive relationship between sitting and 
mortality (van Uffelen et al. 2010). 
Shen and colleagues undertook a systematic review and meta-analysis to examine the 
association between sedentary behavior and incident cancer. A total of 17 prospective studies 
were identified in the systematic review, including 857,581 participants and 18,553 cases. 
The present study was determined that time spent in sedentary behaviour was associated 
with increased risk of cancer (RR = 1.28, 95% CI = 1.08 – 1.53), in endometrial cancer, (RR 
= 1.30, 95% CI = 1.12 – 1.49), in colorectal cancer, (RR = 1.17, 95% CI = 1.03 – 1.33), in 
breast cancer, (RR = 1.27, 95% CI = 1.06 – 1.52), in lung cancer. However, there was no 
association of sedentary behaviour with ovarian cancer (RR = 1.26, 95 % CI = 0.87 –1.82), 
renal cell carcinoma (RR = 1.11, 95% CI = 0.87 – 1.41) or non-Hodgkin lymphoid neoplasms 
(RR = 1.09, 95% CI = 0.82 – 1.43) (Shen et al. 2014). 
One of the most important recent meta-analyses was undertaken by Ekelund and colleagues 
in 2016 (Ekelund et al. 2016).  This study aimed to address the following research question: 
“Does physical activity attenuate, or even eliminate, the detrimental association of sitting 
time with mortality?”. Sixteen prospective studies were identified as potentially relevant, 
with an overall sample size across the studies of 1,005,791 participants. In all studies, self-
report questionnaires were used to assess physical activity and sedentary behaviour. Sitting 
time and TV-viewing time were categorised into four groups each. In the least active quartile 
(≤ 2.5 MET-h per week), those sitting > 8 h/day had significantly increased risk of mortality 
compared with those who sat the least (HR = 1.27, 95% CI = 1.22 – 1.32).  However, in the 
most active quartile (>35 MET-h per week) the hazard ratio associated with sitting > 8 h/day 
was not statistically significant (HR = 1.04, 95% CI = 0.98 – 1.10). This suggest that physical 
activity appears to eliminate the excess risk associated with prolonged sitting. In comparison, 
TV viewing for more than 5h/day was associated with increased risk of mortality at all levels 
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of physical activity. These results are in agreement with those obtained by Chau and Wilmot 
(Chau et al. 2013; Wilmot et al. 2012). 
Thus, the available evidence suggests that high levels of sedentary behaviour are associated 
with increased risk of a number of adverse health outcomes. There is also increasing 
evidence that the pattern of sedentary behaviour as well as the total volume may be 
associated with some health outcomes.  This will be considered in the next section.   
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Table 1-3: Meta-analyses of epidemiological studies investigating the association between sedentary behaviours and health outcomes. 
 Meta-
analysis 
Sample  Exposure measure  outcome confounders Main finding 
1 Wilmot et al 
2012 
16 prospective and 2 cross-
sectional studies with a total of 
794,577 participants, aged ≥ 18 
 
 
Self-reported 
Sedentary time 
T2DM,  
CVD, and 
all-cause 
mortality 
Adjusted for 
baseline event 
rate, BMI or waist 
circumference 
Comparing the highest vs. the lowest sedentary time increased the relative 
risk of T2DM by 112% (RR 2.12 ; 95 % credible interval [CrI]1.61, 2.78),  
 
147% increase in the risk of cardiovascular disease (RR 2.47 ; 95 % CI 1.44, 
4.24),  
 
90% increase in the risk of cardiovascular mortality (HR 1.90; 95% CrI 1.36, 
2.66)  and 
 
49% increase in the risk of all-cause mortality (HR 1.49; 95% CrI 1.14, 2.03) 
2 Grontved 
and Hu 
2011 
11 studies (Prospective cohort, 
Case cohort , and nested case-
control designs) with a total of 
236,700 participants, aged 
> 18 years 
Self-reported 
Television viewing 
T2DM,  
fatal or 
non-fatal 
CVD, and 
 all-cause 
mortality 
Dietary variables, 
BMI 
Watching TV for >2 hours per day was associated with a 13% increase in the 
risk of all-cause mortality (RR=1.13; 95% CI=1.07-1.1) P < 0.001. 
 
15% increase in the risk of fatal or non-fatal cardiovascular disease (RR1.15; 
95% CI = 1.06 - 1.23) p < 0.001, and 
 
20% increase in the risk of diabetes 1.20; 95% CI, 1.14 - 1.27) p < 0.001. 
3 Edwardson 
et al. 2012 
10 Prospective and cross-
sectional studies with a total of 
21,393 participants, aged 
> 18 years 
Self-report and 
accelerometer 
measured sedentary 
behaviour 
Metabolic 
syndrome 
BMI Sedentary behaviour increased risk of metabolic syndrome by 73% (OR 1.73, 
95% CI 1.55 – 1.94, p < 0.0001) 
4 Ford and 
Caspersen 
2012 
9 Prospective studies with a 
total of 496,394 participants, 
aged 
≥ 18 
 
 
 
Screen and sitting 
time assessed by Self-
report, accelerometer 
and heart rate monitor 
Fatal and 
non-fatal 
CVD 
Adjusted for 
several cardio 
metabolic factors 
Summary hazard ratio for CVD risk per 2-hour increases in sitting time was 
1.05 (95% CI 1.01-1.09). Summary hazard ratio for CVD risk per 2-hour 
increases in TV viewing time was 1.17 (95% CI 1.13-1.20).  
Compared with lowest levels of sedentary time, risk estimates for fatal and 
non-fatal CVD ranged up to 1.68 for the highest level of sedentary time, and 
2.25 for the highest level of screen time sitting. 
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5 Biswas et al 
2015 
47 Prospective and cross-
sectional studies with a total of 
2,125,989 participants, aged 
> 18 years 
Self-reported 
sedentary behaviour 
CVD, 
T2DM, 
cancer, 
all-cause 
mortality 
MVPA, age, sex,  
and other health 
behaviors 
Comparing the highest vs. the lowest sitting time increased the hazard ratio 
of CVD disease by 14% (HR, 1.14 [CI, 1.00-1.73]),and  
 
18% increase in the risk of cardiovascular disease mortality(HR, 1.18 [CI, 
1.11 to 1.26]) 
24% increase in the risk of all-cause mortality (HR, 1.24 [95% CI, 1.09 to 
1.41]) 
17% increase in the risk of cancer mortality (HR, 1.17 [CI, 1.11 to 1.24]) and 
13% (HR, 1.13 [CI, 1.05 to 1.21]) for cancer. 
 
91% increase in the risk of type 2 diabetes (HR, 1.91 [CI, 1.64 to 2.22] 
 
 
6 Chau et al 
2013 
6 Prospective studies with a 
total of 595,086 participants, 
aged > 18 years 
 
 
Sedentary behaviour 
assessed by self-
report and 
accelerometer 
All-cause 
mortality 
MVPA Each additional hour of daily sitting in intervals 0-3, > 3-7 and > 7 h/day 
total sitting time is associated with increase the risk of all-cause mortality, 
the HRs were 1.00 (95% CI: 0.98 - 1.03), 1.02 (95% CI: 0.99 - 1.05) and 
1.05 (95% CI: 1.02 - 1.08) respectively. 
 
Sitting for more than 10 h/day had 34% (HR = 1.34, 95% CI: 1.28 - 1.40) 
7 Shen et al 
2014 
17 prospective studies with a 
total of 857,581 participants, 
aged >40 years 
 
Self-reported total 
sitting time, 
occupational sitting, 
leisure sitting time or 
TV viewing 
Cancer BMI, PA and 
energy intake 
Time spent in sedentary behaviour was associated with increased risk of 
cancer (RR = 1.28, 95% CI = 1.08 – 1.53), in endometrial cancer, (RR = 
1.30, 95% CI = 1.12 – 1.49), in breast cancer, (RR = 1.27, 95% CI = 1.06 – 
1.52), in lung cancer.  
8 Ekelund et 
al 2016 
16 prospective studies with a 
total of  1,005,791 participants, 
aged > 18 years 
 
 
Self-reported TV-
viewing time 
Mortality Sex, age and PA Sitting for <4 h/day with the lowest activity level ( <2.5 MET-h per week) 
had increased the hazard ratio of mortality by 27% (HR = 1.27, 95% CI = 
1.22 – 1.32).However, in the most active quartile (>35 MET-h per week) the 
hazard ratio associated with sitting > 8 h/day was not statistically significant 
(HR = 1.04, 95% CI = 0.98 – 1.10) 
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 Breaking-up sedentary time (observation studies) 
Another important aspect is the concept that interrupting extended periods of sitting may 
attenuate a proportion of the association with cardiovascular and metabolic health. Several 
cross-sectional studies have examined the relationship between sedentary breaks and risk 
factors associated with cardiovascular and metabolic risk. Table 1-4 lists observational 
studies that have examined the associations of breaking up sedentary behaviour and health 
outcomes in adults. The available evidence from prospective and cross-sectional studies 
suggested that the number of transitions or breaks sedentary time appear associated with 
some adverse biomarkers of metabolic health, such as BMI and waist circumference. These 
studies have all used an intensity-based definition of sedentary behaviour based on 
accelerometer counts from an Actigraph accelerometer, with ≤ 100 count/min defined as 
sedentary. Thus breaks in sedentary time could be defined by an increase in accelerometer 
counts above the >100 counts/min threshold. Accordingly, it is import to note that these 
studies are unable to distinguish between sitting and quiet standing, so a change from 
standing quietly to walking, as well as a change from sitting to upright activities, would be 
classified as a break in sedentary behaviour in these studies. Figure 1-2 provides an 
illustration of  typical profiles of individuals with long and short bouts of sedentary 
behaviour over the course of the day (Healy et al. 2008a).  
 
Figure 1-2: Sedentary time < 100 counts per min in the left-hand panel: Break in sedentary > 100 counts 
per min in the right-hand panel, recorded by accelerometer, but different ways of accumulation (Owen 
et al. 2010a)   
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Observational studies which have evaluated the association between breaks in sedentary 
behaviours and biomarkers of health are summarised in Table 1-4. In an observational study 
with 528 participants, Cooper et al (Cooper et al. 2012), considered the association of 
sedentary time and breaks in sedentary time on biomarkers of metabolic health in patients 
with type 2 diabetes. Waist circumference (WC), fasting HDL-cholesterol, insulin and 
glucose levels, HOMA-estimated insulin resistance (HOMA-IR), and physical activity 
(accelerometer) were measured at baseline and at 6 months follow-up. The results found that 
each hour of sedentary time was associated with larger WC (unstandardised regression 
coefficient [B] [95% CI] (1.89 cm [0.94, 2.83]), higher insulin (B = 8.22 pmol/l [2.80, 
13.65]), lower insulin sensitivity HOMA-IR (B = 0.42 [0.14, 0.70]), and lower HDL 
cholesterol (B = - 0.04 mmol/l [- 0.06 - 0.01]) (P < 0.005 for all). The number of daily breaks 
in sedentary time was associated with lower WC (B = - 0.15 cm [- 0.24, - 0.05] p = 0.003). 
Healy et al (Healy et al. 2008a) investigated the association between breaks of sedentary 
time and metabolic risk. An accelerometer was used to measure their sedentary time, for 
seven consecutive days, with <100 accelerometer counts per minute being defined as 
sedentary. An interruption in sedentary time was defined as an increase from < 100 counts 
per minute to >100 accelerometer counts per minute. As such, participants spent 57% of 
their waking hours sedentary, 39% in light intensity and 4% in moderate to vigorous activity. 
This research demonstrated that interruption of sedentary time has a beneficial effect on 
waist circumference (standardized B = - 0.16, P = 0.026), BMI (B = - 0.19, P = 0.026), 
triglycerides (B = - 0.18, P = 0.029), and 2-h plasma glucose (B = - 0.18, P = 0.025), adjusted 
for  age, gender, employment status, alcohol intake, income, education, smoking status, 
family history of diabetes, diet, moderate to vigorous activity MVPA, sedentary time, and 
the average activity intensity during the breaks. Thus these data provide preliminary 
evidence that more interruptions in sedentary time were beneﬁcially associated with 
metabolic risk variables independent of total sedentary time and moderate-to-vigorous 
intensity activity time. 
In addition, Healy et al (Healy et al. 2011) analysed cross-sectional data from 4757 adults in 
the US NHANES study, to observe the relationship between prolonged sitting and 
interruptions in sitting, on the one hand, and cardio-metabolic and inflammatory biomarkers, 
on the other.  It was found that increased sedentary time negatively affected several 
biomarkers, whereas increasing breaks, independent of total sedentary time, were associated 
with reduction of waist circumference and fasting plasma glucose.  
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Henson et al (Henson et al. 2013a)  performed a cross-sectional analysis of 878 adults at 
high risk of type 2 diabetes mellitus, reporting that breaks in sedentary behaviour were 
strongly and adversely associated with 2 h glucose concentration (β=−0.11 ± 0.055, p = 
0.05), waist circumference (β=−0.21 ± 0.05, p < 0.001)  and BMI (β=−0.15 ± 0.05,  p = 
0.003). However, further adjustment for BMI reduced the association with 2 h plasma 
glucose. Similarly, in a study of 1,367 older adults Bankoski et al (Bankoski et al. 2011), 
observed that people with higher sedentary time and fewer sedentary breaks had a large WC, 
low HDL cholesterol, high triglycerides, and metabolic syndrome (all p < 0.05), adjusted for 
age and sex. Another cross-sectional study by Henson et al (Henson et al. 2013b) observed 
that increased breaks in sedentary time, independent of MVPA, were beneficially associated 
with IL-6 (β = – 0.09 ± 0.05, p = 0.04) and leptin (β = – 0.07 ± 0.04, p = 0.04), in 552 adults 
(mean age 63.7 years, (SD 7.7) with high risk of type 2 diabetes mellitus T2DM. However, 
these relations were reduced when further adjusted for SB and MVPA. 
Current ﬁndings suggest that prolonged bouts of sitting time are positively related to 
metabolic risk, independent of physical activity. It is important to minimize sedentary time 
among older adults, but the most important part is reducing prolonged periods of 
uninterrupted sedentary time and increasing intermittent movements during sedentary time. 
Gupta et al (Gupta et al. 2016) used an isotemporal substitution approach in a group of 692 
workers to report that replacing 30 minutes/day of sedentary behaviours with 30 minutes/day 
of MVPA during whole day was significantly inversely associated with waist circumference 
[B (95% CI); -3.93 (- 6.62 to - 1.23) cm, BMI -1.28 (- 2.2 to - 0.35) kg/m2, and fat percentage 
[B (95% CI - 2.38 (-3.7 to - 1.06) %, (P < 0.05 for all).  
In conclusion, the findings from these studies emphasise that regardless of how long you are 
sedentary over the day, frequently interrupting sedentary time has a beneficial association 
on metabolic markers, particularly those related to adiposity variables, even if the 
interruptions are short and only involve light activity or standing. However, the cross-
sectional and observational nature of these data make it impossible to determine the direction 
of these relationships and potential causality. If these relationships are causal, these findings 
could have practical applications for interventions to attenuate or eliminate the negative 
deleterious health consequences of sedentary time as they suggest that small behavioural 
modifications could potentially have a considerable protective consequence. The beneficial 
results of breaking prolonged sitting on metabolic markers are best investigated using 
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controlled laboratory based intervention studies. In such sedentary studies, breaking in 
sedentary can be directly monitored and the acute or cumulative effects of sedentary on 
metabolic parameters can be observed. Human data from intervention studies supporting a 
causal role for sedentary behaviour in cardio-metabolic disease risk are particularly needed. 
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Table 1-4: Cross-sectional observational studies of the association between breaking sedentary behaviour and metabolic risk markers. 
 Author(Study) Design Sample/ 
country 
Measurement of breaks  Breaks unit Outcomes Confounders Main results 
1 ( Healy et al. 2008a ) 
Breaks in sedentary 
time: beneficial 
associations with 
metabolic risk. 
 
Cross-
sectional 
 
 
168, adults, age 
(SD) 
 53.4 ± 11.8 
years 
BMI(SD) 
27.2 ± 4.7 
 
Australia 
Actigraph (1-min epoch);  
*SB calculated as <100 
counts/min;  
*BSB defined as 
interruption from SB state 
to active state(≥100 
counts/min) for a 
minimum of 20 min  
* Non wear, continuous 0 
cpm  as intervals of 
60min     
Breaks per 
recording 
time (5 -7 
days) 
 
 
 
 
Waist 
circumference, 
BMI, 2-h 
glucose, insulin 
, triglycerides, 
HDL 
cholesterol, 
blood pressure 
Age, gender, alcohol 
intake, employment 
status, education, 
household income 
,smoking status, family 
history of diabetes, diet 
quality, PA time and SB 
tim 
Breaking up sedentary behaviour was 
associated with lower waist 
circumference (standardized B = - 0.16, P 
= 0.026),  BMI (B = - 0.19, P = 0.026), 
triglycerides (B = - 0.18, P = 0.029), 
, and 2-h plasma glucose (B = - 0.18, P = 
0.025), independent of total sedentary 
time and moderate-to-vigorous intensity 
activity time. 
2 (Healy et al. 2011) 
Sedentary time and 
cardio-metabolic 
biomarkers in US adults 
(NHANES03-06) 
 
Cross-
sectional 
 
 
4,757 adults, 
age ≥ 20 years 
  
 
US 
Actigraph(1-minepoch); 
 *SB is <100 counts/min;  
*LTPA (100 – 1951 cpm)  
*MVPA (≥1952cpm) 
*BS(≥100counts/min)  
 was considered as break  
* Non wear, continuous 0 
cpm as intervals of 60min 
Breaks per 
recording 
time     worn 
on the right 
hip for 4-7 
days 
Waist 
circumference, 
BMI,2-h plasma 
glucose, 
triglycerides, 
HDL 
cholesterol, 
insulin level,  
Age, sex, PA, smoking, 
alcohol intake, fat in diet, 
energy intake, 
hypertension, 
hyperlipidemia, medical 
history, family history, 
socio-economic status  
Comparing the lowest vs the highest, 
breaking sedentary time  [B (95% CI); 
99.2 (97,9 – 100.6) vs [B (95% CI); 95.1 
(94.0 – 96.1)  was associated with 
reduction of waist circumference, and 
fasting plasma glucose [B (95% CI); 5.55 
(5.46-5.64) vs [B (95% CI); 5.51(5.40-
5.62) respectively,independent of total 
sedentary time and PA. 
3 (Bankoski et al. 2011) 
Sedentary activity 
associated with 
metabolic syndrome 
independent of physical 
activity 
 
Cross-
sectional 
 
 
 
 
 
1,367, older 
adults, 
 665 with 
metabolic 
syndrome,  
age (SD)  
71.0 ± 7.4 years 
702 without 
metabolic 
syndrome, age 
(SD)71.0 ± 8.0 
U.S. 
Actigraph (1-min epoch) 
*SB defined as<100 
counts/min;  
*BSB defined as 
transition from SB state to 
active state (≥100 
counts/min)  
* Non wear, continuous 0 
cpm  as intervals of 
60min  
 
Breaks per 
day 
 
4 days 
 
 
 
 
 
 
 
 
Waist 
circumference, 
HDL 
cholesterol, 
triglycerides, 
fasting glucose, 
metabolic 
syndrome 
 
 
Age, gender, 
race/ethnicity, education, 
alcohol consumption, 
smoking status, BMI, 
self-reported diabetes and 
heart disease,PA and SB 
time 
 
 
Higher percentage of sedentary time out 
of total wear time (quartile 2: odds ratio 
[OR] 1.52 [95% CI 1.04–2.21]; and fewer 
sedentary breaks (quartile 3: 1.50 [1.02–
2.21]) were related to a signiﬁcantly 
increased likelihood of metabolic 
syndrome, independent of physical 
activity. 
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 Author(Study) Design Sample Measurement of breaks  Breaks unit outcomes Confounders Main results 
4 (Cooper et al. 2012) 
Sedentary time, breaks 
in sedentary time and 
metabolic variables in 
people with newly 
diagnosed type 2 
diabetes 
Cross-
sectional 
and 
longitudinal 
 
 
582 adults, 
 age 30 - 80 
years, newly 
diagnosed with 
type-2 diabetes 
 
UK 
Actigraph(1-minepoch); 
*SB defined as<100 
counts/min; 
* BSB defined as 
transition from SB state to 
active state(≥100 
count/min) 
*Nonwear time was ≥20 
min with continuous 0 
values  
Breaks per 
day 
 
measured 
for 5 - 7  
days 
Waist 
circumference, 
HDL 
cholesterol,  
glucose levels 
and  HOMA of 
insulin 
resistance   
Age, gender, current 
smoking status, family 
history of diabetes, lipid 
lowering or diabetes 
medication, PA and SB 
time 
The number of daily breaks in sedentary 
time was associated with lower WC (B = 
- 0.15 cm [- 0.24, - 0.05] p = 0.003). All 
associations were independent of levels 
of MVPA 
5 (Henson et al. 2013b) 
Sedentary time and 
markers of chronic low-
grade inflammation in a 
high risk population. 
 
 
 
 
 
Cross-
sectional 
 
 
 
 
 
 
 
558 adults, 
age (SD)  
63.6 ±7 .7 
BMI (SD)  
32.2 ± 5.2 
 
 
UK 
Actigraph GTX3(15-s 
epoch); 
*SB defined as < 25 
counts / 15s;  
*BSB defined as 
transition from SB state to 
active state (≥25counts / 
15s) for a minimum of 
15s 
*MVPA ( ≥ 488 counts 
per 15 seconds) 
 
Breaks per 
day 
7consecutive 
days during 
waking 
hours 
 
 
 
 
 
C-reactive 
protein, 
adiponectin, 
leptin,  
 
 
 
 
 
Age, gender, smoking 
status, ethnicity, social 
deprivation, anti hyper 
tensive medication, lipid-
lowering medication, 
aspirin, family history of 
diabetes, PA , and SB 
time 
 
 
 
 
Breaks in sedentary time were beneficially 
associated with lower IL-6 (β = – 0.09 ± 
0.05, p = 0.04) and leptin (β = – 0.07 ± 
0.04, p = 0.04), in people with high risk of 
type 2 diabetes mellitus T2DM, 
independent of total time spent in MVPA. 
 
 
6 (Henson et al. 2013a) 
Associations of 
objectively measured 
sedentary behaviour and 
physical activity with 
markers of 
cardiometabolic health. 
Cross-
sectional 
 
 
878 obese adults 
with high risk of 
diabetes, 
age (SD) 
 58 ± 13y 
BMI (SD) 
 32.5 ± 5.2 
kg/m2 
 
UK 
ActigraphGTX3(15-s 
epoch); 
*SB defined as < 25 
counts / 15s; 
* BSB defined as 
transition from SB state to 
active state (≥ 25 counts 
/15s) ,activity (≥ 25 to < 
488 counts per 15 s)  
* MVPA (≥488 counts 
per 15 s) 
Breaks per 
day 
4 - 7 
consecutive 
days during 
waking 
hours 
 
 
Waist 
circumference, 
BMI, impaired 
fasting glucose, 
triglycerides, 
HDL 
cholesterol, total  
Age, gender, smoking 
status, ethnicity, social 
deprivation, family 
history of type 2 diabetes 
mellitus, PA and SB time 
 
 
Significant beneficial association of 
breaks with waist circumference β=−0.21 
± 0.05, p < 0.001, BMI β=−0.15 ± 0.05, p 
= 0.003 and 2-h plasma glucose β=−0.11 
± 0.055, p = 0.05, independent of total 
time spent in MVPA and sitting time. 
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 Author(Study) Design Sample Measurement of breaks  Breaks unit outcomes Confounders Main results 
7 (Gupta et al. 2016) 
What Is the Effect on 
Obesity Indicators from 
Replacing Prolonged 
Sedentary Time with 
Brief Sedentary Bouts, 
Standing and Different 
Types of Physical 
Activity during 
Working Days? A 
Cross-Sectional 
Accelerometer-Based 
Study among Blue 
Collar Workers 
Cross-
sectional 
 
 
692 worker, age 
(SD)  
45.1 ± 9.9 years 
BMI (SD) 
27.5± 4.9 kg/m2 
 
Sweden 
ActigraphGT3X+ 
*Sedentary time was 
defined as (≤ 5 min), 
*Moderate(> 5and ≤ 30 
min) 
 *Long (> 30 min)bouts 
1– 4 
working 
days 
 
Obesity 
indicators, 
BMI(kg/m2), 
waist 
circumference 
(cm) and fat 
percentage 
Sex, age, smoking, 
alcohol intake, diet 
 
Replacing sitting time with MVPA   was 
significantly inversely associated with 
waist circumference [B (95% CI); -3.93 (- 
6.62 to - 1.23) cm, BMI -1.28 (- 2.2 to - 
0.35) kg/m2, and fat percentage [B (95% 
CI - 2.38 (-3.7 to - 1.06) %, (P < 0.05 for 
all). 
Breaking up sitting time with brief 
activity bouts was associated with lower 
waist circumference by ~3 – 5%; 
equivalent to a meaningful amount of 
~2.6 – 2.7cm, ~1.4 – 1.6% fat percentage, 
and ~ 0.8 – 0.9 kg/m2 BMI per 30min / 
day. 
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 Interrupting sedentary time (intervention studies) 
A number of studies have evaulated the effects of interventions to reduce or break up  in 
Table 1-5 and described below. 
Dunstan et al (Dunstan et al. 2012b) showed that in overweight and obese adults, breaking 
up periods of sitting with 2-min bouts of light-intensity activity every 20 min, resulted in a 
24% reduction in postprandial glucose incremental area under curve iAUC (5.2 mmol/L∙h 
(4.1 - 6.6), p < 0.01) and a 23% reduction in insulin iAUC (633.6pmol/L∙h (552.4 - 
727.1pmol/L∙h), p < 0.01), while sitting interrupted by moderate-intensity lowered 
postprandial glucose iAUC and insulin iAUC by 30 % (4.9mmol/L∙h (3.8 - 6.1); p < 0.01) 
and 23% (637.6 pmol/L∙h (555.5 - 731.9 pmol/L∙h), p < 0.01) respectively.  
Similarity, Peddie et al (Peddie et al. 2013) demonstrated that the regular-activity breaks 
intervention, walking for 1min 40s, twice per hour over 9h, reduced plasma glucose iAUC 
by 39%, 18.9 mmol∙L-1∙9hr-1 (95 % CI: 10.028.0 mmol.L-1∙9hr-1; p < 0.001) compared with 
the prolonged sitting and by 37%, 17.4 mmol.L-1.9hr-1 (8.4 - 26.3mmol.L-1.9hr-1; p < 0.001)  
compared with the physical activity intervention, which comprised walking for 30 min at the 
start of the day. Additionally, the regular-activity-break intervention significantly reduced 
plasma insulin iAUC by 26%, 866.7 IU∙L-1.9hr-1 (506.0 - 1227.5 IU∙L-1.9hr-1; p < 0.001) 
when compared with the long sedentary bouts intervention and by 18%, 542.0 IU∙L-1.9hr-1 
(179.9 - 904.2 IU∙L-1.9hr-1; p= 0.003, when compared with the physical activity intervention. 
The effects of the physical activity and regular activity break interventions on plasma 
triglyceride iAUC were not significantly different from the effects of sitting. The current 
study highlighted that regularly interrupting sedentary time with short bouts of activity is 
beneficially associated with lower postprandial glucose and insulin concentrations compared 
to a single continuous bout of physical activity.  
In a study by Nygaard and colleagues, 14 females were asked to complete 3 experimental 
trials examining the effects of undertaking different durations of walking after consuming a 
carbohydrate-rich meal containing, 1 g carbohydrate per kilogram body mass (cornflakes: 
84 g carbohydrate, 7 g protein, 1 g fat per 100 g; skimmed milk: 4.7 g carbohydrate, 3.3 g 
protein, and 0.7 g fat er 100 g). Participants sat for two hours, or walked for 15, or 40 
minutes, over a 2 hour observation period. The main influence of walking time (15, and 40 
minutes) on the 2-hr blood glucose iAUC were 231 ± 31mmol∙L–1∙min for control, 205 ± 
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29mmol∙L–1∙min for 15 minutes walking and 159 ± 13mmol∙L–1∙min for 40 minutes walking. 
Walking for 40 minutes lowered 2-h glucose iAUC by 31.2% compared to sitting p= 0.014, 
whereas walking for 15 minutes lowered 2-h glucose iAUC by 11% compared to sitting. The 
difference between walking for 15 min and 40 min was 22.7%, although this observation 
was not signiﬁcantly different (p > 0.05) (Nygaard et al. 2009).  
Thorp et al undertook a study in which 23 office workers, aged 48.2 ± 7.9 and BMI 29.6 ± 
4.1 kg/m2 undertook two 5-d experimental conditions (Thorp et al. 2014b). Participants were 
asked to perform their usual work in a deskbound (seated) work posture over 8 h.d-1 in the, 
control condition. The intervention condition required participants to perform their job 
swapping between a seated and standing posture every 30-min for 8 h d-1 using of an electric, 
height-adjustable workstation. The result demonstrated that  glucose concentration iAUC 
was reduced by 11.1% after the prolonged bouts of sitting interrupted every 30min by 30min 
of standing over 8 h observation period, (6.38 mmol/L·h-1 (confidence interval 5.04 - 
7.71mmol/L·h-1)) compared to the prolonged sitting condition (7.18 mmol/L·h-1 (confidence 
interval, 5.85-8.52 mmol/L·h-1). No significant difference was observed between standing 
vs. sitting conditions on the insulin iAUC (p = 0.41), or triglyceride concentration iAUC (p 
= 0.45). The study demonstrated that breaking prolonged sitting with short bouts of standing 
significantly lower postprandial glucose responses in obese office workers. 
 Using a similar protocol, Thorp and colleagues undertook another study to determine 
whether increasing standing at work by using an electric, height-adjustable workstation 
during the workday could improve fatigue levels and lower back discomfort in 23 
overweight/obese, aged 28.2 ± 8 years. This study reported that replacing sedentary time 
with standing every 30 min across the workday led to reduced musculoskeletal discomfort 
by 32% (p = 0.03) compared to sitting in overweight/obese ofﬁce workers (Thorp et al. 
2014a).  
Henson et al (2016) undertook a study in twenty two overweight, postmenopausal women at 
high risk of type 2 diabetes, who underwent trials where they sat continuously for 7.5 h or 
broke up sitting with 5 minutes of walking at 4 km/h or 5 minutes of standing every 30 
minutes (Henson et al. 2016). The postprandial glucose iAUC was reduced by 34% with 
standing (P = 0.022), and by 28% with walking (P = 0.009) and with insulin iAUC reduced 
by 20% (P = 0.045) and 37% (P = 0.008) by standing and walking, respectively. There was 
no difference between standing and walking conditions (P = 0.398). Moreover, the 
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observations for glucose (19% and 17% reductions for standing and walking, respectively) 
and insulin (24% reduction for walking only) persisted into the next day. 
In contrast, Miyashita et al (Miyashita et al. 2013) examined  the effects of the prolonged 
sitting, standing and walking trials on postprandial lipaemia and glucose in 15 healthy men. 
Each participant undertook three, 2-day laboratory-based trials. In the sitting trial, participant 
sat comfortably over 6h observation period.  For the standing trial, participants were asked 
to stand for six, 45-min periods and for the walking trial, participants walked briskly for 30 
min at approximately 60 % of maximum heart rate. On day 2, of each trial, participants rested 
in the laboratory for 6 h and consumed test meals for breakfast and lunch. The result on day 
2 showed that serum TG responses were lower by 18% on the walking trial than the sitting 
(P = 0.031) and standing trials (P = 0.048). Also, the walking intervention significantly 
reduced the postprandial plasma glucose concentrations compared to the sitting (P = 0.008) 
but did not diﬀer signiﬁcantly between sitting and standing trials (P = 0.707) or between 
standing and walking trials (P = 0.146). 
 A further study undertaken by Miyashita et al (Miyashita et al. 2008) aimed to identify the 
difference between continuous session 30 minutes of moderate activity and 10 bouts of 3 
minutes of moderate physical activity every 30 minutes on postprandial plasma TG 
concentrations and resting blood pressure in fifteen healthy men, aged 23.4 ± 0.8 years. The 
main result was that multiple short (3-min) bouts of moderate activity and one session of 30-
min brisk walk reduced postprandial plasma TG AUC concentration by 16% compared to 
sitting (P = 0.005) and resting systolic blood pressure by 6 – 7%  throughout day 2 on  the 
both activities condition (P = 0.005).   
Similarly, Duvivier et al  (Duvivier et al. 2013)  monitored the glucose, insulin and lipid 
responses in 18 healthy young physically inactive participants who performed three different 
conditions: a sitting regime (14 h/d of sitting + 1 h/d of walking + 1 h/d of standing); a 
minimal intensity PA regime (5 h/d of walking + 3 h/d of standing + 8 h/d of sitting); and an 
exercise regime (1-h MVPA and 13 h/d of sitting + 1h /d of walking + 1 h/d of standing). 
Participants completed each condition for 4 d and were assessed on the fifth day. The data 
showed that the minimal intensity PA regime improved the lipid profile and insulin 
sensitivity when compared with the prolonged sitting condition. There was a significant 
intervention effect on AUC for insulin during OGTT after the minimal intensity PA regime 
compared to both sitting and exercise regimes 6727 ± 4329 vs 7752 ± 3014 and 8320 ± 5383 
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mU.min/ml, respectively. The minimal intensity PA regime significantly reduced TG by 
22%, compared to sitting and there was no significant observed in exercise regime, despite 
the comparable energy expenditure to the light-activity protocol.  
Kim et al (Kim et al. 2014) observed that interrupting sitting time with either 1-h moderate-
intensity exercise (65 % VO2max) or intermittent light-intensity walking (25 % VO2max) for 9 
h produced lower triglyceridaemic and glycaemic responses to a high-fat meal on the next 
day in healthy active participants. Moderate intensity exercise and light intensity 
significantly lowered TG iAUC by 33.6 % (P < 0.005) and 19.8 % (P < 0.05), respectively 
compared to sitting. The authors also showed that moderate intensity exercise significantly 
reduced TG iAUC by 17.2% (P < 0.03) compared to light intensity, and also reduced plasma 
glucose response and improved fat oxidation compared to  light intensity and sitting 
conditions (for all, P < 0.05). Notably, moderate intensity exercise and light intensity reduced 
postprandial TG responses compared with sitting. However, moderate intensity exercise was 
more efficacious in reducing postprandial TG compared with light intensity.  
Altenburg et al (Altenburg et al. 2013) undertook a study of  eleven healthy adults, who 
performed two interventions trials, on a different occasion, prolonged sitting for 8 h and 8 h 
of sitting interrupted with 8-min of moderate-intensity cycling (40 % – 60 % of the heart rate 
reserve) per hour. The authors detected that muscle activity during cycling was seven to 
eight times higher compared with prolonged sitting. Breaking sitting time led to signiﬁcantly 
lower postprandial levels of C-peptide (unstandardized regression coefﬁcient = - 0.19; 
conﬁdence interval = [- 0.35; - 0.03]; P = 0.017) compared with prolonged sitting. 
Postprandial levels of glucose, triglycerides and cholesterol were not signiﬁcantly different 
between conditions.  
Van Dijk et al. (van Dijk et al. 2013) evaluated twenty adult males with type 2 diabetes who 
completed a prolonged sitting condition, both a 45-min moderate-intensity continuous 
exercise ( ̴  350 kcal expended) and 3 15-min bouts of light-intensity activity ( ̴ 175 kcal 
expended) throughout the day. The average blood glucose concentrations were signiﬁcantly 
lower by 0.66 ± 0.1mmol/L (P < 0.001) during a single session of moderate-intensity 
exercise, compared with prolonged sitting.  The 35 ± 5% reduction in the cumulative glucose 
iAUC during the moderate-intensity exercise condition was higher than the 17 ± 6% 
reduction detected in the light-intensity activity condition, though this intervention did not 
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differ significantly (P = 0.06). Also, a single session of moderate-intensity exercise 
signiﬁcantly reduced the insulin iAUC compared with light-intensity activity condition (P < 
0.001). 
In contrast, Bailey and Locke (Bailey and Locke 2015) did not find any significant effects 
of  breaking sedentary time with 2-min bouts of standing every 20 min on postprandial 
glucose in 10 normal to overweight participants compared with 5 h of prolonged sitting. 
Interestingly, compared to sitting condition, the postprandial glucose response was 
significantly lower with 2-min bouts of light walking every 20 min by 16.7%. The 
researchers did not observe any positive effects of breaks on lipidemia or blood pressure 
(p > 0.05). Thus, these data suggest that breaking sitting time with frequent brief bouts of 
light-intensity activity, but not standing, can lead to beneficial postprandial responses that 
may enhance cardiometabolic health. These outcomes could be importance in the design of 
practical interventions to minimize the risk of cardiometabolic disease. 
John et al (John et al. 2011),  examined the effects of introducing treadmill desk workstations 
over a 9 month period  for 5 males and 7 females overweight adult office workers in an 
uncontrolled trial. The authors reported significant increases were seen in standing (146 – 
203 min·day-1) and stepping time (52 – 90 min·day-1) and total steps/day (4351 – 7080 
steps/day; P < 0.05) with reductions in sitting. This resulted in significant reductions in waist 
(by 5.5 cm) and hip (by 4.8 cm) circumferences, LDL by cholesterol (by 16 mg·dL-1) and 
total cholesterol (by 15 mg·dL-1), (P < 0.05) during the study. Notably, these positive 
changes were noticed despite no changes in dietary intake. A 3 separate 24-hour dietary 
recall interviews were recorded at each of the 3 time points: baseline, 3 months, and 9 
months, in total of 9 dietary recalls per individual). Participants were asked to recall their 
dietary intake on randomly selected days of the week. 
Alkhajah et al (Alkhajah et al. 2012) studied the effects of introducing sit-stand workstations 
in adult non-obese healthy adult office workers. After 3 months, the intervention group 
reduced sitting time by more than 2h d-1, which was almost exclusively replaced by standing 
with minimal changes to stepping time, compared with the control group. The intervention 
group increased HDL cholesterol by an average of 0.26 mmol/L (95 % CI = 0.10, 0.42). 
However, no significant differences were observed with other biomarker. It is important to 
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consider that food intake was not controlled in this study, which may have affected the 
results. 
Buckley et al  (Buckley et al. 2014) studied the effects of breaking sitting time on adult desk-
based office workers, compared to 4 h of seated desk work. The postprandial glucose was 
reduced by 43% (p = 0.022) with sit-stand desk workstation groups during 4 h. Moreover, 
energy expenditure AUC for 210min, during an afternoon work was 174 ± 66 kcals (0.83 
kcals/min; p = 0.028) greater in standing (487 ± 174 kcals) compared to sitting (313 ± 139 
kcals). While, the researchers did not clearly quantify the time of spent sitting and standing 
in both conditions, these finding recommended that standing could be sufficient to counteract 
the risk of prolonged bouts of sitting in office workers. 
In a further report, Latouche et al (Latouche et al. 2013) observed a positive effects of light- 
and moderate-intensity breaks on postprandial glucose iAUC when compared to sitting, the 
glucose response was effectively reduced by 24.8% (P = 0.004) and 23.4% (P = 0.015) with 
light  and moderate-intensity breaks, respectively. 
Holmstrup et al (Holmstrup et al. 2014) showed that breaking up 12 h of prolonged sitting 
with either 1-h moderate-intensity exercise to vigorous exercise (EX; 60 – 65% VO2peak peak 
or interrupted hourly by 5min of moderate to vigorous exercise (INT; 60 – 65% VO2peak) 
induced a significant differences in the 12-h glucose iAUC (P = 0.021) with glucose 
concentrations highest in the EX group in overweight subjects. The 12-h insulin iAUC was 
higher (P < 0.05) compared to the interrupted of moderate to vigorous exercise and 
moderate-intensity exercise conditions. However, no significant differences were observed 
in the 12-h insulin iAUC response between the EX and INT conditions (P = 0.13). The 2-h 
c-peptide iAUC in a single session exercise and interrupted hourly by 5min of exercise were 
significantly reduced relative to the sedentary control (P < 0.05). 
Larsen et al. (Larsen et al. 2014) also evaluated the impact of breaking sitting time on blood 
pressure. The authors focused on 11male and, 12 females and showed that bouts of 2 min of 
light-intensity walking at 3.2 km/h every 20 min or bouts of 2 min of moderate-intinsity 
walking at 5.8 and 6.4 km/h every 20 min during 5 h of sitting time. Both conditions 
significantly reduced systolic blood pressure (light: 120 ± 1mmHg, p = 0.002; moderate: 121 
± 1 mmHg, p = 0.02), compared to sitting condition (123 ± 1mmHg). Also, diastolic blood 
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pressure was lowered during both of the activity conditions (light: 76 ± 1 mmHg, p = 0.006; 
moderate: 77 ± 1 mmHg, p = 0.03) compared to sitting condition (79 ± 1 mmHg).  
Swartz et al (Swartz et al. 2011) suggested that people who have a desk job, could make a 
small changes, such as breaking sitting time with five minute of walking every hour, may be 
helpful to control or loss weight and prevent obesity in developed countries. 
Thus there have been a substantial number of studies investigating the metabolic 
consequences of breaking up periods of prolonged sitting. Taking these data together, there 
is clear evidence that regularly interrupting sedentary time with multiple short (2-3 min) 
bouts of light or moderate activity throughout the day could decrease postprandial glucose, 
insulin and triglyceride responses, and blood pressure, on the same or following day. 
However, data on whether these benefits could be stimulated by simply breaking up time 
spent sitting down by standing up, and more limited and equivocal.  This knowledge is 
essential as there are a number of ‘standing desk’ interventions being undertaken to decrease 
time spent sitting, but there are only very limited data available to show whether this type of 
intervention can induce a measurable metabolic benefit (Buckley et al. 2014; Reiff et al. 
2012) and whether the pattern of standing and sitting could influence these effects.  
Furthermore, in all of these studies, the intervention to break up sedentary time also reduced 
sedentary time by increasing the amount of time spent standing or walking.  Thus, it is not 
clear from the existing literature whether breaking up prolonged sedentary time with small 
bouts of activity provides any additional benefits over and above simply undertaking the 
same amount of activity in a single bout either before or after a prolonged sedentary period. 
There needs to be further research into the consequences of breaking up sedentary time with 
repeated short bouts of light activity or standing, compared to undertaking the same amount 
of standing or light activity in a single continuous bout on day-long  metabolic responses. 
This will help understanding of the role of the frequency of breaks in sedentary time per se 
on metabolic responses.   
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Table 1-5: Breaking sedentary behaviour (Intervention Studies) 
 
Author & Study Design Sample (n) Measurements Results 
Study 
design 
1 (Dunstan et al. 
2012b) Breaking 
up prolonged 
sitting reduces 
postprandial 
glucose and 
insulin responses. 
1) Uninterrupted sitting for 7 hours 
(420min) 
 
2) Sitting interrupted every 20min by 
two min of light-intensity walking 
(3.2km/h) (14breaks) for 5h 
 
3) Sitting interrupted every 20min by 
2min of moderate-intensity walking 
(5.8-6.4km/h) (14breaks) for 5h. 
19  obese adults 
/11 males 
 
Mean (SD) age 
53.8 ± 4.9years 
 
Mean (SD) BMI 
31.2 ± 4.1 kg/m2 
 
 
 
   
Postprandial 
response 
Serum/plasma 
glucose and 
insulin 
The glucose iAUC which represents the area under the plasma concentration curve 
without resting period, the plasma (mmol/L).h after both activity-break conditions 
was reduced (light: 5.2 [4.1 – 6.6]; moderate: 4.9 [3.8 – 6.1]; both P < 0.01) 
compared with uninterrupted sitting (6.9 [5.5–8.7]).  
 
Insulin iAUC (pmol/L.h) was also reduced with both activity-break conditions 
(light: 633.6 [552.4 – 727.1]; moderate: 637.6 [555.5 – 731.9], P<0.0001) 
compared with uninterrupted sitting (828.6 [722.0 – 950.9]), after adjustment for 
age, sex, weight, period effects. 
  
 
 
Randomized 
crossover 
trial 
 
6-days 
washout 
period 
2 (Peddie et al. 
2013)  Breaking 
prolonged sitting 
reduces 
postprandial 
glycemia in 
healthy, normal-
weight adults: a  
Three conditions: 
1) Uninterrupted sitting for 9h. 
  
2) 30min, walked on the treadmill, 
and then sat continuously for 8 h and 
15 min. 
 (physical activity intervention) 
 
3) Sitting interrupted by 18 breaks of 
1min 40s bouts of brisk treadmill 
walking (total of 30 min) over the 9-h 
period. 
 ( regular-activity-break) 
70 adults/ 42 
males 
 
Mean (SD) age 
25.9 ± 5.3 years  
 
Mean BMI (SD) 
23.6 ± 4.0 
kg/m2 
Postprandial 
response 
Serum/plasma 
glucose, insulin, 
and 
triglycerides. 
The regular-activity-break intervention lowered plasma glucose iAUC by 18.9 
mmol.L-1.9h-1 (95% CI: 10.0, 28.0 mmol.L-1.9h-1; P < 0.001) compared with the 
prolonged sitting intervention and by 17.4 mmol.L-1.9h-1 (95% CI: 8.4, 26.3 
mmol.L-1. 9h-1; P < 0.001) compared with the physical activity intervention, 
walking for 30 min. 
 
The effects of the prolonged sitting and physical activity interventions on plasma 
glucose and insulin iAUC did not differ signiﬁcantly; (P = 0.730), (P = 0.079), 
respectively. 
 
The regular-activity-break intervention lowered plasma insulin iAUC by 
866.7IU.L-1 .9h-1 (95% CI: 506.0, 1227.5IU.L-1.9h-1; P<0.001) when compared 
with the prolonged sitting intervention and by 542.0 IU.L-1.9h-1 (95% CI: 179.9, 
904.2 IU.L-1. 9h-1; P = 0.003) when compared with the physical activity 
intervention, adjusted for age, sex, and BMI 
 
The mean difference between the physical activity intervention and the prolonged 
sitting intervention on plasma triglyceride iAUC was 3.8mmol·L-1 9hr-1 (p = 
0.098) and between the regular activity break and prolonged sitting interventions 
was 2.4mmol·L-1 9hr-1 (p = 0.284).  
Randomized 
crossover 
trial 
6 to 13 d 
washout 
period 
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3 (van Dijk et al. 
2013) 
Effect of 
moderate-
intensity exercise 
versus activities 
of daily living on 
24-hour blood 
glucose 
homeostasis in 
male patients with 
type 2 diabetes. 
Three conditions: 
1) sitting for 11h,  
 
2) 15min of ADL (activities of daily 
living)  (slow-paced strolling,  ̴3 
MET)  
 
3) 45min bout of moderate intensity 
cycling ( ̴ 6MET)  
 
  
20 adult males 
with type 2 
diabetes  
 
Mean (SD) age 
 64 ± 1years 
 
Mean (SD) BMI 
29.5 ± 0.9kg/m2 
Postprandial 
plasma insulin 
and glucose 
 
45 min of moderate-intensity exercise signiﬁcantly reduced blood glucose 
concentrations by 0.66 ± 0.1mmol/L (P < 0.001) compared to the sitting. 
 
The 35 ± 5% reduction in the cumulative glucose iAUC during the moderate-
intensity exercise condition was greater than the 17 ± 6% reduction observed in 
the ADL condition, although this observation did not reach statistical signiﬁcance 
(P=0.06). 
 
The resulting plasma insulin response was 17 ± 5% lower during the ADL 
condition (214 ± 24 nmol/L/11 h; P < 0.05) and 33 ± 4% lower during the moderate 
condition (170 ± 18 nmol/L/11 h; P < 0.001) compared to the sitting (250 ± 23 
nmol/L/11 h). The insulin iAUC during the moderate condition also was lower 
compared with the ADL condition (P < 0.001). 
Randomized 
crossover 
trial 
 
7-d washout 
period 
4 (Holmstrup et al. 
2014)  
Multiple short 
bouts of exercise 
over 12-h period 
reduce glucose 
excursions more 
than an energy-
matched single 
bout of exercise 
1) (SED) sitting for 12h. 
  
2) (EX) 1h, continuous moderate to 
vigorous exercise (EX; 60–65% VO2 
peak followed by sitting for11h.  
 
3) (INT) Sitting, interrupted hourly by 
5min of moderate to vigorous 
exercise (12 breaks) at 60 –65% 
VO2peak. 
11 obese adults 
/ 8 males with 
impaired 
glucose 
tolerance  
 
Age (range) 
 18–35 years, 
 
 BMI > 30kg/m2 
 
Postprandial 
plasma glucose, 
insulin 
There were significant differences in the 12-h glucose iAUC 
SED vs. EX (5536.9 ± 255.3 vs. 6249.6 ± 286.3 mmol/L*min for 12-h; P = 0.042); 
INT vs. EX (5457.0 ± 238.8 vs. 6249.6 ± 286.3 mmol/L*min for 12-h; P = 0.048) 
 
No significant differences were observed in the 12-h insulin iAUC response 
between the EX and INT conditions (P = 0.13). 
 
 
 
Randomized 
crossover 
trial 
7-d washout 
period 
5 (Bailey and Locke 
2015) Breaking 
up prolonged 
sitting with light-
intensity walking 
improves 
postprandial 
glycemia, but 
breaking up 
sitting with 
standing does not 
Three conditions: 
1) Sitting for 5h (300min). 
 
2) Sitting interrupted every 20min by 
2min of standing (14breaks). 
 
3) Sitting interrupted every 20 min by 
2 min of light intensity treadmill 
walking (3.2km/h) (14breaks) 
10 obese adults 
/ 7 males 
 
 Mean (SD) age  
24 ± 3 years 
 
Mean BMI 
(SD): 26.5 ± 
4.3kg/m2 
Postprandial 
triglycerides, 
total cholesterol, 
glucose, and 
blood pressure 
Glucose area under the curve was lower in the walking-break condition compared 
to the uninterrupted sitting and standing-break conditions: mean area under the 
curve 18.5 (95% CI 17, 20mmol L/5-h), 22.0 (20.5, 23.5 mmol L/5-h), and 22.2 
(20.7, 23.7 mmol L/5-h), respectively, p < 0.001.  
Randomized 
crossover 
trial 
7-d washout 
period 
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6 (Thorp et al. 
2014b) 
Alternating bouts 
of sitting and 
standing 
attenuates 
postprandial 
glucose responses 
Two conditions lasting 5 days each 
1) Uninterrupted sitting for 8h (480 
min) 
 
2) Sitting interrupted every 30 min by 
30 min of standing (8 breaks) 
 
Each experimental condition was 
performed for five consecutive 
workdays (Monday to Friday). 
23 Obese adults, 
/17 males 
  
Mean (SD) age 
48.2 ± 8 years  
 
Mean (SD) BMI 
29.6 ± 4 kg/m2 
 
 
Postprandial 
triglycerides, 
glucose, and 
insulin 
Compared to sitting, breaks lowered plasma glucose iAUC by 11.1% 
(6.38mmol/L·h-1 confidence interval, 5.04 – 7.71) relative to the control condition 
(7.18mmol/L·h-1 confidence interval, 5.85 – 8.52)(P = 0.007), 
  
No significant effect on insulin or triglycerides. 
  
 
 
Randomized 
crossover 
trial  
7-d washout 
period 
7 (Altenburg et al. 
2013) The effect 
of interrupting 
prolonged sitting 
time with short, 
hourly, moderate-
intensity cycling 
bouts on 
cardiometabolic 
risk factors in 
healthy, young 
adults. 
1) 8 h prolonged sitting (420min) 
(SIT)  
 
2) 8 h of sitting, interrupted hourly 
with, (8min of moderate-intensity 
cycling at 40%–60% of HRR) 
 (SIT-CYCLE)  
11 adult / 6 
females 
 
Age (range): 
18 – 24year 
 
BMI (range): 
 20 – 26 kg/m2 
Postprandial: 
glucose, TG,  
LDL chol, T-
chol and C -
peptide 
Muscle activity during cycling was seven to eight times higher compared with 
sitting.  
 
Postprandial levels of other cardiometabolic biomarkers (e.g., glucose, 
triglycerides, cholesterol, HDL, LDL cholesterol l) were not signiﬁcantly different 
between conditions.  
 
 
 
 
Randomized 
crossover 
trial  
7-d 
washout 
period 
 
8 (Buckley et al. 
2014) Standing-
based office work 
shows 
encouraging signs 
of attenuating 
post-prandial 
glycaemic 
excursion 
 
1 – Uninterrupted sitting (240min) 
 
2- Standing (240min) 
 
10 adults 
/8females 
 
Age 
(range):males 
22 - 61years 
females, 22 – 59 
years  
 
BMI<30 kg/m2 
Postprandial 
glucose, 
energy 
expenditure  
Glucose AUC was attenuated blood by 43% (p = 0.022) following 185 min of 
standing (143, 95% CI 5.09 to 281.46 mmol/L min) compared to sitting (326; 95% 
CI 228 to 425 mmol/L min).  
 
Open non 
randomized 
crossover 
trial 
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9 (Duvivier et al. 
2013) 
Minimal Intensity 
Physical Activity 
(Standing and 
Walking) of 
Longer Duration 
Improves Insulin 
Action and 
Plasma Lipids 
More than Shorter 
Periods of 
Moderate to 
Vigorous Exercise 
(Cycling) in 
Sedentary 
Subjects When 
Energy 
Expenditure Is 
Comparable 
Participants were instructed to 
perform three activity regimes of four 
days each. 
1) Sitting regime, 14h.d-1 
+walking1h.d-1+ standing 1 h.d-1 and 
8 hr/day sleeping. 
   
2) EX regime: 
Sitting13h.d-1+walking 1 h.d-1+ 
standing 1 h.d-1+ MVPA 1h.d-1 
 
3) minimal intensity PA regime: 
sitting 8h.d-1 + walking 5h.d-1+ 
standing 3 h.d-1 
 
18 healthy 
adults / 11males 
 
Mean (SD) age 
21 ± 2years 
 
Mean (SD) BMI 
22.6 ± 3.6kg/m2 
Postprandial 
response on the 
next day: 
glucose, insulin, 
TG, HDL-chol, 
and LDL 
Area under the curve for insulin during OGTT was significantly lower after the 
minimal intensity PA regime compared to both sitting and exercise regimes 6727.3 
± 4329.4 vs 7752.0 ± 3014.4 and 8320.4 ± 5383.7 mU.min/ml, respectively. 
 
 Triglyceride level improved significantly in the minimal intensity PA regime 
compared to sitting and showed non-significant trends for improvement compared 
to exercise. 
 
 
Randomized 
crossover 
trial 
10-d 
washout 
period 
10 (Nygaard et al. 
2009) 
Slow postmeal 
walking reduces 
postprandial 
glycemia in 
middle-aged 
women 
After  CHO rich meal the subject 
completed 3 experimental trials 
 1) Sitting, for 2 hours 
 2) Slow walking (15mins) (W15) 
 3) Slow walking (40 mins) (W40)   
 
14 females, 
 
 age >50 years 
 
Mean (SD) BMI 
24 ± 3 kg/m2 
Glucose 
 
 The main influence of walking time (0,15, and 40 minutes) on the 2-hr blood 
glucose iAUC  were 231 ± 31mmol∙L–1 ∙min for control, 205 ± 29mmol∙L–1∙min 
for 15 minutes walking and 159 ± 13mmol∙L–1∙min for 40 minutes walking.  
Randomised 
crossover 
trial 
 
4-30 days 
washout 
period 
11 (Miyashita et al. 
2008) 
Accumulating 
short bouts of 
brisk walking 
reduces 
postprandial 
Subjects completed three 2d trials:            
On day1 
1) sitting for 7h, 
2) 10 bouts of 3 minutes of moderate 
physical activity every 30 minutes  
3) One 30-min bout of of moderate 
physical activity 
15 healthy adult 
males 
 
Mean (SD) age 
23.4 ± 0.8 years 
 
postprandial 
triacylglycerol 
and  blood 
pressure 
On day 2, TG AUC was 16% lower on the accumulateing of 30 min of walking 
9.98 ± 0.67, continuous 30min walking 9.99 ± 0.76 than control trial 11.90 ± 1.02 
mmol. 7h/L, P = 0.005. 
 
 Resting systolic blood pressure was 6–7% lower throughout day 2 on the 
accumulated walking 109±1 and continuous walking 110 ± 1 compared with 
control trial 117 ± 2 mm Hg, P < 0.0005).  
Randomized 
crossover 
trial  
6-d 
washout 
period 
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plasma 
triacylglycerol 
concentrations 
and resting blood 
pressure in 
healthy young 
men 
On day 2, 
subjects rested and consumed high-fat 
test meals for breakfast and lunch 
 
Mean (SD) BMI 
23.4 ± 0.6 
kg/m2 
 
 
12 (Latouche et al. 
2013) 
Effects of 
breaking up 
prolonged sitting 
on skeletal muscle 
gene expression. 
three 5-h interventions were 
completed in the postprandial state 
after a standardized test drink  
1- Un interrupted sitting 
(420min)(SIT) 
 
2- Sitting (402min) +2-min LIPA 
every20min for 5h (3.2km.h-1), 14 
breaks,  
 
3- Sitting (402min) +2-min MVPA 
every20 min for 5h (5.8–6.4km.h-1 
8 obese 
adults/1female 
 
Mean (SD) age 
55.6 ± 6years 
 
Mean (SD) BMI 
30.9 ± 2.9kg/m2 
postprandial 
glucose and 
insulin 
The glucose iAUC was reduced by 24.8% (P = 0.004) after sitting interrupted with 
LIPA and 23.4% (P = 0.015) after sitting interrupted with MVPA compare to 
sitting.  
 
The insulin-to-glucose ratio incremental area under the curve was 25.1% (P = 
0.001) lower after LIPA and 21.9% (P = 0.014) lower after sitting interrupted with 
MVPA compared with sitting, adjusted for age, sex, body weight. 
Randomized 
crossover  
trial 
6-d washout 
period 
13 (Larsen et al. 
2014) 
Breaking up 
prolonged sitting 
reduces resting 
blood pressure in 
overweight/obese 
adults.  
1) sitting, 5 h 
 
2) Seated with 2-min bouts of LIPA 
(walking at 3.2 km/h) every 20 min 
 
3) Seated with 2-min bouts of MVPA 
(walking 5.8 and 6.4 km/h) every 20 
min 
19 obese/ 
overweight 
adults /8 
females 
Mean (SEM) 
age 53.8 
±1.1years  
Mean (SEM) 
BMI 
31.2 ± 0.9 
kg/m2 
Systolic and 
diastolic blood 
pressure 
Breaking up prolonged sitting with LIPA and MVPA was lower systolic blood 
pressure (light: 120 ± 1mmHg, p = 0.002; moderate: 121 ± 1 mmHg, p = 0.02), 
compared to sitting (123 ± 1 mmHg). 
 
Diastolic blood pressure was also significantly lower during both of the activity 
conditions (light: 76 ± 1 mmHg, p = 0.006; moderate: 77±1mmHg, p=0.03) 
compared to sitting (79 ± 1 mmHg).   
Adjusted for sex, age, BMI, fasting blood pressure. 
Randomized 
crossover  
trial 
7-d washout 
period 
14 (Miyashita et al. 
2013) 
postprandial 
lipaemia: eﬀects 
of sitting, 
2-day trials in a random order:                 
Day 1 : 
1) sitting 6h, 
 
2) Standing, for six, 45-min periods. 
15 healthy 
males 
 
Mean (SD )age 
26.8 ± 2.0 years  
Postprandial TG 
concentrations 
postprandial 
lipaemia 
On day 2 of the intervention, after the consumption of the test meals 
Walking trial was signiﬁcantly reduced the total AUC for TG by (8.0 ± 1.6 mmol∙6 
h/L) than the sitting (9.8 ± 3.7 mmol∙6 h/L, P = 0.028), and walking compared to 
standing (9.7 ± 2.6 mmol∙6 h/L, P = 0.043). 
 
Randomized 
crossover  
trial 
7-d washout 
period 
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standing and 
walking in healthy 
normolipidaemic 
humans 
  
3) Walking briskly for 30 min at 60 % 
of maximum heart rate. Participants 
consumed a packed lunch midway 
through the day were instructed to 
consume an early evening meal and to 
rest for the remainder of the evening. 
On day 2  
Of each trial, participants rested and 
consumed test meals for breakfast and 
lunch. 
 
Mean (SD) BMI 
22.5 ± 1.5 kg/m 
2 
 
 
postprandial 
plasma glucose, 
insulin 
However, insulin iAUC was not signiﬁcantly different between conditions, 
standing (927 ± 347pmol·6 h/L), walking (834 ± 260pmol·6 h/L, or sitting (916 ± 
319 pmol·6 h/L)  
 
  
 
15 (Swartz et al. 
2011) Energy 
expenditure of 
interruptions to 
sedentary 
behavior 
1) Sitting for 30 consecutive minutes. 
   
2)  14 minutes of sitting one minute 
of walking and 15 minutes of sitting, 
for a total of 30 minutes  
 
3) 13 minutes of sitting two minutes 
of walking and 15 minutes of sitting, 
for a total of 30 minutes. 
  
4) 13 minutes of sitting five minutes 
of walking and 12 minutes of sitting, 
for a total of 30 minutes. 
20 males and 
females  
 
Mean (SD) age 
28.1 ± 5.7 years 
 
Mean (SD) BMI 
27.8 ± 6.6 
kg/m2  
Body 
composition and 
resting 
metabolic rate 
Significantly more energy was expended during walking break than sitting (p < 
0.05 for all comparisons).  
 
On average, participants expended an additional 3.0, 7.4, and 16.5 additional 
activity kilocalories during activites 2, 3, and 4, respectively compared to sitting. 
 
Randomized 
crossover 
trial  
14-d 
washout 
period 
 
16 (Thorp et al. 
2014a) Breaking 
up workplace 
sitting time with 
intermittent 
standing bouts 
improves fatigue 
and 
musculoskeletal 
discomfort in 
overweight/obese 
ofﬁce workers 
Each trial was performed for five 
consecutive workdays (Monday to 
Friday)  
 
1) Uninterrupted sitting for 8h.  
 
2) Sitting interrupted every 30 min by 
30 min of standing.  
 
23 overweight/ 
obese adults /17 
males  
Mean (SD) age 
48.2 ± 7.9 years 
Mean (SD) BMI 
29.4 ± 1.4 
kg/m2 
fatigue, 
musculoskeletal 
discomfort 
The total fatigue score was signiﬁcantly higher during the sitting condition (mean 
67.8 (95% CI 58.8 to 76.7)) compared with the sit-stand condition (52.7 (43.8 to 
61.5); p < 0.001). 
 
 Lower back musculoskeletal discomfort was signiﬁcantly lower during the sit-
stand condition compared with the sitting condition (31.8% reduction; p = 0.03).  
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17 (Kim et al. 2014) 
Effects of 
moderate- and 
intermittent low-
intensity exercise 
on postprandial 
lipemia 
1- Sitting (420min) (CON), 
2-Sitting (360min)+60min  of 
running MVPA (65%V˙O2max)at the 
end of sitting (MOD) 
 
3-Sitting (260) min+9breaks 
intermittent walking exercise at (self-
selected walking speed 25% V˙O2max 
(LOW) but energy matched to the 
MVPA condition8h 
9 healthy males 
 
Mean (SD) age: 
24.0 ± 4.0 years 
 
BMI < 30 kg/m2 
Postprandial 
response the 
next day: TG, 
glucose 
MOD and LOW reduced incremental triglyceride (TG) area under the curve (TG 
AUCI) compared with that in CON by 33.6% (P < 0.005) and 19.8% (P < 0.05), 
respectively.  
MOD also reduced TG AUCI compared with that in LOW by 17.2% (P < 0.03). 
The reduced TG AUCI in MOD was accompanied by reduced plasma glucose 
response and enhanced fat oxidation compared with those in LOW and CON (for 
all, P < 0.05), respectively. 
 
Both MOD and LOW were effective in reducing PPTG compared with CON. 
However, MOD was more effective in reducing PPTG compared with LOW. 
Randomized 
crossover 
trial  
7-d 
washout 
period 
 
18 (Peddie et al. 
2013) 
Breaking 
prolonged sitting 
reduces 
postprandial 
glycemia in 
healthy, normal-
weight adults: a 
randomized 
crossover trial 
1) Sitting (810min) 9 hours (SIT) 
 
2) Sitting (780min)+1bout of 
Walking for 30-min  MVPA 
(60.5%VO2peak) and then sitting 
(Physical activity) 
 
3) Sitting (272min) +18 breaks 
(1min40s total 30min) every 30 
minutes (45.6% of VO2peak)  
(Regular activity breaks). 
42 men / 28 
females 
 
Mean (SD) age: 
25.9 ± 5.3 years 
 
Mean (SD) BMI 
23.6 ± 4.0 
kg/m2 
 
Postprandial 
response during 
trial: glucose, 
insulin, TG,T-
chol, HDL-chol, 
LDL, 
Glucose, 
insulin, 
triglycerides 
The plasma iAUC for insulin differed between interventions (overall p < 0.001). 
Regular activity breaks lowered values by 866.7IU·L-1·9h-1 (p < 0.001) when 
compared with sitting and by 542.0 IU·L-1·9h-1 (p = 0.003) when compared with 
physical activity.  
Plasma glucose iAUC also differed between interventions (overall p < 0.001). 
Regular activity breaks lowered values by 18.9mmol·L-1 (p < 0.001) when 
compared with prolonged sitting and by 17.4 mmol·L-1 (p < 0.001) when compared 
with physical activity. Plasma triglyceride iAUC differed between interventions 
(overall p = 0.023).    
Regular activity breaks were more effective than continuous physical activity at 
decreasing postprandial glucose and insulin 
Randomized
crossover 
trial 
6 to 13 - d 
washout 
period 
19 Alkhajah etal, 
2012  
Sit-stand 
workstations: a 
pilot intervention 
to reduce office 
sitting time. 
1) Intervention group,used sit-stand 
work stations. 
 
2) Comparison group,maintain 
normal work routine 
Intervention,n=
18 
Mean (SD) age 
33.5 ± 8.7 years, 
Mean (SD) BMI 
22.6 ± 2.6 
kg/m2 
Comparison,n=
14 
 Mean (SD) age 
39.9 ± 7.2 years 
Mean (SD) BMI 
22.1 ± 2.6 
kg/m2 
PA,  
Fasting levels of 
HDL- chol, T-
chol,TG, 
glucose 
The intervention group compare to the comparison group reduced sitting time at 
1-week follow-up by 143 minutes/day at the workplace (95% CI= -184, -102) and 
97 minutes/day during all waking time (95% CI= -144, -50).  
 
The intervention group increased HDL cholesterol by an average of 0.26 mmol/L 
(95% CI=0.10, 0.42) compare to comparison group. Other biomarker differences 
were not significant.  
Randomized 
controlled 
trial. 
Measurement 
at baseline 
and 3 
months 
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20 (John et al. 2011)  
Treadmill 
workstations: a 
worksite physical 
activity 
intervention in 
overweight and 
obese office 
workers. 
 
 
Treadmill desk workstations  
 (TMWS) were used to replace sitting 
time with standing or walking 
The total duration of the study was 9 
months 
12 obese adults 
/ 7 females 
Mean (SD) age 
males 
47.2 ±11.8 years 
females 
45.6 ± 7.8 years 
Mean (SD) BMI 
males 
33.7 ± 5.8 
kg/m2  females  
34.0 ± 4.9 
kg/m2 
physical activity A significant increases were obseved in the standing time (146–203 min·day-1) and 
stepping time (52 – 90 min·day-1) and total steps/day (4351–7080 steps/day; P < 
0.05).  
 
Correspondingly, the time spent sitting/lying decreased (1238–1150 min·day-1; P 
<0 .05). Using the TMWS significantly reduced waist (by 5.5 cm) and hip 
circumference (by 4.8 cm), low-density lipoproteins (LDL) (by 16 mg·dL-1), and 
total cholesterol (by 15 mg·dL-1) during the study (P < 0.05).  
 
Prospective
uncontrolled
trial  
9-month 
follow-up 
21 Henson et al. 
2016 
Breaking Up 
Prolonged Sitting 
With Standing or 
Walking 
Attenuates the 
Postprandial 
Metabolic 
Response in 
Postmenopausal 
Women: A 
Randomized 
Acute Study 
Day 1  
1) Sitting 7.5 h 
 
2) Standing for 5min every 30 min  
 
3) Walking at light intensity 4km/h 
for min every 30 min 
 
Day 2  
1) Sitting for 7.5 h 
22 overweight/ 
Obese, 
postmenopausal 
females 
 
Mean (SD) age 
66.6 ± 4.7 years 
 
Mean (SD) BMI 
32.9 ± 4.7 
kg/m2 
Glucose, 
insulin and TG 
Breaking sedentary time with standing or walking reduced postprandial glucose 
iAUC by 34% (3.5 ± 0.8 mmol/L.h and 28% (3.8 ± 0.7 mmol/L. h compared to 
sitting 
 
Standing and walking activities reduced insulin iAUC by 20% (437.2 ± 73.5 
mU/L.h) and 37% (347.9 ± 78.7 mU/L.h, respectively, compared to sitting. 
Standing (6.2 ± 0.8 mmol/L.h) and walking (6.1 ± 0.8 mmol/L.h) signiﬁcantly 
reduced the TG iAUC compared with the sitting (5.6 ± 0.7 mmol/L. h). 
 
On day 2, the glucose iAUC (standing and walking) and insulin iAUC (walking 
only) persisted into the next day by (3.9 ± 0.8 mmol/L. h and 4.0±0.7mmol/L.h) 
and (354.3±57.3mU/L.h). 
 
There was no signiﬁcant difference in triglyceride between three conditions. 
Randomized 
crossover 
trial  
7-d 
washout 
period 
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 Measurement of Physical Activity and Sedentary Time 
Today, there is much evidence indicating sedentary behaviour as an independent risk factor 
for a number of diseases (Edwardson et al. 2012;Katzmarzyk et al. 2009;Wilmot et al. 2012). 
Accurate quantification of PA and SB is needed to evaluate current and changing physical 
activity and sedentary behaviour levels. Validity, reliability, easy collection, and cost are the 
main concerns when choosing a measurement method (Prince et al. 2008). Self-report, heart 
rate monitor, pedometer and accelerometers are the major methods that have been used to 
quantity PA and SB. 
Subjective methods included self-report questionnaires, diaries, interviewer-administered 
questionnaires, proxy-report questionnaires (Sirard and Pate 2001;Vanhees et al. 2005). 
Self-report is the major commonly method of assessing PA and SB in epidemiological 
research e.g. the international physical activity questionnaire (IPAQ) (Bauman et al. 
2011;Craig et al. 2003;Prince et al. 2008). Subjective methods are reasonably priced, 
feasible for use and analyze data, appropriate for across large samples. However, these 
methods can be limited due to reduced levels of validity, particularly recall and report biases 
and under-estimates or overestimation of levels of activity from participants, also, it is not 
valid to assess the energy expenditure level. Thus, there is a strong need to accurately and 
objectively assess physical activity and sedentary behaviour (Atkin et al. 2012;Vanhees et 
al. 2005). In a study comparing actual PA utilizing accelerometers, pedometers, etc vs self-
reported PA, it was found that both men and women overestimated their PA considerably by 
44% and 138%, respectively (Mozaffarian et al. 2016). Moreover, a study evaluating the 
validity of self-report found that watching TV was significantly lower when measured by 
self-report compared with an objective measurement (Atkin et al. 2012). Similarity, the 
Zutphen questionnaire (modified to include housework questions) was poor for measuring 
PA compared to Actigraph and pedometer. There was a strong convergent validity between 
accelerometers and pedometers for counting steps (R = 0.86, P < 0.001) but the relation was 
weaker between both accelerometer (R = 0.34, P < 0.001), pedometer step count (R = 0.36, 
P <0.001) and self-report Zutphen Physical Activity Questionnaire (Harris et al. 2009). A 
further study was undertaken by Dyrstad which compared between the self-administered 
IPAQ and (ActiGraph GT1M) for measuring total sedentary behavior and physical activity. 
The results shown that the subjects informed via IPAQ questionnaires additional vigorous 
PA and less sitting time compared with the accelerometer. The correlation between self-
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reported and accelerometer-measured PA decreased with higher activity MVPA and 
intensity levels (Dyrstad et al. 2014).  
A number of objective methods for measuring physical activity and sedentary behavior have 
been used to address some of limitations associated with subjective methods. Objective 
methods such as pedometers, heart rate monitors, and accelerometer have been utilized 
positively in adults and children. 
Pedometers are the simplest method and inexpensive electronic devices, used to estimate the 
number of steps taken during ambulatory activity and can therefore be used on large numbers 
of population. However, they are limited in that they only count the number of steps and do 
not distinguish between different patterns or intensity of activity such as if someone sprinted 
100 steps and another one walked 100 steps, the pedometer would classify register 
approximately 100 steps for each person (Berlin et al. 2006;Sirard and Pate 2001;Vanhees 
et al. 2005).  Furthermore, pedometers may underestimate steps taken at slower speeds (i.e., 
< 0.9 m/s), and do not accurately measure sitting time, or upper-extremity activity, e.g.; 
pushing, lifting, or carrying objects. The way of measuring steps by utilizing a horizontal 
acceleration suspended lever arm that moves up and down in response to vertical 
accelerations of the hip. Another limitation of the pedometers are that they do not have 
internal clocks, so they are unable to give data on the pattern or period of specific activities. 
Pedometers have been validated vs accelerometer measure of PA (Berlin et al. 2006).  
Heart rate monitors can be used to estimate EE according to the relationship between heart 
rate and oxygen consumption. They can be used to measure the frequency, intensity and 
duration of physical activity. The association between heart rate and oxygen consumption is 
linear with moderate or vigorous activity, however, at low levels of activity, the relationship 
is not linear. This can lead to error because most people spend a large period of their time in 
sedentary and light activity, and heart rate can be confounded by emotional stress, caffeine, 
smoking, type of activity undertaken. On the other hand, heart rate moitors are relatively 
inexpensive (Sirard and Pate 2001;Vanhees et al. 2005). Some work has been done to 
validate the use of heart for EE.  In one report, HR was an accurate method for predicting r 
=0.87 after adjusting for age and fitness (Strath et al. 2000). However, it seems clear that 
further research is required, taking a combined HR and movement sensing measure as staring 
point to measure sedentary behaviour (Atkin et al. 2012).  
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Sufficient and accurate methods of assessing sedentary time and physical activity which 
minimise the chance of misclassification are essential to further our understanding the links 
between sedentary behaviour and disease (Lagerros and Lagiou 2007). Celis-Morales and 
colleagues compared the impact of objective vs subjective measurements of sitting time and 
physical activity on the dose-response association with metabolic risk factors (Celis-Morales 
et al. 2012). The IPAQ significantly over reported physical activity by 55 minutes per day 
(2.6-fold). Also, for some metabolic risk factors such as triglyceride concentrations, 
significant trend were exposed between amount of MVPA and the risk factor when activity 
was measured by accelerometer  p = 0.022 but not with  the IPAQ  p = 0.139. This study 
found that a poor method for measuring sedentary behavior or activity leads to 
misclassification the strength of some associations between activity and risk factors. 
Accurate assessment of physical activity and sedentary time is required to prevent the risk 
of health (Celis-Morales et al. 2012).  
Assessing physical activity and sedentary behavior become more attainable in recent time 
because of small devices such as accelerometers and inclinometers. Accelerometers are now 
being widely used in laboratory and non-laboratory conditions (e.g., at home, work and 
leisure time activities) (Healy et al. 2008b;Patel et al. 2010).  These devices are easy to use 
and obtain adequate data (Healy et al. 2008b;Matthews et al. 2008). Accelerometers are 
categorized as uniaxial, biaxial, and triaxial depending on the number of planes in which 
movement is observed. Uniaxial devices register vertical acceleration in 1plane, and biaxial 
devices register acceleration in 2 planes. Triaxial devices register acceleration in 3 planes by 
3 different accelerometers positioned internally at 90 degrees from one another, X-axis 
(vertical), Y axis (mediolateral) and Z axis (anterioposterior)  (Berlin et al. 2006). Astatic 
acceleration due to gravity is recorded in the vertical axis; when walking or moving, a 
dynamic accelerations are superimposed on this and measured in all three planes. The vector 
magnitude acceleration can be used to summarise overall acceleration values (Stanton et al. 
2014). 
Accelerometer can measure the frequency, intensity of movement total time spent sedentary 
and physical activity. It can be used to estimate short incidental breaks in sitting time which 
might not be practically recorded by self-report measures (Atkin et al. 2012). Accelerometer 
has an internal clock so physical activity can be time stamped which allows to record daily 
patterns of physical activity and storing for later recall.  
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While objective measures, such as accelerometers, can quantify activity and sedentary time, 
the quality of measuring sedentary time using accelerometers might depend on the wear 
location. One of the most used accelerometers for measuring sedentary behaviour and 
physical activity is the ActivPAL Professional physical activity monitor (PAL technologies 
Ltd, Glasgow, UK), )5.4cm x 3.5cm x 0.6cm), which is usually attached to the thigh and 
integrates a tri-axial sensor to measure acceleration in three different axes (x, y, and z), 0.05 
- 2.5 g, and it measures acceleration at a sampling frequency of 20 Hz. From determining 
the axis through which the static acceleration due to gravity (g) is observed, the orientation 
of the accelerometer can be determined.  As the orientation of the thigh changes between 
sitting and upright activities, the thigh placement of the ActivPAL enables determination of 
sitting and upright postures and therefore enables measurement of sedentary behaviour 
according to the posture-based definition.  In addition the device can measure dynamic 
accelerations due to stepping and can therefore quantify number of steps and stepping rate.  
The ActivPAL has been validated for use with adults as a measure of physical activity and 
body posture, for assessing posture during free living activities (Dahlgren et al. 2010; Dowd 
et al. 2012; Godfrey et al. 2007; Grant et al. 2006; Harrington et al. 2011; 
PAL.technologies.Ltd 2006; Ryan et al. 2006). 
Grant et al determined the validity of the ActivPAL compared to direct observation to 
measure sitting time in a laboratory environment. The mean percentage difference between 
sitting time between the accelerometer and direct observation was 0.19% (Grant et al. 2006). 
In another validation study,  Kozey-Keadle et al 2012 (Kozey-Keadle et al. 2012) determined 
that the relationship between the ActivPAL and the direct observation for measuring sitting 
time was high (R2 = 0.94). Consequently, the activPAL is a valid tool to estimate the time 
spend sitting in adults (Atkin et al. 2012; Grant et al. 2006; Kozey-Keadle et al. 2011). In 
addition, studies have determined that the ActivPAL was valid for determining the number 
of transitions between sitting and standing (breaks in ST) in both laboratory (Grant et al. 
2006) and free-living conditions (Lyden et al. 2012). The ActivPAL has also been shown to 
have better agreement with direct observation of sitting time compared the Actigraph 
accelerometer (model GT3X) (Dowd et al. 2012). 
The activPAL has been established as a potentially useful tool for measuring sitting, standing 
time and step counts. One limitation of the ActivPAL is that it can only provide accurate 
step counts, but cannot gain any information of different types of activity being undertaken 
(Atkin et al. 2012).  The ActivPAL’s thigh-based accelerometer position may also provide 
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advantages for the assessment of physical activity, over other body locations, as 
accelerations at the thigh must be generated by the person moving their leg.  Currently, the 
ActivPAL generates an output of step counts, based on a proprietary algorithm, but an 
opportunity exists to develop more sophisticated physical activity output metrics from the 
acceleration signals generated by thigh movement. 
Recently, researchers explored whether acceleration data generated by ActivPAL monitor 
could be used to adequately discriminate between time sitting or lying. Lyden and colleagues 
developed and validated a new method to distinguish between sitting and lying by using the 
acceleration signal from the y-axis of a thigh-placed AP to define rotation of the thigh.  The 
author detected that the algorithm correctly recognized 96.7% of the sedentary time as lying 
and 92.9% of the time as not lying. This study can assist researchers in understanding the 
relationship between the actual time spend sitting and health outcomes (Lyden et al. 2016).  
Another popular device for the academic measurement of physical activity is ActiGraph, 
which is a small tri-axial monitor accelerometer (size: 38x37x18mm, weight: 27g). It is 
designed to be worn on the hip by using an adjustable belt, and integrates a tri-axial sensor 
to measure acceleration in three axes at sampling rates up to 100 Hz, using cut points with 
traditionally a cut-point of < 100 counts per minute (cpm) applied to estimate sedentary time. 
Although much progress has been made in the assessment of physical activity with 
accelerometers, there are several limitations when using hip-based accelerometers to assess 
sedentary time. Accelerometers do not include an inclinometer for measuring postures and 
it could not, therefore, distinguish between sitting and standing pattern.  As a result, time 
spent standing is counted as sedentary (Atkin et al. 2012). Recent models of the ActiGraph 
such as GT3X and GT3X+ contain an inclinometer algorithm which can define sitting, lying, 
standing time and when the device not been worn. However, when the device is worn at the 
hip, the output between sitting and standing is similar, leading to misclassification of 
standing as sitting time (Atkin et al. 2012;Carr and Mahar 2012;Lyden et al. 2012). Further 
research is needed to examine the validity of this additional feature (Carr and Mahar 2012). 
Kozey-Keadle et al (Kozey-Keadle et al. 2011) tested the validity of an Actigraph 
accelerometer in quantifying sedentary time using the threshold value of 100 counts per 
minute. It was found that the Actigraph underestimated sedentary time by 4.9% (SE 3.4 %) 
compared to direct observation. Similarly Lyden et al (Lyden et al. 2012), found that the 
ActiGraph is not a valid tool to assess breaks in sitting time.  However, the ActiGraph is one 
of the most widely used and extensively validated tools for assessing physical activity 
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intensity. The Freedson cut-points are one of the common approaches (Freedson et al. 1998) 
that have been used to evaluate time spent in light intensity activity (100 – 1951 cpm) and 
MVPA ( ≥ 1952 cpm). Freedson and colleagues (1998) developed the regression equation 
on a sample of 50 adults (mean age 24.8 years) men and women. Subjects achieved slow 
(4.8 km.h-1) and high walking speeds (6.4 km.h-1), and jogging (9.7 km.h-1) speeds. The 
equation was thereafter cross-validated on a random sample of 15 subjects. The result 
indicated that there was a good correlation between actual and predicted EE from Actigraph 
using the developed equation (r=0.93, SEE = ± 0.93 kcal.min-1, P < 0.05). The developed 
Freedson equation is: Kcal.min-1 = (0.00094 x cnts·min-1) + (0.1346 x body mass (kg)) – 
7.37418 (r2 = 0.82, SEE = ± 1.40 kcal·min-1) (Freedson et al. 1998). The Actigraph can also 
be used to determine step counts. A recent study suggested that step outputs gained from 
ActiGraph accelerometers at waist and wrist positions are in general not equivalent under 
both laboratory and free-living conditions (Tudor-Locke et al. 2015). 
In another study, Steeves et al. (Steeves et al. 2015) compared the Actigraph and ActivPAL 
when worn on the thigh during controlled and free-living conditions. Participants were asked 
to perform (six sitting, two standing, nine stepping, and one cycling) and writing on a 
whiteboard with intermittent stepping under laboratory conditions, and under free-living 
conditions for 3 d. In the laboratory condition, both monitors acceptably quantified 100% of 
standing time and >95% of the time spent in 4 of 6 sitting postures. Both devices misclassifed 
sitting on a laboratory (Actigraph 14% vs ActivPAL 95%). ActivPAL misclassified 14% of 
sitting time with legs elongated; whereas ActiGraph classified this correctly in all cases. 
Both devices were >95% accurate for stepping rate, while Actigraph was less accurate for 
descending stairs (86%), ascending stairs (92%), and running at 2.91 m.s-1 (93%). The two 
accelerometers categorised whiteboard writing differently (ActiGraph 85% standing and 
15% stepping vs activPAL 98% standing and 2% stepping). ActivPAL categorized 93% of 
cycling time as stepping, in contrast to the Actigraph categorized <1% of cycling time as 
stepping. In free-living condition, accelerometers were similarly accurate in correclyu 
classifying activities (86% observed). The two accelerometers categorized similar amounts 
of time as sitting (ActiGraph 64% vs ActivPAL 62%). There was variation in time recorded 
as standing (ActiGraph 21% vs ActivPAL 27%) and stepping (ActiGraph 15% vs ActivPAL 
11%).  
Berendsen et al (Berendsen et al. 2014) observed the validity of activPAL3, ActiGraphGT3X 
and CAM under laboratory and free-living conditions. This study presented that ActiGraph 
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(worn at the waist) correctly classified 33.9% of the time during sitting, lying and upright 
posture time, whereas the activPAL and CAM were100% accurate. Skotte et al. (Skotte et 
al. 2014) assessed the validity of triaxial accelerometer ActiGraph GT3X+, placed on the 
hip and thigh for measuring sitting time through controlled and free-living conditions. Under 
free living conditions, the thigh position showed improved performance of sensitivity (98%) 
and specificity (93%) for identify sitting time compared to the hip position (73 and 58% 
respectively). In another study Carr et al, (Carr and Mahar 2012) evaluated the accuracy of 
ActiGraph GT1M, ActiGraph GT3X+, and StepWatch for measuring light-intensity 
activities and various sedentary under controlled conditions. Their findings showed that all 
three monitors correctly assessed most behaviors. 
Another study has done by Judice (Judice et al. 2015b) to observe the accuracy of the GT3X 
and Actiheart for measuring sitting time and break sitting in 10 overweight/obese adults in 
free living conditions, using the ActivPAL as the criterion reference. Sedentary time was 
overestimated by GT3X and underestimated by Actiheart (bias = 135min: bias = -156 min 
respectively), and both devices overestimated time of sedentary breaks (bias = 78min: bias 
= 235 min respectively).  
Another study has done to observe the validity of inclinometer functions of Actigraph (AG) 
GT3X+ positioned on waist vs wrist and ActivPAL in measuring 3 different postures (sitting, 
standing and stepping). Sixty two participants were asked to complete 15 activities which 
included 5 patterns of sitting, 4 patterns of standing, climbing stairs, walking at 2.0, 3.0 mph 
and walking at 3.0mph and typing at a treadmill-desk (TrekDesk) and running at 4.5mph, 
5.5mph. Based on direct observation, ActivPAL seemed to be accurate for measuring sitting 
and standing compared to waist and wrist AG (An et al. 2016). 
However, although the available evidence suggests that the thigh-positioned ActivPAL 
accelerometer provides the gold-standard position for the measurement of sedentary 
behaviour, the current outputs for physical activity from this device are relatively limited, 
with outputs limited to step count and stepping rate.  This has resulted in a number of 
researchers using two devices to obtain a complete assessment of sedentary behaviour and 
physical activity – an ActivPAL for the former and another device, such as the Actigraph 
with a more comprehensive output of physical activity for the latter (An et al. 2016).  Thus, 
there is an opportunity to develop new physical activity outputs from the activPAL, such as 
walking speed and an estimation of oxygen uptake and energy expenditure which will enable 
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researchers to use a single device to obtain comprehensive assessment of both sedentary 
behavoiur and physical activity. 
This thesis therefore has two main sections.  The first is to determine the effects of 
interventions which break up sedentary time of metabolic responses which may influence 
vascular and metabolic risk.  The second is to undertake studies to facilitate better 
measurement of physical activity using a thigh-worn accelerometer device.  
The aims of this thesis are therefore:           
1) To compared the effects of prolonged sitting, prolonged periods of standing, and the same 
total amount of standing undertaken in multiple short standing bouts, on metabolic responses 
over the course of a day. This will help to determine whether, in principle, the number of 
transitions between sitting and standing influences metabolism independent of total time 
spent sitting or upright. 
2) To determine whether, breaking up prolonged sedentary time by undertaking ‘chair 
squats’ repeated sit-to-stand transitions over a short period (sitting and standing 10 times 
over 30 seconds, every 20 minutes) – provides measureable metabolic benefits. This will 
help to determine the efficacy of a practical, light touch intervention, which could potentially 
be used in a real-world intervention. 
 
3) To determine the accuracy of measurement and validate new metrics of physical activity 
for thigh-worn accelerometers.  Specifically, these aims are to: 
3a) To compare the accuracy of measurement of directly observed stepping rate with thigh- 
and hip-placed accelerometers across a range of walking and running speeds.  
3b) To determine the relationship between raw accelerations and walking and running 
speeds for thigh- and hip-placed accelerometers for treadmill-based walking and running. 
3c) To determine the relationship between raw accelerations and oxygen uptake for thigh- 
and hip-placed accelerometers for treadmill-based walking and running. 
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3d) To compare the relationships between raw accelerations and walking and running speeds 
for treadmill-based compared with overground walking and running. 
3e) To use the information above to develop and validate algorithms to estimate energy 
expenditure from raw acceleration counts for thigh- and hip-placed accelerometers. 
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2. General Methods 
This chapter provides a description of all general methods that have been implemented in 
the following experimental chapters. Methods specific to individual chapters will be 
highlighted separately in each experimental chapter. Methods used for statistical and data 
analyses are outlined in the relevant study chapters. 
 Participants 
Participants were recruited from the students and staff of University of Glasgow and 
residents in the Glasgow area via emails, online advertising and advertisement in the public 
places. Participants were required to attend for baseline screening at the University to ensure 
they fulfilled the inclusion criteria of each study.  The study was explained in detail and all 
the questions were answered. The information sheets were provided to describe the aim of 
the study, the experimental procedures involved and the risk and benefits of participation 
(Chapter 3: Appendix A, Chapter 4: Appendix I, Chapter 5: Appendix N). Volunteers 
were also encouraged to ask any questions before agreeing to participate. Each participant 
completed health screening questionnaire and were asked to sign a consent form to 
participation in the study, which was approved by Research Ethics Committees of Medical, 
Veterinary and Life Sciences from the University of Glasgow (Appendix B). Their resting 
blood pressure measurements were taken using an automated sphygmomanometer (Omron 
Healthcare, Inc., Illinois, USA), three measurements were taken, of which values were 
averaged, and fasting finger-prick blood sample were also tested to measure glucose 
following a 12-hour overnight fast. Common exclusion criteria were used as follows frank 
diabetes (physician diagnosed or fasting glucose (>7 mmol.l-1 on screening), uncontrolled 
hypertension (>160/90 mmHg on anti-hypertensive medication), previous history of 
established CHD or current medications known to affect lipid or glucose metabolism, 
smoker and non-overweight (body mass index < 25 kg/m²). 
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 Anthropometric Measurements 
 Statuse 
Height was measured using a standard stadiometer (Invictus Plastics Ltd., Leicester, 
England). Each Participants were asked to stand barefoot, with both feet alongside one 
another, and with their back of the head, back, buttocks, calves and heels against a 
stadiometer.  The head was positioned in the Frankfort plane. The participant was asked to 
look straight. This was then immediately followed by recording the last measurement on the 
on the rule. Measurement was recorded to the nearest 0.1 cm. 
 Body Mass 
Body mass was measured in light and minimal clothing (i.e. generally light-weight shorts 
and t-shirt) without shoes. Measurement was recorded to the nearest 0.01 kg using a 
balanced-beam scale. Participants were asked to stand in the centre of the platform, facing 
forward and with arms straight to the sides of their body.  Body mass was estimated using 
the same scale through all the experimental studies. BMI was then calculated as body mass 
in kilograms divided by the square of height in metres. 
 Waist and hip Circumference Measurement 
Hip and waist circumference were measured in touch with the skin using a flexible, steel 
tape measure (Supralip 160, West Germany). Hip circumference was measured horizontally 
around the maximum circumference over the trochanters (buttocks), with the participants 
standing with both feet alongside one another and arm the side. The waist circumference 
measurement points were noted in precise and exact terms (namely, between the costal 
margin and iliac crest. The measurements were taken twice and then the average was 
calculated. If the two readings were inconsistent by more than 0.5 cm, a third reading was 
taken. 
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 Expired Air Measurements and Heart Rate Monitoring 
 Measurement of oxygen uptake and carbon dioxide production  
Oxygen uptake and carbon dioxide production in Chapters 3, 4 and 5 were determined at 
rest before and during exercise.  Expired air was collected using the Douglas bag method, 
which was also used as the gold standard comparison. Prior to all resting measurements, 
participants achieved a ten-minute run in period to ensure they were comfortable and in a 
true resting state. Participants were fitted a nose clip, breathing through a rubber mouthpiece 
connected to a lightweight large 2-way respiratory valve (2700 series, Hans Rudolph Inc. 
USA), which in turn was connected to a flexible plastic tubing. The tubing was connected to 
evacuated 100,150 or 50-litre Douglas bag via another two-way valve to control the flow of 
expired air into the Douglas bag. 50-litre Douglas bag was used for measuring the gas when 
the expired values were small, for example during 30 second collections of chair squats 
activity, 100 and 150-litre bags were used at other activities.  
 Once the gas sample was collected, a small amount of gas was extracted from the used 
Douglas bag measured by a Servomex Gas Purity Analyser (Analyser Series 1400) to 
determine the FEO2 %, FECO2% in each separate bag. The gas analyser was calibrated prior 
to each test using certified reference gases (BOC Gases, Surry, UK) with known reference 
gases (i.e. 100% nitrogen, 16% O2, 5% CO2 and room air calibration). The remaining expired 
sample volume in the bag was extracted out using a dry gas meter (Harvard Apparatus, Kent, 
UK) to record Gas sample volume and temperature. Barometric pressure was recorded using 
a standard mercury barometer during each test. These were utilised alongside fractional 
expired oxygen (FEO2) and carbon dioxide concentration (FECO2) to evaluate oxygen uptake 
(VO2) and carbon dioxide production (VCO2), expired air fractions and volumes were 
corrected for standard room temperature and pressure for a dry gas (STPD) (760 mmHg) to 
indicate VO2 (STPD), VCO2  (STPD), and respiratory exchange ratio (RER).  The respiratory 
exchange ratio uses the ratio of VCO2 to VO2 as a marker of substrate oxidation and is typically 
between 0.7 and 1.0; 0.7 reflecting total fat oxidation and 1.0 total carbohydrate oxidation 
(Ferrannini, 1988).  
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 Calculation of fat and carbohydrate oxidation, and energy expenditure by 
indirect calorimetry 
 Fat and carbohydrate oxidation rates, were calculated via indirect calorimetry using the 
equations defined by Frayn (Frayn 1983) as described below.  
VO2 (1.min-¹)      =       0.746 C + 2.03 F+ 6.04 N                  (Equation 2-1( 
VO2 (1.min-¹)      =       0.746 C+ 1.43 F+ 4.89 N         (Equation 2-2( 
Where: 
C = carbohydrate oxidation in grams per minute 
F = fat oxidation in grams per minute 
N = urinary nitrogen excreted in grams per minute 
 
No direct measure of urinary nitrogen excretion was performed in any experimental chapter, 
therefore, a constant rate of nitrogen excretion of 0.00011 g.kg-1.min-1 was utilized, a value 
which has previously used in the literature (Flatt et al. 1985; Melanson et al. 2005). 
The constant nitrogen was calculated as the equation below as follow: 
N (g.min-1) = 0.00011 x body mass                                (Equation 2-3(      
Therefore, non-protein oxygen consumption (NP VO2) and non-protein carbon dioxide 
production (NP VO2) and the non-protein respiratory quotient (NPRQ) can be calculated as 
follows: 
 NP VO2 (l.min-1) = 0.746 C + 2.03 F- 6.04 N               (Equation 2-4( 
NP VO2 (l.min-1) = 0.746 C + 1.43 F - 4.89 N            (Equation 2-5)    
NPRQ = NP VCO2 / NP VO2                                (Equation 2-6(  
Substrate utilization, was calculated as below based on the protein corrected values from 
above: 
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 Fat oxidation (g.min-1) = (NP VO2 - NP VCO2) / 0.6                            (Equation 2-7( 
 Carbohydrate oxidation (g.min-1) = (NP VO2 - 2.03 x Fat ox) / 0.746    (Equation 2-8( 
 Protein oxidation (g.min-1) = N x 6.25                                                    (Equation 2-9( 
Total energy expenditure (EE) was calculated by multiplying the amount of substrate 
oxidised by their appropriate energy density value which were taken from (Brody, 1999; 
Mottram, 1979):   
Energy expenditure (kJ) = (F x 39.0) + (C x 15.5) + (P x 17.0)             ) Equation 2-10( 
Net energy expenditure and energy substrate utilisation rates were calculated by subtracting 
the baseline rate from the total energy expenditure or substrate utilisation to give the rise 
above resting values (Brody 1999; Mottram 1979).  
  Heart Rate Monitoring  
Heart rates were monitored during exercise by a Polar heart rate system which consisted of 
a heart rate transmitter and a wrist receiver (POLAR, Kempele, Finland).  
 Dietary Assessment 
 2-Day Dietary Record  
In Chapters 3 and 4, participants were asked to weigh and record their food intake, and 
refrain from alcohol on the two days preceding their first main experimental trial and to 
replicate this for the two days preceding subsequent trials. Scales, record sheet and written 
instruction were provided to record as detailed as possible each item that they ate or drank, 
the time that ate it and the quantity in grams (Appendix D).  
 Test meal 
In Chapters 3 and 4 participants were given a standardised breakfast and lunch comprising 
a buttered bagel and strawberries (Complan Foods Ltd, UK) made up with whole milk to 
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form a strawberries milkshake drink, which provided (~ 8 kcal/kg body weight with ~ 37% 
energy from fat, ~ 49% from carbohydrate and ~ 14% protein). All participants were asked 
to consume each test meal within 10 minutes and water was allowed during this time.  
 Daily Physical Activity Assessment 
Participants were asked to refrain from planned exercise (undertaking only the activities of 
normal daily living) for 3 days. Physical activity and sedentary behaviour was objectively 
measured using ActivPAL accelerometers (PAL Technologies Ltd., Glasgow, UK). 
 For each subject, the number of activities (sitting, standing, walking, steps number and the 
number of transitions (“breaks”) were calculated using the summary formed Figure 2-1 
generated by the activPAL Professional Research Edition software (Version 5.8.2.3). Non-
wear time was known from the subject’s activity recording sheet (Appendix E). 
   Blood Sampling and Analysis 
In chapters 3 and 4, blood samples were used for analysis of postprandial metabolites 
analysis. Subjects arrived at the metabolic suite in the morning on an overnight fast. Subjects 
were asked to rest in a semi-supine position while a cannula was placed in an antecubital 
vein, to which a 10 cm three-way stopcock (Connecta plus 3, BD, Sweden) was connected. 
A baseline sample was collected after 10 min the cannula was kept patent by flushing with 
a small amount of non-heparinized saline solution 0.9% after each sample collection. A 
saline waste remaining in the connector tube was taken off by a 2 ml syringe, before each 
blood samples, then, a blood samples were taken in 10 ml tube containing K3EDTA (Becton 
Drive Vacutainer, New Jersey, USA) during the observation period, as specified in chapter 
3 and 4, and placed immediately in ice and centrifuged (GS-6KR, Beckman Instruments, 
Inc, California, US) within 15 minutes at 4000 revolutions per minute (rpm) at 4 C, 2580 
relative centrifugal force (RCF). When the plasma and red blood cells were separated, 3 ml 
aliquots of plasma were extracted and placed into 200 μl in 0.5 ml labelled tubs (Alpha 
laboratories, Ltd, UK).  All samples were frozen immediately at -80°C.  
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 Insulin Analysis 
 Insulin was measured in freshly frozen EDTA plasma using commercially available ELISA 
kits (Mercodia AB, Uppsala, Sweden).  All ELISA procedures were based on a ‘sandwich’ 
technique which two monoclonal antibodies are directed against separate antigenic 
determinants on the insulin molecule.  The wells of the plates were coated with antibody 
specific to the protein of interest being measured in plasma. A plasma samples (25 µl) was 
added to the wells. Then a 100 µl of freshly prepared enzyme conjugate solution was pipetted 
to each well. The plates were then incubated on a plate shaker for 1 hour at room temperature. 
During this incubation period, insulin in the samples reacted with peroxidase-conjugated 
anti-insulin antibodies and anti-insulin antibodies bound to plate wells. After that, the plates 
were washed and dried 6 times by automatic washer to remove any unbound enzyme labelled 
antibody using the provided wash buffer solution. Bound conjugates which remained in the 
wells were identified by adding 200 µl of 3,3’,5,5’-tetramethylbenzidine (TMB). Then, the 
plates were incubated for 15 minutes at room temperature to allow reaction between 
substrate TMB and bound conjugates. After incubation, 50 µl of the Stop solution containing 
0.5 M sulphuric acid were pipetted to each well to stop the reaction. A yellowish-tint colour 
developed according to the concentration of conjugate-substrate complex. The optical 
density of each well was read at 450 nm using a spectrophotometer.  All samples were run 
in duplicate together with the standards ranging from 0 to 200 mU/l. A standard curve was 
obtained by computerised data reduction of the absorbance for the standards against the 
concentration using cubic spine regression. The concentration of insulin in the samples was 
then determined by comparing the optical density of the samples to that of the standard curve 
for each respective plate. All reagents and samples were brought to room temperature before 
use. Coefficients of variation for the assay were <5%. 
 Glucose Analysis  
Glucose was measured in fresh EDTA plasma using (YSI 2300 STAT PlusTM Glucose and 
Lactate Analyser, YSI (UK) Ltd.). EDTA plasma was used after centrifugation for 15 min 
at 4000 rpm, the Relative Centrifugal Force or G-force 2580 (RCF). The analyser was 
calibrated prior to each test in the morning, afternoon and after last sample using high and 
low certified reference. A sample was placed into a manual sample station. The result 
appeared on a small screen and a printer paper was obtained. Each sample was measured 
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twice and the average has been taken. All samples within each subject were performed on a 
single run and in duplicates with coefficients of variation of <3%. 
The YSI 2300 STAT PLUS uses a sensor technology with an immobilized enzyme 
membrane. Glucose in plasma is rapidly oxidized by glucose oxidase enzyme producing 
hydrogen peroxide (H2O2).   The hydrogen peroxide, in turn, is oxidized at a platinum anode 
producing electrtons. The electron flow, which is measured by the senor, is linearly 
proportional to the concentration of glucose.  
     Glucose Oxidase 
-D-glucose   +   O2    glucono--lactone    +    H2O2  
         Platinum anode 
H2O2     2 H
+ + O2 + 2 e
‒  
 Triglyceride Analysis 
Plasma TG concentrations were measured by members of staff in the Clinical Biochemistry 
Department at Glasgow University.   
A lipoprotein lipase derived from micro-organisms is used to rapidly and completely 
hydrolyse TG to glycerol followed by the oxidation of glycerol to dihydoxylacetone 
phosphate and hydrogen peroxide. The hydrogen peroxide then reacts with 
4aminophenazone and 4-chlorophenal under the catalytic action of peroxidase to form a red 
dyestuff. All samples within each subject were performed on a single run and in duplicates 
with coefficients of variation of <2%.    
 Lipoprotein lipase 
Triglycerides + H2O                                    glycerol + fatty acide    
                   glycerokinase 
Glycerol + ATP                          glycerol-3-phosphate + ADP    
        glycerol-3-phosphate oxidase 
Glycerol-3-phosphate + O2                                       dihydroxyacetone phosphate + H2O2    
      Peroxidase 
H2O2 + 4- aminoantipyrine + p-chlorophenol                        Quinoneime + 4 H2O   
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 Objective measurement of Physical Activity and Sedentary 
Behaviour 
In chapter 5, participants performed two experimental trials – one involving walking and 
running on a treadmill and one involving walking and running on an athletics track.  For 
each trial, participants wore activPAL devices (small commercially-available matchbox-
sized accelerometer/inclinometers on in a number of locations on the body (lower thigh, 
upper thigh, and hip on the left and right sides), and Actigraph accelerometers (small 
commercially-available matchbox sized accelerometers, fixed on the right and left hips, to 
record body accelerations and posture changes. 
 ActivPAL (AP) Accelerometer  
Sitting, standing, walking and other types of physical activity were measured using the 
ActivPAL professional monitor (PAL Technologies Ltd., Glasgow, UK) (Firmware: v 
5.8.2.3), which is a tri-axial accelerometer and inclinometer (is a single-unit monitor based 
on a uniaxial) (5.4cm (L) x 3.5cm (W) x 0.6cm (D)), weighing approximately 15g. Typical 
activPAL devices are shown in Figure 2-2.  The device is manufactured by PAL 
technologies Ltd. Glasgow, Scotland. The AP designs to wear midline on the anterior aspect 
of the thigh Figure 2-3, which is attached to the skin using double-sided hydrogel adhesive 
pads, (PALstickies), and covered with clear adhesive tape. The device produces a signal 
related to thigh inclination which responds to gravitational accelerations resulting from 
segmental movement (Dowd et al. 2012; Ryan et al. 2006), that is recorded the activity by 
measuring raw accelerations counts in three orthogonal axes, X plane (vertical),Y plane 
(mediolateral) and Z plane (anterioposterior) (Stanton et al. 2014), Figure 2-4  shows 
illustration of ActivPAL axis: x, y and z. The activPAL provide outputs including time spent 
sitting /lying, standing, step count and cadence and has been shown to be valid  and reliable 
measurement to quantify poster, activity of daily living (Dowd et al. 2012;Grant et al. 2006), 
step number and cadence in a healthy adult population (Ryan et al. 2006). This monitor has 
a sampling frequency of 20 Hz for each 15 second time interval (epoch), and has the memory 
of 4 Mb and battery life capacity to record and store data for >8 days. Propriety software 
(ActivPAL Professional Research Edition) permit the monitor to be initialised for data 
collection start and end dates and times via the PAL3 USB Dock charging system. There are 
five stations on the docking cable, four for charging Figure 2-2 and one for initializing, data 
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transfer, and charging as well. PAL3 USB Dock Charging System can be used to download 
the data retrieval to the computer in the form of daily and hourly activity, which is classified 
as time spent sitting/lying, standing, stepping, step cadence and energy expenditure over 1h 
and numeric formats can be exported to Microsoft Excel. In addition, proprietary algorithms 
also, classifies and records posture transitions [sit-to-stand (u) and stand-to-sit (d)] Figure 
2-5. The result can be obtained per hour, day and week.  
                                                          
Figure 2-2: ActivPAL Monitor                                              
                                                                
                                                           Figure 2-3: ActivPAL Placement    
                                      
  
Figure 2-4: Raw Accelerations Counts (X,Y and Z) 
X 
Z Y 
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Figure 2-5: ActivPAL output (summarized by hour).  
Sit/lie times in yellow, standing time in green, and walk-steps in red. Transitions (sit-to-stand (u), stand-
to-sit (d)) are presented at the right side. 
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 ActiGraph (AG) Accelerometer 
The second selected type of movement sensing device is Actigraph accelerometer which is 
used for measuring physical activity (PA). The device is attached to a belt strapped around 
the waist. The Actigraph GT3X+ (Firmware v 4.1.0) (model 7123: Actigrph, LLC, Fort 
Walton Beach, Florida) is small (2.0 × 1.6 × 0.6 inches (5.1 × 4.1 × 1.5 cm)) and lightweight 
(19 grams). AG is a tri-axial accelerometer and can measures acceleration in three individual 
orthogonal planes using a vertical axis activity acceleration data (Axis 1), horizontal axis 
activity acceleration data (Axis 2), and perpendicular axis activity acceleration data (Axis 
3), indicates whether a subject is standing, sitting or lying down when the device is worn at 
the hip as well as indicating that a device is not being worn at all has enable to directly 
identify periods of sitting/lying, standing and stepping. When worn on the hip and perfectly 
vertical, the y-axis alone should contain the total acceleration due to gravity. As a subject 
inclines, the offset angle (θy) increases. If the device is not being worn, then one expects the 
z-axis to reflect the total acceleration due to gravity as the device rest on a table-top for 
example. Therefore, the addition of the z-axis offset angle (θz) is required to distinguish 
between lying and off. Figure 2-6 contains examples of this y-axis offset angle in the 
standing (top-left), sitting (top-right), lying (bottom-left), and z-offset angle in the off 
(bottom-right) positions.  The AG sample acceleration at rate of 30-100Hz, for each 1 second 
time interval (epoch), and a memory capacity of 4 GB that allows recording of data in excess 
of 180 days. The AG interfaces with a windows compatible PC and the software package 
(ActiLife 6) analyses the activity record using proprietary algorithms. The device also 
connects with a PC program via a USB to initialize and download the data. The software 
summarises activity over 10 sec periods in graphical format, the data and graph were saved 
in Excel file and PDF respectively. (Freedson et al. 1998)  cut-points used to define intensity 
domains (light < 1952 count.min-1; moderate 1952-5724 count.min-1; vigorous 
>5725count.min-1). A sedentary bout was define as a period of < 100 count.min-1, while non-
wear time was defined as intervals of least 60 min of 0 activity counts (Actigraph 2017).  
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Figure 2-6: Sitting, Standing, Lying and Off Position 
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3. Frequency of breaks in sedentary time and 
postprandial Metabolism  
 Introduction 
There is a large body of observational data showing strong associations between time spent 
engaged in sedentary behaviour – defined as non-sleeping activities in a sitting or reclining 
posture with energy expenditure ≤1.5 METS (where 1 MET is resting energy expenditure) 
(Sedentary Behaviour Research Network 2012) – and a number of adverse health outcomes, 
including mortality, cardiovascular disease, type 2 diabetes and obesity (Edwardson et al. 
2012; Healy et al. 2011; Thorp et al. 2011; Wilmot et al. 2012). These relationships are often 
independent of time spent engaged in moderate-to-vigorous physical activity (>3 METS) 
(Edwardson et al. 2012; Healy et al. 2011; Thorp et al. 2011; Wilmot et al. 2012).  In 
addition, recent observational data in almost 700 adults from the AusDiab study, using a 
postural sensor to objectively monitor time spent sitting, standing and stepping, suggested 
that isotemporally replacing sitting with standing was associated with favourable changes to 
glucose and lipid metabolism (Healy et al. 2015). There is also observational evidence to 
suggest that individuals who break up sedentary time more frequently have a more 
favourable cardio-metabolic risk profile – particularly with respect to adiposity variables – 
than those who habitually engage in prolonged periods of uninterrupted sedentary time, 
independent of total time spent sedentary (Cooper et al. 2012; Healy et al. 2008a; Healy et 
al. 2011).  However, the mechanisms by which more frequent breaks in sedentary time may 
impart these benefits, independent of total sedentary time, are unclear.  A number of short-
term intervention studies have shown that interrupting sedentary periods with multiple short 
(≤3 min) bouts of light or moderate activity throughout the day can reduce postprandial 
glucose, insulin and triglyceride (TG) responses, and blood pressure, on the same or 
following day (Dunstan et al. 2012b; Larsen et al. 2015; Miyashita et al. 2008; Peddie et al. 
2013).  Other studies have shown that interrupting prolonged sitting with periods of static 
standing ranging from five minutes every 30 minutes (Henson et al. 2016) to 30 minutes 
every hour (Thorp et al. 2014b), can reduce postprandial glucose concentrations.  However, 
in all of these studies sedentary time was replaced by standing or walking leading to a 
reduction in total time spent sedentary, so the effects of altering the frequency of breaks in 
sedentary time, independent of changing total time sedentary, on these metabolic responses 
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are not known.  It is also not known whether altering the frequency of breaks in sedentary 
time influences metabolic rate and substrate utilisation, which may provide an explanation 
for the association between frequency of sedentary breaks and adiposity observed in the 
epidemiological data (Cooper et al. 2012; Healy et al. 2008a; Healy et al. 2011).  The aim 
of this study was therefore to compare the metabolic effects of breaking up sedentary time 
with prolonged periods of standing versus multiple shorter standing bouts with the same total 
duration to determine whether – in principle – altering the frequency of breaks in sedentary 
time, influences metabolic responses over the course of the day. 
 Methods 
 Participants 
 
Ten men, aged 33 ± 13 years, with body mass index (BMI) 28.3 ± 2.8 kg.m-2, waist 
circumference 100.2 ± 9.5 cm [mean ± SD], and low levels of habitual physical activity (less 
than 2 hours per week of moderate-to-vigorous physical activity as assessed by the 
International Physical Activity Questionnaire), were recruited for this study though personal 
contacts and local advertising.  All participants had BMI >25 kg.m-2, were non-smokers, had 
no known history of CVD or diabetes (and fasting glucose <6.0 mmol.l-1 on screening), and 
were not taking any medications known to affect lipid or glucose metabolism. The study was 
conducted in accordance with the principles of the Declaration of Helsinki and approved by 
the College of Medical, Veterinary and Life Sciences Research Ethics Committee at the 
University of Glasgow.  All participants provided written informed consent.  
 Study design 
 
Participants each completed three 8-hour experimental trials; uninterrupted sitting (SIT), 
prolonged standing (PRO-Stand), and intermittent standing (INT-Stand) in a randomised 
order, with an interval of 1 week between trials (Figure 3-1).  
Uninterrupted sitting trial (SIT): Participants arrived at the metabolic suite after a 12-hour 
overnight fast.  They sat comfortably for 10 minutes, before two sequential 5-minute expired 
air samples were collected via a mouthpiece into a Douglas bag to calculate metabolic rate 
and substrate utilisation using indirect calorimetry (Frayn and Macdonald 1997).  The 
average of these samples was used as the baseline value.  A cannula was then inserted into 
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an antecubital vein for repeated blood sampling, with was kept patent by flushing with saline 
throughout the day. A baseline fasting blood sample was drawn in K2EDTA tube and placed 
immediately on ice. Further blood samples were taken at 30, 60, 120, 180 and 240 minutes 
after breakfast (see section 2-7 for more details).  Four hours after breakfast, participants 
consumed a test lunch, which was identical to breakfast, and further blood samples were 
taken 30, 60, 120, 180 and 240 minutes after lunch (i.e. 270, 300, 360, 420 and 480 minutes 
after breakfast).  Expired air samples for the determination of metabolic rate and substrate 
utilisation were collected at 15-minute intervals every 30 - minute throughout the 8-hour 
observation period.  Participants sat comfortably and continually (reading, watching TV, 
doing paperwork etc) throughout the observation period and were permitted to drink water 
throughout the day.  Comfort breaks to the toilet (which was ~20 m from the metabolic 
investigation suite) were permitted using a wheel chair: these were recorded, and as far as 
possible replicated in subsequent trials.   
Prolonged standing trial (PRO-Stand): This was identical to the SIT trial, except that in 
each 30-minute period throughout the day, participants were asked to sit for 15 minutes and 
stand stationary for 15 minutes, so that in total they stood for 4 hours and sat for 4 hours, 
with 16 sit-to-stand and 16 stand-to-sit transitions over the 8-hour observation period but the 
total time of sitting was consistent at 8 h for all trials.  All blood samples were taken during 
15-minute sitting periods. 
Intermittent standing trial (INT-Stand): This was identical to the SIT trial, except that in 
each 30-minute period, participants sat for 5 minutes; then undertook 10 cycles of standing 
for 90 seconds followed by sitting for 30 seconds (20 minutes in total); then sat for 5 minutes.  
Thus they stood for 15 minutes and sat for 15 minutes every 30 minutes, but the standing 
occurred in 10 x 90-second blocks, rather than a single 15-minute block.  Thus, over the 8-
hour observation period they stood for 4 hours and sat for 4 hours, with 160 sit-to-stand and 
160 stand-to-sit transitions, ditto previous comment.  All blood samples were taken during 
the 10 minutes of continuous sitting in each 30-minute period. The full protocols can be seen 
in Appendix G. Participants were paid £100 as a token of thanks for completing the study.  
The study was involved participants spending ~24 hours in the lab over 3 occasions, and we 
feel that this modest recompense could help us with recruitment. 
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Figure 3-1: Study protocol. The 8-hour observation period for each trial day. Participants completed 
three trials in random order: Uninterrupted sitting (SIT), Prolonged standing (PRO-Stand), and 
Intermittent standing (INT-Stand). 
The grey boxes represent each 30-minute intervention period throughout the day, with the protocol 
undertaken during each 30-minute period expanded below.  
 
 Standardised Meals 
Participants consumed two standardised meals for breakfast and lunch.  Each meal consisted 
of a buttered bagel and a meal replacement drink (Complan Foods Ltd, UK) made up with 
whole milk, which provided 8 kcal energy per kg body mass (37% energy from fat, 49% 
carbohydrates, and 14% protein) to match the typical Scottish daily macronutrient intake 
(Marriott and Buttriss ). Energy, protein, lipid, and carbohydrate intake were calculated 
using nutrient information obtained from respective online sources or food labels. 
Participants were asked to consume the meal within 10 minutes.  
 Standardisation of diet and exercise 
Standardisation of diet and exercise have previously been described in (see section 2-5, and 
2-6). Sitting, standing, walking and other types of physical activity were monitored using 
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the ActivPAL. Participants were instructed to wear the monitors on the right thigh all times, 
except when showering, swimming and sleeping for 3 days before each trial. At the end of 
monitoring period, the monitor was returned to the researcher and the output of the activPAL 
(summarized by hour) was installed by using the activPAL professional software. Total time 
recorded as sitting, standing and steps for the preceding 3-d period before observation day 
is clarified in Figure 3-2. Data output is expressed as mean time (hours) spent in various 
level of activity. In this study, a 3 days before each trials were considered to explore the 
difference in the activity between the participants. Statistical analyses and calculations were 
conducted using the statistical software version and Microsoft Office Excel 2010. Data were 
tested for the normality. All data were normal distributed using Shapiro-Wilk. One-way 
ANOVA was used to compare the physical activity during each trail.  There were no 
significant differences in daily activity across trials p > 0.05.  
 
Figure 3-2: Mean time spent in various physical activity levels during the preceding 3-d period in sitting, 
prlonged standing and intermittent standing trials (n=10). Values are expressed as means, with standard 
errors represented by vertical bars. 
 Calculation of energy expenditure and substrate utilization  
Fat, carbohydrate oxidation and energy expenditure were calculated using indirect 
calorimetry (Frayn and Macdonald 1997) (see section 2-3 for more details).  For these 
calculations urinary nitrogen excretion was assumed to be 0.11 mg.kg-1.min-1 throughout 
each trial, based on data from previous studies in the literature (Flatt et al. 1985;Melanson 
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et al. 2005). The first expired air samples were taken twice after 10 min period to determine 
the metabolic rate, gas samples were collected during the final 4 minutes of each 15 min 
bout of sitting, intermittent and prolonged standing throughout the 8 hour observation period.   
 Power calculation 
As the most consistent association between frequency of sedentary breaks and health 
outcomes related to adiposity variables (i.e: BMI and waist circumference) (Cooper et al. 
2012; Healy et al. 2008a; Healy et al. 2011), For example, those in the highest quartile of 
breaks in sedentary time had, on average, a 5.9 cm lower waist circumference than those in 
the lowest quartile. However, this is an observational study using cross-sectional data, and 
further investigations are required to determine possible causal associations. (Healy, 2008). 
Sedentary behaviour can increase the risk of obesity in adulthood. Some evidence also exists 
for breaks in sedentary time to be associated with a more favourable BMI, and for use of a 
car to be associated with greater risk of obesity (Biddle et al. 2017).  We primarily based our 
sample size on the number of participants needed to detect a difference in overall energy 
expenditure over the observation period, as this would be the likely mechanism by which 
changes in sedentary breaks could influence adiposity.  Our previous data had shown that 
the within-person SD for difference in resting oxygen uptake was 6.1% (Farah and Gill 
2013).  We assumed that the within-person SD for differences in energy expenditure between 
trials here would be similar.  Accordingly, we calculated that ten participants would enable 
detection of a ~6% difference in energy expenditure between trials with 80% power at p < 
0.05.  In addition, based on our earlier observations that the within-person SD for 
postprandial glucose, TG and insulin responses were 3.4%, 10.1% and 22.9%, respectively 
(Gill et al. 2005), our sample would enable detection of respective differences between trials 
of ~3%, ~10% and ~23%, in glucose, TG and insulin responses.     
 Statistical analysis 
Statistical analyses were performed using Statistica (Version 10, StatSoft, Inc.) and Minitab 
(Version 14, Mintab Inc.).  Data were tested for normality using the Anderson-Darling 
normality test, and where necessary, data were logarithmically transformed prior to 
statistical analysis. The area under curve (AUC), calculated using the trapezium rule was 
used as a summary measure of the postprandial responses for energy expenditure, fat 
oxidation and carbohydrate oxidation. This provides a measure of total amount of energy 
expended or substrate used over the observation period. For glucose, insulin and TG 
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concentrations, the time-averaged AUC (i.e. AUC divided by the duration of the observation 
period) was used as a summary measure.  This provides a measure of the average 
concentration over the observation period. Comparisons between trials were made using 
repeated measures ANOVA, with post-hoc Fisher LSD tests used to identify where any 
differences lay. Cohen’s d effect sizes were calculated to describe the magnitude of 
differences between trials (>0.8 large, 0.5-0.8 medium, <0.5 small, <0.2 trivial) (Cohen 
1992).  Data are presented as mean ± SEM unless otherwise stated, and p < 0.05 was 
considered significant. 
 Results 
 Baseline values   
Baseline values in the three trials are shown in Table 3-1. There were no differences in body 
mass, rates of energy expenditure, carbohydrate oxidation, or plasma glucose, insulin or TG 
concentrations between the three experimental conditions in the fasted state, before the 
interventions were commenced, indicating that control of lifestyle in the days preceding the 
trials was sufficient to ensure that the baseline metabolic state in all trials were similer.  
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Table 3-1: Baseline values in the fasted state in the three experimental conditions. Values are mean ± SEM, n = 10. astatistics performed on log-transformed data.  
 
 SIT PRO-Stand INT-Stand p 
SIT vs PRO-Stand     SIT vs INT-Stand      POR-Stand vs INT 
Cohen`s d effect size 
Body mass (kg)  89.9 ± 3.4 89.8 ± 3.4 89.7 ± 3.3 0.92 0.004 
 
0.20 
             0.31 
 
            0.15 
 
0.04 
 
0.09 
 
0.05 
0.009 
 
            0.17 
            0.05 
 
            0.18 
 
0.24 
 
0.16 
 
0.01 
0.004 
 
            0.01 
            0.34 
 
            0.36 
 
            0.21 
 
0.07 
 
0.07 
Resting Energy 
expenditure (kJ.min-1) 
5.6 ± 0.2   5.4 ± 0.2 5.4 ± 0.2 0.12 
Fat oxidation (g.min-1)   0.1 ± 0.01 0.1 ± 0.01 0.1 ± 0.01 0.50 
Carbohydrate 
oxidation (g.min-1) 
  0.1 ± 0.02 0.1 ± 0.01 0.1 ± 0.01 0.18 
Plasma glucose 
(mmol.l-1) 
5.2 ± 0.2 5.2 ± 0.1 5.4 ± 0.2 0.09 
Plasma insulin  
(mU.l-1) 
7.4 ± 0.9 8.1 ± 1.4 8.8 ± 1.7 0.26 
Plasma TGa 
(mmol.l-1) 
1.2 ± 0.2 
 
1.2 ± 0.1 
 
1.2 ± 0.2 
 
0.49 
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 Energy expenditure and substrate utilisation during the interventions 
  
Energy expenditure and substrate utilisation over the 8-hour observation period are shown 
in Figures 3-2, 3-3 and 3-4 with summary data for these responses shown in Table 3-2.  
Compared to the SIT trial total energy expenditure over the 8 hours was 320 ± 62 kJ (10.7 ± 
2.0%) higher in the PRO-Stand trial and 617 ± 76 kJ (20.4 ± 2.3%) higher in the INT-Stand 
trial: energy expenditure in the INT-Stand trial was 296 ± 78 kJ (9.0 ± 2.3%) higher than the 
PRO-Stand trial (all p<0.001).  The Cohen’s d effect sizes for all of these differences were 
large.   Total fat oxidation over the observation period was 7.1 ± 1.9 g (20.2 ± 6.7%) greater 
in the INT-Stand trial than the SIT trial (p<0.01), with a large effect size, but the 2.5 ± 2.2 g 
(7.6 ± 5.4%) difference in fat oxidation between the PRO-Stand and SIT trials was not 
statistically significant and the effect size was small.  Total fat oxidation was 4.6 ± 2.6 g 
(13.7 ± 7.6%) greater in the INT-Stand trial than the PRO-Stand trial (p=0.06), with a large 
effect size.  Compared to the SIT trial, total carbohydrate oxidation was 14.4 ± 5.2 g (30.8 ± 
12.6%) higher in the PRO-Stand trial (p = 0.038) and 22.0 ± 6.0 g (44.0 ± 12.8%) higher in 
the INT-Stand trial (p = 0.008).  The difference in carbohydrate oxidation between the INT-
Stand and PRO-Stand trials (7.6 ± 7.8 g; 15 ± 12.4%) was not statistically significant and 
had a small effect size. 
In post-hoc observations, it became apparent that the pattern of substrate utilization between 
trials differed between the post-breakfast (0-240 minute) and post-lunch (240-480 minute) 
postprandial observation periods.  We therefore decided to analyse these periods separately. 
In the post-breakfast period 19.6 ± 1.5 g, 20.1 ± 1.5 g, and 25.0 ± 1.8 g of fat were oxidised 
in the SIT, PRO-Stand and INT-Stand trials, respectively.  Fat oxidation over this period 
was significantly higher in the INT-Stand trial than the other two trials (p < 0.001 for both), 
but did not differ significantly between the SIT and PRO-Stand trials (p = 0.68). In contrast, 
fat oxidation over the post-lunch period did not differ significantly between any of the trials 
(SIT: 18.9 ± 1.4 g; PRO-Stand: 20.8 ± 1.8 g; INT-Stand: 20.5 ± 1.4 g).   
In the post-breakfast period, carbohydrate oxidation was significantly higher than SIT (31.2 
± 3.2 g) in the PRO-Stand stand trial (41.0 ± 3.3 g) (p = 0.007) and tended to be higher than 
SIT in the INT-Stand trial (38.0 ± 2.7 g) (p = 0.055), but did not differ significantly between 
the PRO-Stand and INT-Stand trials (p = 0.36).  Carbohydrate oxidation was significantly 
higher in the INT-Stand trial (48.1 ± 3.6 g) than both the SIT trial (32.8 ± 3.1 g) (p = 0.002) 
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and the PRO-Stand trial (37.4 ± 3.4 g) (p = 0.02) but did not differ significantly between the 
SIT and PRO-Stand trials (p = 0.30). Thus, the increment in energy expenditure in the INT-
Stand trial over the PRO-Stand trial was largely mediated by an increase in fat oxidation in 
the post-breakfast period and an increase in carbohydrate oxidation in the post-lunch period.  
       
Figure 3-3: Energy expenditure over the 8-hour observation period. Values are mean ± SEM. Boxes 
indicate test breakfast and test lunch. 
 
Figure 3-4:  Fat oxidation over the 8-hour observation period. Values are mean ± SEM. Boxes indicate 
test breakfast and test lunch. 
 
3. Frequency of breaks and postprandial metabolic responses 
©Nabeeha Hawari (2017)  70 
 
Figure 3-5:  Carbohydrate oxidation over the 8-hour observation period. Values are mean ± SEM. Boxes 
indicate test breakfast and test lunch.
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Table 3-2: Summary postprandial responses over the 8-hour postprandial observation period in the three experimental conditions.  
Values are mean ± SEM, n = 10.  #p=0.06, *p < 0.05, **p<0.01, ***p<0.001.  
 SIT PRO-Stand INT-Stand SIT vs  
PRO-Stand 
SIT vs  
INT-Stand 
PRO-Stand 
vs INT-Stand 
 Mean ± SEM Effect size  
Total energy expenditure (kJ)       2980 ± 78        3301 ± 112 3597 ± 139 1.64***  2.56***  1.19***  
Total fat oxidation (g)        38.4 ± 2.7 40.9 ± 2.9 45.5 ± 3.0 0.36  1.19**  0.54#  
Total carbohydrate oxidation (g)        64.1 ± 5.9 78.4 ± 5.6 86.1 ± 5.5 0.87*  1.17**  0.31 
 
 
 
3. Frequency of breaks and postprandial metabolic responses 
©Nabeeha Hawari (2017)  72 
 Blood glucose, insulin and TG responses during the interventions 
Blood glucose, insulin and TG responses over the 8-hour observation period are shown in 
Figure 3-5, 3-6 and 3-7, with summary data for these responses shown in Table 3-3.  There 
were no significant differences between the three trials in glucose, insulin and TG responses.  
The effect sizes for the differences between trials in the insulin and TG responses were trivial 
to small.  Although not statistically significant, a medium effect size was observed when 
comparing the glucose response in the PRO-Stand trial with the SIT trial (p = 0.16) and the 
INT-Stand trial (p = 0.48). 
 
           
Figure 3-6: Glucose responses over the 8-hour observation period. Values are mean ± SEM. Boxes 
indicate test breakfast and test lunch. 
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Figure 3-7: Insulin responses over the 8-hour observation period. Values are mean ± SEM. Boxes 
indicate test breakfast and test lunch. 
 
 
Figure 3-8: Triglyceride responses over the 8-hour observation period. Values are mean ± SEM. Boxes 
indicate test breakfast and test lunch.
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Table 3-3: Time-averaged concentrations - AUC/ over the 8-hour postprandial observation period in the three experimental conditions.  
Values are mean ± SEM, n = 10. astatistics performed on log-transformed data.  
 SIT PRO-Stand INT-Stand SIT vs  
PRO-Stand 
SIT vs  
INT-Stand 
PRO-Stand 
vs INT-Stand 
 Mean ± SEM Effect size  
Plasma glucose AUC (mmol.l-1)   5.9 ± 0.2   5.7 ± 0.2   5.9 ± 0.2 0.78  -0.19  -0.61  
Plasma insulin AUC (mU.l-1) 44.4 ± 5.9  41.9 ± 7.5 41.1 ± 5.7 0.23 0.24 0.06 
Plasma TG AUCa (mmol.l-1)  1.8 ± 0.3  1.9 ± 0.2   1.7 ± 0.2         -0.17 0.23 0.38 
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 Discussion 
The main finding of this study is that increasing the frequency of breaks in sedentary time, 
while keeping total sedentary time constant, increased energy expenditure and fat oxidation 
over an 8-hour postprandial observation period.  This is the first time that an independent 
effect of the number of sedentary breaks on day-long metabolic responses has been 
demonstrated and these findings provide an explanation for the association between 
frequency of sedentary breaks and adiposity observed in the epidemiological data (Cooper 
et al. 2012; Healy et al. 2008a; Healy et al. 2011).     
A number of studies have reported that energy expenditure during quiet standing is 2-33% 
higher than observed during sitting (Judice et al. 2015a; Levine et al. 2000; Reiff et al. 2012; 
Speck and Schmitz 2011).  The present findings are consistent with this.  In the PRO-Stand 
condition – where participants alternated 15 minutes of sitting with 15 minutes of standing 
throughout the observation period – energy expenditure was 10.7% higher than the SIT 
condition, an absolute increase in expenditure of 320 kJ over 8 hours.  In the INT-Stand 
condition – where participants undertook 10 1.5-minute bout of standing in every half-hour 
– there was a further increase in energy expenditure of 9.0% (296 kJ), despite participants 
sitting and standing for the same total duration in both trials.  To put these figures into 
context, if participants replicated the protocol in the trial for 4 weeks, energy expenditure in 
the PRO-Stand and INT-Stand conditions would be 9.0 MJ and 17.3 MJ higher than the SIT 
condition.  Assuming no change in energy intake, this would equate to ~1.2 kg weight loss, 
relative to SIT, in the PRO-Stand condition and a ~2.2 kg weight loss in the INT-Stand 
condition.  Interestingly a large proportion of the increase in energy expenditure from 
increasing the frequency of sedentary breaks was in fat oxidation.  Participant oxidised 7.1 
g more fat and 7.7 g more carbohydrate in the INT-Stand compared with the PRO-stand 
trials, which equates to 277 kJ increased fat and 131 kJ increased carbohydrate oxidation in 
terms of energy.  This disproportionate increase in fat oxidation with increasing sit-to-stand 
transitions may have implications for the long-term regulation of body weight as high levels 
of fat oxidation have been shown to be protective against long-term weight gain, independent 
of metabolic rate (Marra et al. 1998; Seidell et al. 1992; Zurlo et al. 1990). 
 
 The increased energy expenditure in the INT-Stand compared with the PRO-Stand 
condition, was likely mediated by the increased concentric and eccentric muscular activity 
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associated with the larger number of sit-to-stand transitions.  A recent study by Judice and 
colleagues (Judice et al. 2015a) attempted to quantify the energy expended in sit-to-stand 
transitions per se by comparing the energy expended over 10 minutes when participants 
stood and sat down immediately once per minute for10 minutes with 10 minutes of sitting, 
reporting the energy cost of a single sit-to-stand transition was ~0.02 kJ per kg body mass. 
In the present study, participants stood for 4 hours and sat for 4 hours, with 16 sit-to-stand 
(and 16 stand-to-sit) transitions in the PRO-Stand condition and stood and sat for the same 
duration but with 160 sit-to-stand (and 160 stand-to-sit) transitions in the INT-Stand 
condition.  Thus, the 296 kJ difference in energy expenditure represents the energy expended 
in 144 sit-to-stand/stand-to-sit transitions, i.e. ~2 kJ per transition or ~0.02 kJ per kg, in line 
with Judice et al’s calculations.  Thus the present findings suggest that the ‘snapshot’ 
calculation of the energy expended during short-duration sit-to-stand transitions in the fasted 
state, can be extended over the course of a day under ‘real-life’ postprandial conditions.   
We found no significant effects of either prolonged or intermittent standing breaks on 
postprandial incremental glucose, insulin or TG responses.  The effect sizes for the 
difference in incremental insulin and TG responses between trials were trivial to small. Thus 
the lack of a statistically significant effect of prolonged or intermittent standing on these 
responses appears to reflect the absence of a physiologically important influence of the 
standing interventions on these outcomes, rather than a lack of statistical power to detect a 
clinically relevant effect.  The postprandial glucose response was ~3% lower in the PRO-
Stand trial, but ~1% higher in the INT-Stand, than the SIT trial.  Neither of these differences 
were statistically significant, but there was a medium effect size for the difference between 
the PRO-Stand and SIT conditions, suggesting that this difference could conceivably be 
physiologically relevant, but that the study did not have sufficient statistical power to detect 
it.  However, while we cannot definitively exclude a potential glucose-lowering effect of 
PRO-Stand – albeit a relatively modest one – it is intriguing that a similar pattern was not 
observed for INT-Stand, where the glucose response was not lower than the SIT condition.  
This could conceivably be a consequence of the concentric and eccentric muscular activity 
associated with the repeated sit-to-stand and stand-to-sit transitions in INT-Stand condition, 
which are essentially equivalent to performing 160 bodyweight squats over the observation 
period.  Thus, the INT-Stand condition could be considered analogous to a session of 
resistance exercise spread over a number of hours.  While resistance exercise training 
programmes have been shown to improve insulin sensitivity and reduce glucose 
concentrations over the long-term, particularly in people with type 2 diabetes (Ishiguro et al. 
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2016), there is evidence of a transient increase in plasma glucose concentrations in response 
to resistance exercise (Fatouros et al. 2009; Kraemer et al. 2004).  Thus, it is conceivable 
that an acute muscle contraction-mediated glucose-raising effect could have offset any 
potential glucose-lowering effect of standing per se in the INT-Stand condition.  Further 
work is therefore needed to confirm whether this hypothesis is correct and, importantly, to 
determine whether over the longer-term, adaptations in skeletal muscle in response to such 
repeated contractions could elicit favourable effects of high frequency breaks in sedentary 
behaviour on glucose metabolism.   
A number of previous reports have demonstrated that breaking up continuous sitting time 
with ≤3-minute intervals of light or moderate intensity physical activity every 20-30 minutes 
can reduce postprandial glucose, insulin and TG concentrations (Dunstan et al. 2012b; 
Larsen et al. 2015; Miyashita et al. 2008; Peddie et al. 2013).  Studies evaluating the effects 
of breaking up sitting with static standing on these postprandial blood responses have had 
more mixed results.  Henson and colleagues (Henson et al. 2016) recently reported that in 
postmenopausal women (mean age 66 years) with impaired glucose regulation, breaking up 
sitting time with 5 minutes of quiet standing every 30 minutes over a 7.5-hour postprandial 
observation period reduced the glucose and insulin incremental AUCs by 34% and 20%, 
respectively, with no significant effect on the postprandial TG response.  In an intervention 
by Thorp and colleagues (Thorp et al. 2014b), in which overweight/obese middle-aged 
participants (mean age 48 years) performed normal work tasks over an 8-hour workday 
either seated or alternating 30 minutes of sitting and 30 minutes of standing using a sit-to-
stand workstation, the incremental glucose response was 11% lower in the sit-to-stand 
condition, but there was no significant effect of the intervention on insulin or TG responses.  
In contrast, Bailey and Locke (Bailey and Locke 2015) recently reported that in young (mean 
age 24 years) non-obese adults, breaking up prolonged sitting with 2 minutes of standing 
every 20 minutes had no effect on postprandial glucose or TG responses over a 5-hour 
period, but breaking up sitting with 2 minute breaks of light ambulation (3.2 km/h walking) 
every 20 minutes reduced glucose (but not TG) responses by ~16%.  In the present study we 
found no significant effects of either prolonged or intermittent standing breaks on 
postprandial incremental glucose, insulin or TG responses in our group of relatively young 
(mean age 33 years), overweight/obese, normoglycaemic men, although we could not 
definitely exclude a modest potential glucose-lowering effect in the PRO-Stand condition.  
Thus, no intervention study has observed a statistically significant acute effect of standing 
on postprandial insulin or TG concentrations in normoglycemic adults – in contrast to the 
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findings of studies where sitting was broken up by light to moderate physical activity 
(Dunstan et al. 2012b; Larsen et al. 2015; Miyashita et al. 2008; Peddie et al. 2013) 
suggesting that a greater stimulus than standing is needed to positively alter these responses 
in young to middle-aged adults without pre-existing dysglycaemia.  Observational data from 
AusDiab study of middle-aged and older adults (mean age 57.9 years) reported that 
reallocation of 2 hours of sitting with 2 hours of standing per day was associated with ~2% 
lower fasting glucose and ~11% lower fasting TG concentration (Healy et al. 2015).  While 
the causality and direction of these associations cannot be confirmed from such a cross-
sectional analysis, these data do raise the possibility that metabolic benefits of standing may 
be more clearly observed in interventions undertaken in an older population. Further study 
is therefore needed to determine i) whether interventions to replace sitting with standing 
improve postprandial glucose, insulin and TG metabolism in older individuals, and ii) 
whether interventions to increasing the frequency of interruptions to sitting might enhance 
the previously reported benefits of standing breaks on postprandial glucose, insulin and TG 
metabolism in those with glucose dysregulation (Henson et al. 2016).   
 Conclusion 
In conclusion, this study was designed to determine whether, in principle, the number of 
transitions between sitting and standing could influence postprandial metabolic responses 
independent of total time spent sitting and standing.  Our data clearly indicate that the 
frequency of interruptions to sedentary time has a marked independent influence on 
metabolic rate, which is likely due to the increased energy expended due to muscular 
contractions in the sit-to-stand and stand-to-sit transitions.  Each additional sit-to-stand 
transition cycle expended ~2 kJ energy, which can help explain the epidemiological 
observation between sedentary breaks and adiposity (Cooper et al. 2012; Healy et al. 2008a; 
Healy et al. 2011). While our INT-Stand protocol, with 20 sit-to-stand transition cycles per 
hour is clearly impractical to implement in ‘real world’ settings, these findings can help 
inform the design of practical interventions to reduce sedentary behaviour.  For example, 
performing 4 sit-to-stand transition cycles per hour (i.e. standing then sitting once every 15 
minutes) over the course of the waking day would lead to ~100-120 kJ of additional daily 
energy expenditure over and above the increment in metabolic rate elicited by standing per 
se.  We found no evidence that standing, either in prolonged bouts or intermittent bouts could 
influence postprandial insulin or TG responses in these normoglycaemic participants 
(although we cannot definitively exclude a potential modest glucose lowering effect of 
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prolonged standing from the present data)  suggesting that it may be necessary to break up 
sitting with activities of greater intensity than quiet standing to positively influence 
postprandial metabolism in relatively young, normoglycaemic overweight/obese men.   
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4. Effects of breaking up sedentary time with 
`sit/stand` on postprandial metabolism 
 Introduction 
There is a growing body of epidemiological evidence that high levels of sedentary behaviour 
(defined as non-sleeping activities in a sitting or reclining posture with energy expenditure 
≤1.5 METS (where 1 MET is resting energy expenditure) (Sedentary Behaviour Research 
Network 2012) are associated with adverse cardio-metabolic biomarker risk profiles and 
with increased risk of cardiovascular disease, diabetes, metabolic syndrome, obesity and 
death from any cause, with this effect often independent of time spent engaged in moderate-
to-vigorous physical activity (MVPA) (> 3 METS), except when levels of physical activity 
are very high  (Celis-Morales et al. 2012; Edwardson et al. 2012; Healy et al. 2011; Thorp 
et al. 2011; Wilmot et al. 2012).  In addition, observational studies suggest that the pattern 
as well as total amount of sedentary behaviour may be important: it has been reported that 
individuals who regularly break up their periods of sedentary time have a more favourable 
cardio-metabolic risk profile, particularly with respect to adiposity-related variables, than 
those who habitually engage in prolonged periods of uninterrupted sedentary time, 
independent of total time spent sedentary (Cooper et al. 2012; Healy et al. 2008a; Healy et 
al. 2011).  
Building on these observational findings, data presented in chapter 3 and recently published 
(Hawari et al. 2016) has demonstrated that breaking prolonged sitting with intermittent 
standing (10 x 1.5 minutes of standing per 30 minutes) had significantly greater effects on 
metabolic rate (21% vs 11% increase) and fat oxidation (18% vs 7% increase) than breaking 
up sitting with prolonged standing (1 x 15 minutes per 30 minutes) over an 8-hour 
observation period in 10 overweight men.  Thus, these data provided proof-of-principle that 
frequency of sedentary breaks influences energy expenditure and substrate utilisation, 
independent of total time spent sedentary.  This provides a potential explanation for the 
independent effect of frequency of sedentary breaks on indices of adiposity observed in large 
epidemiological studies (Cooper et al. 2012; Healy et al. 2008a; Healy et al. 2011). Although 
the intermittent protocol used in that study was clearly not feasible to implement as a 
practical intervention, it demonstrated that the number of transitions from sitting to standing 
 4. Effects of breaking up sedentary time with `sit/stand` on postprandial metabolism  
©Nabeha Hawari (2017)       81 
had effects on metabolism independent of the total time spent sitting or upright.  The aim of 
the present study was therefore to  build on this observation to determine whether, breaking 
up prolonged sedentary time by undertaking ‘chair squats’ – repeated sit-to-stand transitions 
over a short period (sitting and standing 10 times over 30 seconds, every 20 minutes) – 
provides measureable metabolic benefits.  If so, this approach could conceivably be used as 
a practical intervention to improve metabolic health in individuals who are required to sit for 
long periods of time.  
 Methods 
 Participant.  
Fourteen participants (11 men, 3 women), aged 37 ± 16 years, with body mass index (BMI) 
30.5 ± 3.8 kg.m-2, waist circumference 102.3 ± 10.7 cm [mean ± SD], and low levels of 
habitual physical activity (less than 2 hours per week of moderate-to-vigorous physical 
activity as assessed by the International Physical Activity Questionnaire), were recruited for 
this study though personal contacts and local advertising.  Female participants were all post-
menopausal.  All participants had BMI > 25 kg.m-2, were non-smokers, had no known 
history of CVD or diabetes (and fasting glucose < 6.0 mmol.l-1 on screening), and were not 
taking any medications known to affect lipid or glucose metabolism. The study was 
conducted in accordance with the principles of the Declaration of Helsinki and approved by 
the College of Medical, Veterinary and Life Sciences Research Ethics Committee at the 
University of Glasgow.  All participants provided written informed consent. 
 Study design 
Participants each completed two 6.5 hours experimental trials; (Sit) and (Sit/stand), in a 
randomised order, with an interval of 1 week between trials. The experimental protocol is 
shown in Figure 4-1 and described below. 
a) Uninterrupted sitting trial (sit) –  Participants arrived at the metabolic investigation 
suite at the West Medical Building after 12-hours an overnight fast. Participants sat on a 
chair and rested for 10 min before two sequential 5-minute expired air samples were 
collected via a mouthpiece into a Douglas bag to calculate metabolic rate and substrate 
utilisation using indirect calorimetry (Frayn and Macdonald 1997).  The average of these 
samples was used as the baseline value.  A cannula was then inserted in an antecubital vein 
for repeated blood sampling and was kept patent by flushing with saline throughout the day. 
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A baseline fasting blood sample was drawn in K2EDTA tube and placed immediately on ice. 
Further blood samples were taken at 30, 60, 120, 180, 210 minutes after breakfast (see 
section 2-7 for more details). Three and a half hours after breakfast, Participants were asked 
to consume a standardised lunch, which was identical to breakfast,  and further  blood 
samples were taken at 240, 270, 330 and 390 minutes after lunch. Expired air samples for 
the determination of metabolic rate and substrate utilisation were taken at ~10 minute 
intervals throughout the 6.5-hour observation period. Samples were collected into 100 L or 
150 L Douglas bags while participants were fitted with a nose clip and 2-way respiratory 
value (see section 2-3 for more details).  Participants sat comfortably (reading, watching TV, 
doing paperwork etc) throughout the observation period and were permitted to drink water 
throughout the day. Comfort breaks to the toilet (which was ~20m from the metabolic 
investigation suite) were permitted.   
b) Sit/stand trial ‘chair squats’ – This trial was identical to the Sit trial, except that 
participants were asked to repeatedly sit and stand 10 times over 30 seconds, every 20 
minutes, without using their arms to assist them, throughout the 6.5-hour observation period, 
(except when blood samples were taken or meals were consumed). All details can be seen 
in Appendix K. 
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Figure 4-1: Study protocol. Participants completed two trials in random order: Uninterrupted sitting (Sit) and (Sit/stand).  The grey boxes represent each 20- minute intervention 
period throughout the day. 
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 Standardised Meals 
Participants consumed two standardised meals for breakfast and lunch.  Each meal consisted 
of a buttered bagel and a meal replacement drink (Complan Foods Ltd, UK) made up with 
whole milk.  The meal was designed to provide 8 kcal.kg-1 of body mass with 37 % of energy 
from fat, 49 % from carbohydrates and 14 % from protein.  Participants were asked to 
consume the meal within 10 minutes.  
 Standardisation of diet and exercise 
Standardisation of diet and exercise have previously been described in (Chapter 2-5). Sitting, 
standing, walking and other types of physical activity were monitored using the ActivPAL. 
Participants were instructed to wear the monitors on the right thigh all times, except when 
showering, swimming and sleeping for 3 days before and during each trial (Chapter 2-6). 
Total time recorded as sitting, standing and steps for the preceding 3-d period before 
observation day is clarified in Figure 4-2 Data output is expressed as mean time (hours) 
spent in various level of activity. In this study, a 3 days before each trials were considered 
to explore the difference in the activity between the participants. Statistical analyses and 
calculations were conducted using the minitab software version and Microsoft Office Excel 
2010. Data were tested for the normality. All data were normal distributed using. There were 
no significant differences in any activity between both trials in steps, sitting and standing, 
p= 0.65, p= 0.91 and p= 0.90 respectively.  
                     
Figure 4-2: Mean time spent in various physical activity levels during the preceding 3-d period in sitting 
and sit/stand trials (n=14). Values are expressed as means, with standard errors represented by vertical 
bars. 
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 Calculations of Energy expenditure and substrate utilisation 
Fat, carbohydrate oxidation and energy expenditure were calculated using indirect 
calorimetry (Frayn and Macdonald 1997) (Chapter 2.3).  For these calculations urinary 
nitrogen excretion was assumed to be 0.11 mg.kg-1.min-1 throughout each trial, based on data 
from previous studies in the literature (Flatt et al. 1985; Melanson et al. 2005).  The first 
expired air samples were taken twice after 10 min period to determine the metabolic rate.  
Gas samples were collected for 8 minutes of each 10 min bout of sitting trial and 6 times gas 
collection every 10 minutes in sit/stand trial throughout the 6.5 hours observation period. 
 Power calculation 
As the most consistent association between frequency of sedentary breaks and health 
outcomes related to adiposity variables (Cooper et al. 2012; Healy et al. 2008a; Healy et al. 
2011), we primarily based our sample size on the number of participants needed to detect a 
difference in overall energy expenditure over the observation period. Previous data from our 
lab had shown that the within-person SD for difference in resting oxygen uptake was 6.1 % 
(Farah and Gill 2013).  We assumed that the within-person SD for differences in energy 
expenditure between trials here would be similar.  Accordingly, we calculated that ten 
participants would enable detection of a ~ 6 % difference in energy expenditure between 
trials with 80 % power at p < 0.05. Based on the previous chapter, where differences between 
prolonged standing and intermittent standing for EE was 9 %. It would provide sufficient 
power to detect the likely differences between trials. In addition, based on earlier 
observations that the within-person SD for postprandial glucose, TG and insulin responses 
were 3.4 %, 10.1 % and 22.9 %, respectively (Gill et al. 2005), this sample size would enable 
detection of respective differences between trials of ~3 %, ~10 % and ~23 %, in glucose, TG 
and insulin responses.    
 Statistical analysis 
Statistical analyses and calculations were performed using Minitab (Version 14, Mintab Inc.) 
and Microsoft® Office Excel 2013.  Data were tested for normality using the Anderson-
Darling normality test, data were logarithmically transformed prior to statistical analysis. 
The area under curve (AUC), calculated using the trapezium rule was used as a summary 
measure of the postprandial responses for energy expenditure, fat oxidation and 
carbohydrate oxidation. This provides a measure of total amount of energy expended or 
substrate used over the observation period. For glucose, insulin and TG concentrations, the 
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time-averaged AUC (i.e. AUC divided by the duration of the observation period) was used 
as a summary measure.  This provides a measure of the average concentration over the 
observation period.  AUC was calculated separately for the post-breakfast (0 to 180 mins) 
and post-lunch (210-390 mins) as well as the overall observation period. Comparisons of 
summary measures between trials were made by paired t-test. Where appropriate (i.e. when 
differences were observed in baseline values between conditions) statistical analyses of 
postprandial responses were adjusted for fasting values. Cohen’s d effect sizes were 
calculated to describe the magnitude of differences between trials (>0.8 large, 0.5-0.8 
medium, <0.5 small, <0.2 trivial) (Cohen 1992). Data are presented as mean ± SEM unless 
otherwise stated, and p < 0.05 was considered significant.  
 Baseline values 
Baseline values in the two trials are shown in Table 4-1. There were no differences in body 
mass, fat oxidation or carbohydrate oxidation, or plasma glucose, insulin or TG 
concentrations between experimental conditions in the fasted state, before the interventions 
were commenced, but baseline energy expenditure was ~7% higher in the sit/stand trial than 
the sit trial.  
Table 4-1:Baseline values in the fasted state in the two experimental conditions. 
Values are mean ± SEM, n = 14. There were no significant differences in any variable between trials. 
 
sit 
sit/stand p Cohen`s d 
effet size 
Body mass (kg) 92.5 ± 3.8 92.5 ± 3.8 0.93 0.002 
Energy expenditure 
(kJ.min-1) 
5.40 ± 0.2 5.85 ± 0.3 0.01 0.22 
Fat oxidation (g.min-1) 0.1 ± 0.006 0.1 ± 0.005 0.18 0.22 
Carbohydrate 
oxidation (g.min-1) 
0.1 ± 0.01 0.1 ± 0.01 0.89 0.01 
Plasma glucose 
(mmol.l-1) 
4.9 ± 0.1 5.0 ± 0.1 0.47 0.09 
Plasma insulin (mU.l-1) 12.0 ± 1.1 12.6 ± 1.4 0.52 0.10 
Plasma TG (mmol.l-1) 1.3 ± 0.1 1.2 ± 0.1 0.46 0.02 
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 Energy Expenditure and substrate utilisation during the interventions 
Energy expenditure and substrate utilisation over the 6.5-hour observation period are shown 
in Figures 4-2, 4-3 and 4-4, with summary data for these responses shown in Table 4-2.  
Compared to the sit trial total energy expenditure over the 6.5 hours was 410 ± 42 kJ (16.6 
± 1.7%) higher in the sit/stand trial (p < 0.0001). This difference remained statistically 
significant after adjustment for baseline energy expenditure (p = 0.0007). The Cohen’s d 
effect sizes for this difference was 2.55, a large effect. Total carbohydrate oxidation was 
21.0 ± 4.5 g (33.9 ± 8.2 %) higher in the sit/stand trial than the sit trial (p < 0.0005), and had 
large effect size 1.17; the difference in total fat oxidation between trial over the 6.5-hour 
observation period was not statistically significant 2.2 ± 1.3 g (9.7 ± 5.3%) higher in 
sit/stand, p = 0.11). As we previously observed differences in the effects of standing on 
postprandial responses in post breakfast and post-lunch observation periods (Hawari, 2016), 
we decided to analyse these periods separately. Energy expenditure over both the post-
breakfast period (0 - 180 mins) (by 219 ± 21 kJ (19.9 ± 1.6%)) and post-lunch period (210 - 
390 mins) (by 185 ± 21kJ (16 ± 2 %)) were significantly higher in the sit/stand than the sit 
trial (p <0.0001 for both). The Cohen’s d effect sizes was 2.81 (post-breakfast period) and 
2.35 (post-lunch period). Similarly, carbohydrate oxidation was higher in the sit/stand than 
the sit trial over both the post-breakfast (by 9.4 ± 2.2 g (44.1 ± 13.6 %)) and post-lunch (by 
10.6 ± 2.3 g (31 ± 7.1 %)) periods (both p < 0.001) The Cohen’s d effect sizes was 1.15 
(post-breakfast period) and 1.22 (post-lunch period).  Fat oxidation was higher in the 
Sit/stand trial than the Sit trial over the post-breakfast period (by 1.9 ± 0.7 g (15.9 ± 5.8 %), 
p < 0.01), but did not differ significantly between trials over the post-lunch period (p = 0.48) 
The Cohen’s d effect sizes was 1.87 (post-breakfast period) and 0.20 (post-lunch period).  
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Figure 4-3: Energy expenditure over the 6.5 - h observation period. Values are mean ± SEM. Boxes 
indicate test breakfast and test lunch. 
 
 
 
Figure 4-4: Fat Oxidation over the 6.5 - h observation period. Values are mean ± SEM. Boxes indicate 
test breakfast and test lunch. 
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Figure 4-5: CHO Oxidation over the 6.5 - h observation period. Values are mean ± SEM. Boxes indicate 
test breakfast and test lunch 
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Table 4-2: Summary postprandial responses for energy expenditure, fat oxidation and carbohydrate oxidation over the post-breakfast, post-lunch and overall 6.5h observation 
period in the Sit and Sit/stand conditions. Results are mean ± SEM, n=14. P value for the difference between means of the two trials.  
 
Post-Breakfast period (0-210 mins) Post-Lunch period (210-390 mins) Overall (0 to 390 mins) 
Sit Sit /stand p Sit Sit /stand P Sit Sit /stand P 
Total Energy 
Expenditure (kJ) 
1105.9 ± 47.3 1325.3 ± 59.4    0.0001 1201.8 ± 51.5  1386.5 ± 57.0   0.00008 2502.5 ± 105.3 2912.3 ± 123.4   0.0001 
Total Fat Oxidation (g)    13.4 ± 1.1    15.3 ± 1.3      0.01    11.3 ± 1.0   11.7 ± 1.1       0.48     26.7 ± 2.2    28.9 ± 2.4     0.113 
Total CHO Oxidation (g)   25.1 ± 2.9    34.5 ± 3.6     0.001    36.6 ± 2.4   47.2 ± 3.2      0.001     67.1 ± 5.5       88 ± 7.1   0.0005 
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 Blood glucose, insulin and TG responses during the interventions 
Blood glucose, insulin and TG responses over the 6.5-hour observation period are shown in 
Figures 4-5, 4-6 and 4-7 with summary responses shown in Table 4-3.  Postprandial insulin 
concentrations over the post-breakfast period were 10.9 ± 8.4% lower in the sit/stand trial 
than the sit trial (p = 0.047), but the insulin response in the post-lunch period, or when taken 
over the overall 6.5 hour observation period did not differ significantly between the two 
trials. There were no significant differences between the two trials in glucose and TG 
responses.  
 
 
 
 
Figure 4-6: Plasma glucose, the Post breakfast and lunch over the 6.5 - h observation period. Values are 
mean ± SEM. Boxes indicate test breakfast and test lunch. 
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Figure 4-7: Insulin Concentration, the Post breakfast and lunch over the 6.5 - h observation period. 
Values are mean ± SEM. Boxes indicate test breakfast and test lunch. 
 
 
 
Figure 4-8: TG Concentration, the Post breakfast and lunch over the 6.5 - h observation period. Values 
are mean ± SEM. Boxes indicate test breakfast and test lunch. 
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Table 4-3: Time-averaged concentrations – AUC/ postprandial responses over the post Breakfast, Lunch and overall 6.5h observation period in the two conditions. Results are 
mean ± SEM, n=14. P value for the difference between means of the two trials. 
 
Post-Breakfast period (0-210 mins)  Post-Lunch period (210-390 mins)  Overall (0 to 390 mins)  
Sit Sit /stand p 
Cohen`s 
d effect 
size 
Sit Sit /stand P 
Cohen`s 
d effect 
size 
Sit Sit /stand P 
Cohen`s 
d effect 
size 
Plasma 
Glucose 
(mmol.l-1) 
6.2 ± 0.3 6.1 ± 0.2 0.72 
 
0.10 5.8 ± 0.2 5.9 ± 0.2 0.75 
 
0.09 5.9 ± 0.2 5.9 ± 0.2 0.94 
 
0.05 
Plasma 
Insulin  
(mU.l-1) 
91.0 ± 14.5 75.5 ± 10.9 0.047 
 
    0.58 87.5 ± 14.6 79.8 ± 11.0 0.21 
 
0.35 86.1 ± 13.8 75.2 ± 10.1 0.10 
 
0.38 
Plasma TG 
(mmol.l-1) 
1.4 ± 0.2 1.4 ± 0.2 0.53 
    0.17 
2.0 ± 0.3 2.0 ± 0.3 0.98 
     0.01 
1.7 ± 0.2 1.7 ± 0.2 0.71 
   0.16 
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 Discussion 
The major finding of this study is that breaking up prolonged sedentary time with repeated 
‘chair squats’ transitions for 30 seconds every 20 minutes significantly increased energy 
expenditure by 16.6% over a 6.5-hour observation period during which a test breakfast and 
test lunch were consumed.  Over the 3 hours following breakfast, post-prandial fat oxidation 
was 15.9% higher and postprandial insulin concentrations were 10.9% lower, but these 
changes did not persist in to the post-lunch period. There were no differences between the 
two trials in postprandial glucose or insulin responses.  
These findings build on the work presented in the previous chapter (Hawari et al. 2016), 
which we observed that intermittently standing for 1.5 minutes 10 times every 30 minutes 
led to 9% higher energy expenditure over an 8-hour postprandial period than standing 
continuously for 15 minutes every 30 minutes over the same time-frame.  The difference 
between these conditions was the number of sit-to-stand transitions - there were 144 
additional sit-to-stand transitions in the intermittent standing condition and 296 kJ additional 
energy was expended: from this it was possible to calculate that a sit-to-stand transition 
expended ~2 kJ of energy.  The findings from the present study are consistent with this, 
energy expenditure was 410 kJ higher in the Sit/stand compared with the Sit condition and 
180 additional sit-to-stand transitions were undertaken in the former – equivalent to 2.3 kJ 
energy expenditure per transition.  Thus, the present data provide confirmation that the 
differences in energy expenditure between the two standing conditions in the previous 
chapter can be fully accounted for by the energy expended in the transition from sitting to 
standing and taken together these two chapters provide a robust estimation of energy 
expended in a sit-to-stand transition cycle.  Interestingly in both the previous and present 
chapters, increasing the number of sit-to-stand transitions resulted in an increase in fat 
oxidation in the postprandial period following breakfast, but not following lunch, where the 
increase in energy expenditure was accounted for by an increase in carbohydrate oxidation.  
It is not immediately clear why this was the case, although the consistency to this observation 
across two different studies suggests that this effect is likely to be real. One potential factor 
is that the Sit/stand intervention had a larger attenuating effect on postprandial insulin 
concentrations in the post-breakfast period, which could conceivably have led to reduced 
suppression of fatty acid release from adipose tissue, increasing availability of fatty acids for 
oxidation over this time-frame.   
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There were no differences between trials in the postprandial glucose or TG responses, which 
is consistent with the observations from the study in Chapter 3, suggesting that the stimulus 
this volume of sit-to-stand transitions, with or without periods of standing between them, is 
insufficient to materially affect these aspects of the postprandial metabolic response in 
normoglycaemic adults.  However, in contrast to the earlier observations where sit-to-stand 
transitions were separated by an interval of 1.5 minutes of standing (Hawari et al, 2016), 
postprandial insulin concentrations were lower in the post-breakfast period in the Sit/stand 
trial than the Sit trial, although this did not persist into the post-lunch period.  This may 
reflect the increased frequency of the contractions stimulating contraction-mediated glucose 
uptake (Krook et al. 2004), thereby reducing the requirement for insulin to maintain glucose 
homeostasis.  Indeed, the repeated sit-to-stand transitions over 30 seconds, in effect 
represents multiple sets of bodyweight squats over the course of the day.  Interestingly, 
Dempsey and colleagues recently reported that breaking up prolonged sitting with 3 minutes 
of bodyweight resistance exercises every 30 minutes over a 7-hour postprandial observation 
period reduced postprandial glucose, insulin and TG concentrations in adults with type 2 
diabetes (Dempsey et al. 2016).  This more potent intervention effect in Dempsey’s study 
may reflect two things. First, the volume of resistance exercise undertaken in that study (6 
vs 1.5 mins per hour) was substantially higher than in the present study.  It may well be that 
a larger volume of sit-to-stand transitions – for example 60 seconds of ‘chair squats’, rather 
than 30 seconds, every 20 minutes – may elicit more substantial effects on postprandial 
insulin, glucose and TG responses.  Secondly, the participants in the present study were 
normoglycaemic and it may be the case that the stimulus required to positively affect 
postprandial metabolic responses may be greater in healthy normoglyaemic individuals than 
those with metabolic dysfunction where there is greater capacity for improvement.  For 
example, lab-based interventions breaking up sitting with standing have been effective at 
reducing postprandial glucose and insulin concentrations in post-menopausal women with 
impaired glucose regulation (Henson et al. 2016), but this effect has not be replicated in 
similar interventions in younger, normoglycaemic individuals (Bailey and Locke 2015; 
Hawari et al. 2016; Miyashita et al. 2013).  Thus, going forward, studies are needed i) to 
determine whether the present intervention is effective at reducing postprandial glucose, 
insulin and TG responses in individuals with impaired glucose regulation and ii) to determine 
whether the metabolic benefits observed here would be enhanced in normoglycaemic 
individuals with an increased ‘dose’ of ‘chair squats’ transitions. 
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The intervention undertaken in the present study is simple, requires no equipment and little 
space and only takes 1.5 minutes per hour.  Thus, it should be readily implementable in real-
world situations, for example, amongst office workers.  It increased EE, together with the 
modest reductions in postprandial insulin concentrations, suggest that pragmatic, low 
volume, and interventions of this nature may have the potential to elicit benefits to metabolic 
health.  Thus, the present findings provide a rationale for undertaking longer-term 
randomised controlled trials to determine whether interventions of this nature are acceptable 
to individuals and sustainable in practice and whether they induce long-term benefits to 
metabolic health.  
This study does have some limitations. Firstly, although it had sufficient power to clearly 
detect an effect of the intervention on energy expenditure, with 14 participants, it may have 
been underpowered to detect clear effects on the postprandial insulin response in the post-
lunch period.  Secondly, we did not consider different doses of sit-to-stand transitions to 
determine the nature of the dose-response relationship.  Further research is required to define 
whether effects can be generalised to other population such as the non-obese and patients 
with impaired glucose regulation or type 2 diabetes.     
 Conclusion 
In conclusion, this study demonstrated that a simple, unobtrusive intervention of performing 
10 ‘chair squats’ transitions over 30 seconds every 20 minutes over a 6.5-hour observation 
period increased energy expenditure by over 400 kJ, a 16.6% increase over prolonged sitting 
on normoglycaemic overweight and obese men and women.  The intervention also reduced 
insulin concentrations in the post-prandial period following breakfast.  Further study is 
needed to determine whether larger ‘doses’ would induce greater metabolic benefits and 
whether this approach can be translated into an effective longer-term intervention.  
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5. Development and validation of algorithms to 
objectively assess activity using an 
accelerometer/inclinometer device 
 Introduction 
A large body of evidence has shown that physical activity (PA) associated with reduced risk 
of several illnesses such as cardiovascular disease (CVD) and diabetes (Gill and Cooper 
2008; Nocon et al. 2008; Warburton et al. 2010). Conversely, high levels of sedentary 
behaviour are associated with increasing the risk of these adverse health conditions 
(Edwardson et al. 2012; Marshall and Ramirez 2011; Owen et al. 2010a; Wilmot et al. 2012). 
Most of the evidence evaluating the strength and dose-response relationship between 
physical activity and sedentary behaviour with prospective health outcomes – including the 
evidence underpinning guidelines for physical activity (Department of Health 2011; Haskell 
et al. 2007; World Health Orgnisation 2010) has been based on estimates of physical activity 
and sedentary behaviour from self-reported questionnaires. However, such questionnaire 
provide relatively crude markers of activity status (Craig et al. 2003; Hagstromer et al. 2006; 
Rosenberg et al. 2008; Shephard 2003; van Poppel et al. 2010), and this measurement error 
can lead to underestimation of the strength of the relationship between activity and disease 
risk (Celis-Morales et al. 2012). This highlights the need to accurately and objectively assess 
physical activity and sedentary behaviour.  In recent years, accelerometers - small devices 
which, by measuring accelerations in one or three axes, can be used to detect motion changes 
- have been used to accurately quantify physical activity behaviours.  Objective measurement 
of physical activity in this manner leads to stronger associations being observed between 
physical activity and biomarkers of cardio-metabolic disease risk (Celis-Morales et al. 
2012).   One such accelerometer device - the ActivPAL – is worn on the front of the thigh 
and thus by measuring changes in the axis through which the static acceleration due to 
gravity is felt, it is able to distinguish between sitting and upright postures. Other placement 
positions for accelerometers - often the hip, but increasingly the wrist, - are more commonly 
used for assessment of physical activity, but recent validation studies have demonstrated that 
these positions are inferior to the thigh for determination of sedentary behaviour (Edwardson 
et al. 2016; Koster et al. 2016; Lyden et al. 2012). However, ActivPAL’s thigh-based 
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accelerometer position may also provide advantages for assessment of physical activity over 
other body locations, as accelerations at the thigh during locomotion are greater than other 
body locations such as the hip, so it is possible that low intensity incidental activities, such 
as very slow walking, may be more accurately determined in the thigh-based position. 
Currently, the ActivPAL generates an output of step counts based on a proprietary algorithm; 
however, it is possible to develop more sophisticated physical activity output metrics from 
acceleration signals generated by thigh movement. This would enable use of a single thigh-
based accelerometer to be used for the robust and detailed assessment of both sedentary 
behaviour and physical activity.  The aims of this study are therefore to compare thigh and 
hip positions for accelerometer placement for the measurement of step-based physical 
activity and to develop an algorithm for the estimation of walking or running speed and 
energy expenditure from acceleration outputs from a thigh-based accelerometer.  Specific 
objectives of the study are: 
1) To assess the reproducibility of stepping rate outputs for ActivPAL and Actigraph 
accelerometers in thigh and hip positions across a range of walking and running speeds by 
comparing outputs from devices worn on the left and right sides of the body. 
2) To assess the accuracy of measurement of stepping rate of ActivPAL and Actigraph 
accelerometers in thigh and hip positions in comparison to directly observed stepping rate 
across a range of walking and running speeds. 
3) To assess the reproducibility of vector magnitude acceleration outputs for ActivPAL and 
Actigraph accelerometers in thigh and hip positions across a range of walking and running 
speeds by comparing outputs from devices worn on the left and right sides of the body. 
4) To determine the relationship between vector magnitude acceleration outputs and oxygen 
uptake for thigh- and hip-placed accelerometers across a range of walking and running 
speeds on a treadmill. 
5) To compare the relationships between vector magnitude acceleration outputs for treadmill 
compared with overground walking and running across a range of walking and running 
speeds. 
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6) To use the information above to develop and validate algorithms to estimate oxygen 
uptake (and therefore metabolic exercise intensity) from vector magnitude acceleration 
outputs for thigh- and hip-placed accelerometers. 
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 Methodology 
 Subjects  
A total of 40 healthy adults (20 female), aged 26.6 ± 5.7 years, with body mass index (BMI) 
23.43 ± 4.5 kg.m-2, [mean ± SD], were recruited for this study though personal contacts and 
local advertising. All participants had no known history of CVD or uncontrolled 
hypertension (>160/95 mm Hg on anti-hypertensive medication), and did not having any 
conditions such as arthritis or injuries that alter gait and/or limit ability to walk or run on a 
treadmill. The study was conducted in accordance with the principles of the Declaration of 
Helsinki and approved by the College of Medical, Veterinary and Life Sciences Research 
Ethics Committee at the University of Glasgow. All participants provided written informed 
consent. 
 Study Design   
Forty participants completed a treadmill experimental trial. Moreover, to address aim 
number 4 in this study, 15 out of 40 participants completed both treadmill and overground 
trials, with an interval of at least three days.  
Participants who completed treadmill and overground trials were asked to meet with the 
researchers on three occasions and two occasions for participants who completed treadmill 
trial. On the first occasion, participants attended the lab in west medical building for baseline 
screening. The study was explained in more detail and all the questions were answered. If 
the participant was still interested to take part she\ he was asked to complete a health 
screening questionnaire. Body measurements were taken including blood pressure, body 
mass and height, from which the body mass index (BMI) was calculated.15 participants 
performed two experimental trials – one involving walking and running on a treadmill 
(treadmill) and one involving walking and running on a (track) and 40 participants performed 
one experimental trial  which  involved walking and running on a treadmill (treadmill). For 
each trial, subject’s wore ActivPAL devices at some locations on their body (lower thigh, 
upper thigh and hip, on the left and right sides). The subjects also wore Actigraph 
accelerometers on the right and left hips Figure 5-1, to record body accelerations and posture 
changes. The specific location of these devices were described as listed: 
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Lower Thigh: 10 cm above mid-line of the knee on the Lower Left and Right Thigh. 
Upper Thigh: 20 cm above mid-line of the knee on the Upper Left and Right Thigh. 
Hip: at the highest point of the iliac crest of the Left and Right Hip. 
 
 
Figure 5-1: 6 (ActivPAL) and 2 (Actigraph) were attached on the body. 
 
 Treadmill trials 
The subjects undertook the treadmill test in West Medical Building, University of Glasgow. 
For the trial, subjects initially sat for 10 minutes. Thereafter, 5 minutes standing; after which, 
they undertook 5 minutes-stages of walking on the treadmill at 1, 2, 3, 4, 5, 6, 7 and 8 km/h 
and running on the treadmill at 7, 8, 9, 10 and 11 km/h Figure 5-2. The treadmill sat at a 0% 
incline for the period of the testing.  Expired air samples were collected during both sitting 
and standing; and 2 minutes gas collection for each speed between 3-5 minutes by using 
Douglas bags that were connected to a mouthpiece via a 2 way non-rebreathing valve and 
tubing to determine oxygen uptake Figure 5-3.  Heart rate was measured by short-range 
telemetry.  The trial was video-recorded using (Coolpix S6300, Nikon) to count the stepping 
for each speed and comparison with the values from ActivPAL and Actigraph devices. 
Subjects could have a break at any time for as long a period that they needed during the 
protocol. Subject was also able to stop testing at any time and had the decision to return on 
a different day to complete testing if he or she felt unable to carry out the entire protocol in 
one session. At the end of the test, a cool down period on the treadmill was carried out. 
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Figure 5-2: Study Design. 
 
 
Figure 5-3: Oxygen consumption measurement during the experimental trial: a) sitting on a treadmill, 
b) walking on treadmill. 
 
 Gas Analysis, Heart Rate Monitoring and Step count 
Expired air samples were collected during the treadmill protocol using Douglas bags. The 
fractional oxygen uptake (FeO2%) and fractional carbon dioxide production (FeCO2%), the 
volume and temperature of the expired air was measured using a Servomex Gas Purity 
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Analyser (Analyser Series 1400) and a Harvard Dry Gas Meter. These values were used to 
calculate the corresponding oxygen consumptionVO2 and carbon dioxide productionVCO2 
values for each speed (Chapter 2-3). Heart rate was monitored (Monitor FTI, Polar UK) and 
recorded throughout testing (Chapter 2-4).  The exercise testing was stopped when the heart 
rate exceeded 90% of the subject’s predicted age–related maximum heart rate (220-age). All 
the speeds completed by the subject on the treadmill below the 90% heart rate cutoff point 
were matched in the track protocol. A camera (Coolpix S6300, Nikon) was set up on a tripod 
next to the treadmill and at the end of the track to record the feet of the subjects at each speed 
completed, allowing step count for each speed to be analysed post testing, using Movie 
Maker, version 2012(Build 16.43503.0728, Samsung) and a hand tally counter. Steps count 
as measured by each ActivPAL and Actigraph devices were also recorded. 
 Track trials 
The track trial was performed at Scotstoun Stadium in Glasgow Figure 5-4. The testing 
protocol involved participants walking at 1, 2, 3, 4, 5, 6, 7 and 8 km/h and running at 7, 8, 
9, 10 and 11 km/h round the indoor track for 100 m.  Subjects were asked to walk and run 
three times for each speed. The aim of this trial was therefore to compare the relationships 
between raw accelerations and walking and running speeds for treadmill-based compared 
with overground walking and running. On one side of the track, every 1 metre interval was 
marked by a trundle wheel, using adhesive index tabs. Subjects required to achieve 40 m 
distances for walking speed, 1 km/h, 2 km/h, 3 km/h, 4 km/h, 5km/m, and 6 km/h. Each 
speed was done 3 times. A chair was placed at the end of this 40m.  The subject sat on the 
chair before each time that achieved a distance. 
  
Figure 5-4: Scotstoun Stadium Indoor Track. 
 
5. Development and validation of algorithms using an accelerometer/inclinometer device 
©Nabeha Hawari (2017)           104 
With 7 km/h, 8 km/h walking and running at 7 km/h, 8 km/h, 9 km/h, 10 km/h and 11km/h, 
the chair was were then repositioned to use a 90m distance. In addition, the protocol was 
done as same as walking protocol. To ensure that participants were walking and running at 
required target speed, a spotter walked and ran beside the participant in the adjacent lane to 
reduce any differences. A flags and metronome were used to enable the subject to walk and 
run close to the target speed. Flags placed depend on which speed want to achieve and each 
beats of the metronome (Metronome Beats for Android devices, Version 2.2, Stonekick) the 
subject and spotter had to reach the flag Figure 5-5. One beat was equal 17 beat per minute 
(bpm). For example, to walk 1km/h, a flag was placed at every 1m mark and to walk at 2 
km/h a flag was placed every 2 m marks, and so on.  A stopwatch was using to record the 
time that took to complete each attempt that led to know the actual time of each speed of the 
subject to be calculated in case it changed from the target speed. The trials were being video-
recorded to enable stepping rates to be counted after completion of the experiment and 
compared to calculated values from the ActivPAL and Actigraph devices. HR was 
monitored, using AG heart rate belt. Participants were able to have a rest between stages as 
required. 
 
Figure 5-5: Track Protocol.             
 
  Data Analysis 
 Steps analysis 
 The activPAL software (PALTechnologies) classiﬁed data (i.e., sitting/lying, standing, 
stepping) by proprietary algorithms and it can be saved as csv ﬁles in numerous formats. A 
15-s epoch summary ﬁle shows the number of seconds spent in various activities, number of 
steps and sit-to-upright transitions occurring during that 15-s time window over 24 hours. In 
the treadmill protocol, the average over the four 15s epochs in the third minute of stepping 
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activity in each five-min period was selected to calculate the number of steps/min for each 
speed. In the track protocol, the average of two 15s epochs acquired in each attempt, this 
was averaged for the three attempts to calculate the stepping rate.  
The Actigraph software classified data (i.e., sitting, lying, standing, stepping, and non-wear) 
by proprietary algorithms and that were downloaded to a computer in the form of csv ﬁles. 
A summary ﬁle shows the number of seconds spent in various activities occurring during 
that 1-s time window over 24 hours. In the treadmill protocol, the third minute of stepping 
activity in the middle of the five-min period was selected for each speed. In the track 
protocol, the average stepping rate over each attempt was calculated, and the average of the 
three attempts was used to calculate the stepping rate. 
Participants were video-recorded during the trials to enable their actual stepping rates to be 
determined and compared with the values recorded by the ActivPAL and Actigraph devices. 
For the treadmill trials, only the lower body of participants was videotaped, however, for the 
track trials, it is likely that some identifying shots was taken. The stepping time was 
compared to the direct observation data to examine the accuracy of stepping activity for the 
AP and AG. Video recordings were analysed by a researcher categorising time as sitting, 
standing and steeping and classified speed and steps taken.  From the video the timing of the 
third min of stepping activity in the middle of the five-min period on the treadmill was 
selected. The total number of steps observed on video within the third min period was used 
as the gold standard measure. The time synchronisation was achieved between the video 
record and the activity monitors by identifying the first stride of walking commencing in the 
video records. This time synchronisation was used across the whole activity. All descriptive 
data are presented as mean ± SD. For each participant, the steps number for each treadmill 
and outdoor walk and run were calculated by a researcher.  
 Decision Rules 
ActivPAL device measures raw acceleration of X, Y and Z axis count at 20Hz frequency. 
The ActivPAL accelerometer which uses the static acceleration (due to gravity)  acting on 
X, Y and Z axis to determine orientation of the thigh and therefore distinguish between time 
spent sitting/lying and standing, and uses dynamic acceleration (due to body movement) to 
determine stepping rate. This is illustrated in Figure 5-6.  The monitor produces a 10 bit 
output with a range from 0 to 1024 in each of the three axes, to cover the a 16 g acceleration 
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range, with 0 = - 8 g and 1024 = + 8 g, where g is gravitational force, equivalent to 9.81 m/s² 
(g = 9.81 m/s²).  This is illustrated in Figure 5-7.  
  
Figure 5-6: ActivPAL acceleration (x, y and z axis), during sitting, standing and walking. 
 
   
Figure 5-7 : Raw data output, expressing data acceleration due to gravity. 
The ActivPAL measurs raw acceleration in three different planes (X, Y and Z) at a frequency 
of 20 Hz. An example of raw data outputs for the x-axis during stepping activity is shown 
on the top panel of Figure 5-9. The magnitude of the difference between each acceleration 
value was then summed over one second, expressing the value as the sum of changes in 
acceleration as illustrated in Figure 5-8. The magnitude of the differences is shown on the 
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second panel in Figure 5-9 and a rolling average of these summed over one second are 
shown on the third panel.  To further smooth this signal to obtain a relatively stable single 
value which could summarise the acceleration output for that intensity, a rolling average of 
these one second summed values was calculated.  This is shown in the bottom panel of 
Figure 5-9. This process was undertaken for each of the X, Y, Z and the vector magnitude 
(VM) accelerations were calculated summarise the acceleration profile for each speed, using 
the equation, VM= √(𝑥2 + 𝑦2 + 𝑧²) as illustrated in Figure 5-10.  
       
Figure 5-8: The differences of 20 Hz in X acceleration values summed over one second. X acceleration  
= a + b + c + d ….. etc. 
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Figure 5-9: ActivPAL raw acceleration data analysis during walking and running speed.  
Raw acceleration data over 1 
min. 
       X-axis accelatations (g) 
Raw acceleration data over 1 
min 
Absolute difference between 
successive points 
Sum of differences over 1 
second 
The values were cumulated 
over second. 
Sum of differences averaged 
over 10 seconds 
The average over 10 second 
was presented for each speed, 
in x, y, z and vm accelerations. 
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Figure 5-10:ActivPAL axis acceleration and VM acceleration which calculated as VM= √(𝒙𝟐 + 𝒚𝟐 + 𝒛²). 
 Statistical Analysis 
To address the first aim in this chapter, stepping rates from ActivPAL and Actigraph devices 
worn in comparable positions on the left and right sides of the body were plotted against 
each other and the proximity of this relationship to the line of equality was assessed.  This 
analysis was performed on data collected from the treadmill-based trials.   
To address aim two, the mean of left and right side values for ActivPAL and Actigraph 
derived stepping rates from each position were plotted against directly measured stepping 
rates and compared with the line of equality. This analysis was performed on data collected 
from the treadmill-based trials.   
To address aim three, the vector magnitude acceleration outputs from ActivPAL and 
Actigraph devices worn in comparable positions on the left and right sides of the body were 
plotted against each other and the R2 value for the linear regression between these variables 
and the proximity of this relationship to the line of equality were determined.  This analysis 
was performed on data collected from the treadmill-based trials.   
To address aim four, the linear regression (and R2 value) and vector between vector 
magnitude accelerations and VO2 was assessed over a range of walking and running speeds. 
To assess whether a linear relationship provided the best fit, the R2 values for higher order 
regressions (quadratic, cubic) were also assessed. This analysis was performed on data 
collected from the treadmill-based trials.   
To address aim five, the linear regression and proximity to the line of equality was assessed 
for the comparison of vector magnitude acceleration outputs for treadmill-based and 
overground walking and running at a range of speeds.  
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To address aim six, the study population was randomly divided 1:1 into derivation and 
validation groups. In the derivation group, the linear regression between vector magnitude 
accelerations and VO2 was assessed for each accelerometer position.  The equation of the 
regression line was then used in the validation group to predict VO2 based on the vector 
magnitude acceleration. This predicted VO2 value was then compared with the actual 
directly measured VO2 value.  The validity of the VO2 prediction was assessed from the R2 
values between predicted and actual VO2 values and the standard error of the estimate (SEE) 
for the predicted compared with actual VO2 values. 
  Results 
 Reproducibility of measurement of stepping rate outputs 
The relationship between stepping rates from accelerometers worn on the left and right sides 
of the body at a range of walking speeds from 1 km/h to 8 km/h and running speeds from 7 
km/h to 11 km/h was assessed for the ActivPAL accelerometer worn in lower thigh, upper 
thigh and hip positions and the Actigraph accelerometer worn in the hip position.  These data 
are shown in Figures 5-11, 5-12, 5-13 and 5-14. Observation of these figures shows that 
stepping rate outputs for left and right sides closely follow the line of equality across the 
range of walking and running speeds, suggesting that the reproducibility of stepping rate 
outputs is good for both accelerometers across all positions tested.   
 
Figure 5-11: Mean Lower Left Thigh steps in relation to mean Lower Right Thigh ActivPAL steps 
during walking and running on treadmill testing. 
5. Development and validation of algorithms using an accelerometer/inclinometer device 
©Nabeha Hawari (2017)           111 
 
Figure 5-12: Mean Upper Left Thigh steps in relation to mean Upper Right Thigh ActivPAL steps during 
walking and running on treadmill testing. 
 
 
Figure 5-13: Mean Left Hip steps in relation to mean Right Hip ActivPAL steps during walking and 
running on treadmill testing. 
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Figure 5-14: Mean Actigraph Left Hip steps in relation to mean Right Hip steps during walking and 
running on treadmill testing. 
 
 Accuracy of measurement of stepping rate of ActivPAL and Actigraph 
accelerometers 
Figures 5-15, 5-16, 5-17 and 5-18 show the relationship between accelerometer-derived 
stepping rates and actual directly-measured stepping rates for the ActivPAL in lower thigh, 
upper thigh and hip positions and the Actigraph in the hip position across a range of walking 
and running speeds, with the line of equality plotted.  Observation of the data shows that for 
the two thigh positions, ActivPAL-derived stepping rates agree closely with the actual 
stepping rates down to a walking speed of 2 km/h, or a stepping rate of ~60 steps per minute, 
but below this speed the ActivPAL systematically under-reports the stepping rate.  In 
contrast, observation of the data show that the ActivPAL and Actigraphs worn on the hip 
were only able to accurately assess stepping rates down to a walking speed of ~ 4 km/h, or 
a stepping rate of ~100 steps per minute, underestimating stepping rate below this speed.   
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Figure 5-15: Mean Actual steps in relation to mean Lower Thigh ActivPAL steps during walking and 
running on treadmill testing. 
 
 
Figure 5-16: Mean Actual steps in relation to mean Upper Thigh ActivPAL steps during walking and 
running on treadmill testing. 
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Figure 5-17: Mean Actual steps in relation to mean Hip ActivPAL steps during walking and running on 
treadmill testing. 
 
 
Figure 5-18: Mean Actual steps in relation to mean Hip Actigraph steps during walking and running on 
treadmill testing. 
 
 
5. Development and validation of algorithms using an accelerometer/inclinometer device 
©Nabeha Hawari (2017)           115 
 Reproducibility of vector magnitude acceleration outputs 
To determine the reproducibility of the vector accelerometer outputs, data collected from 
left and right sides for each ActivPAL position (lower thigh, upper thigh and hip) and for 
the Actigraph in the hip position were compared. These data are shown in Figures 5-19, 5-
20, 5-21 and 5-22. For all positions, the strength of the relationship between vector 
magnitude acceleration outputs between the left and right sides was very high, with R2 values 
> 0.098 and the relationships closely followed the line of equality, indicating that 
reproducibility of vector magnitude acceleration outputs was very good.  
 
 
Figure 5-19: Mean Lower Left Thigh Vector magnitude accelerations in relation to mean Lower Right 
Thigh ActivPAL vector magnitude accelerations during walking and running on treadmill testing. 
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Figure 5-20: Mean Upper Left Thigh Vector magnitude accelerations in relation to mean Upper Right 
Thigh ActivPAL Vector magnitude accelerations during walking and running on treadmill testing. 
 
 
Figure 5-21: Mean Left Hip vector magnitude accelerations in relation to mean Right Hip ActivPAL 
Vector magnitude accelerations during walking and running on treadmill testing. 
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Figure 5-22: Mean Left Hip Vector magnitude accelerations in relation to mean Right Hip Actigraph 
Vector magnitude accelerations during walking and running on treadmill testing. 
 
 Relationship between vector magnitude acceleration outputs and VO2 
The relationships between vector magnitude acceleration outputs (mean of left and right side 
values) and VO2 across a range of walking and running speeds for the ActivPAL 
accelerometer worn on the lower thigh, upper thigh and the hip and the Actigraph worn on 
the hip are shown in Figures 5-23, 5-24, 5-25 and 5-26. These data indicate that R2 value 
for the relationship was very high for the ActivPAL (0.87 to 0.90) across all positions.  The 
R2 for the relationship between vector magnitude acceleration output and VO2 was slightly 
less strong for the hip-worn Actigraph.  Fitting quadratic and cubic regression equations did 
not improve the R2 values (data not shown) indicating that these relationships were best 
described using a linear model.  The coefficient of regression equation differed between the 
three ActivPAL positions, with a given VO2 value corresponding to the highest vector 
magnitude acceleration value at the lower thigh and lowest at the hip.     
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Figure 5-23: Mean VO2 in relation to mean Lower Thigh ActivPAL Vector magnitude acceleration 
counts during walking and running on treadmill testing. 
 
 
Figure 5-24: Mean VO2 in relation to mean Hip Actigraph Vector magnitude acceleration counts during 
walking and running on treadmill testing. 
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Figure 5-25: Mean VO2 in relation to mean Hip ActivPAL Vector magnitude acceleration counts during 
walking and running on treadmill testing. 
 
 
Figure 5-26:  Mean VO2 in relation to mean Hip Actigraph Vector magnitude acceleration counts during 
walking and running on treadmill testing. 
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 Relationship between vector magnitude acceleration outputs during 
treadmill vs overground walking and running  
This analysis was undertaken in 15 adults (9 female), aged 29.1 ± 6.7 years, with body mass 
index (BMI) 24.8 ± 5.4 kg.m-2, [mean ± SD], who undertook trials on both the  treadmill and 
track, in which they walked and ran at the same speeds under both conditions. Figures 5-27, 
5-28, 5-29, and 5-30 show the relationship between vector magnitude acceleration outputs 
between treadmill and overground (track) walking and running at a range of speeds for 
ActivPAL devices worn in the lower thigh, upper thigh and hip positions and the Actigraph 
worn on the thigh positions.   These data reveal a very strong relationship between treadmill 
and track accelerometer outputs for the ActivPAL placed in thigh positions (R2 ~ 0.97) with 
the relationship strong but slightly weaker for the hip-placed ActivPAL or the Actigraph (R2 
~ 0.93). For the thigh-worn devices the outputs lay close to the line of equality, with a slight 
deviation to higher acceleration outputs for the thigh-based devices.  This indicates that, 
particularly for accelerometers worn on the thigh, there is a broad equivalence in outputs 
between treadmill-based and overground walking and running, suggesting that it is 
reasonable to extrapolate data obtained from track-based trials to the broader ‘real life’, 
overground walking and running situations.  
   
Figure 5-27: Mean Lower Vector magnitude in Treadmill in relation to mean Lower, Upper Thigh and 
Hip Vector magnitude in Track during walking and running , with line of equality plotted. 
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Figure 5-28:Mean Upper Thigh Vector magnitude in Treadmill in relation to mean Lower, Upper Thigh 
and Hip Vector magnitude in Track during walking and running , with line of equality plotted. 
 
 
Figure 5-29: Mean Hip Vector magnitude in Treadmill in relation to mean Lower, Upper Thigh and Hip 
Vector magnitude in Track during walking and running , with line of equality plotted. 
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Figure 5-30: Mean Actigraph Hip Vector magnitude in Treadmill in relation to mean Lower, Upper 
Thigh and Hip Vector magnitude in Track during walking and running , with line of equality plotted. 
 
 
 Development and validation of algorithms to estimate VO2 from vector 
magnitude acceleration outputs 
Characteristics of the derivation and validation groups are shown in Table 5-1. Figure 5-31 
shows the linear regression relationships between vector magnitude acceleration outputs and 
VO2 for the ActivPAL in lower thigh, upper thigh and hip positions and for the Actigraph in 
the thigh position in the derivation group, with the equation of the regression line and the R2 
for the relationship displayed.   
Table 5-1: Characteristics of Derivation and Validation group. Values are mean ± SD, n = 40. 
 
Derivation 
group 
Validation 
group 
Age (year) 28 ± 6.3 25 ± 4.5 
Sex    9 F      11M 9F      11M 
Body mass (kg) 69.3 ± 16.7 65.9 ± 16.6 
BMI  23.4 ± 4.2 23.3 ± 4.8 
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Figure 5-31:  The linear correlation between mean Lower, Upper Thigh, Hip and Actigraph Vector 
magnitude in relation to mean oxygen uptake in Treadmill during walking and running , with the 
regression line and R2 value shown. 
a 
b 
c 
d 
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Figures 5-32 shows VO2 values predicted from the regression equations displayed in Figure 
5-31 plotted against actual VO2 values in the validation group.  The prediction oxygen uptake 
values in relation to the actual oxygen uptake values observed on treadmill for different 
positions. For the ActivPAL accelerometer, the R2 for the relationship between predicted 
and actual VO2 was high (0.88-0.92) in all positions. The R2 for the relationship between 
predicted and actual VO2 for the Actigraph was slightly lower at 0.81.  In all cases the 
relationship between predicted and actual VO2 was close to the line of equality and the 
standard error of the estimate was <4 ml.kg-1.min-1 for all of the ActivPAL positions and <5 
ml.kg-1.min-1 for the Actigraph.   
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Figure 5-32: Predicted Oxygen uptake, using Lower, Upper Thigh, Hip and Actigraph Vector magnitude 
acceleration in relation to actual oxygen uptake in Treadmill during walking and running , with the 
linear regression line, R2 value and standard error of the estimate shown.   Solid black line is the line of 
equality.  
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 Equations to predicted VO2 and Energy expenditure from vector magnitude 
acceleration values 
Thus, the equations displayed in Figure 5-32 can be used to predict VO2 (in ml.kg-1.min-1) 
across a range of walking and running speeds based on accelerometer outputs.  The equations 
for each accelerometer position are shown below Equations 5-1, 5-5, 5-9 and 5-13.  In 
addition it is possible to use this information to express exercise intensity in METs. During 
rest, the VO2 is approximately 3.5 ml.kg-1.min-1. This is defined as 1 MET.  Thus, METs can 
be calculated by dividing VO2 (ml.kg-1.min-1) by 3.5. The equations for predicting exercise 
intensity in METs for each accelerometer position are shown below Equations 5-2, 5-6, 5-
10 and 5-14. Furthermore, as each litre of O2 consumed by the individual is associated with 
an energy expenditure of approximately ~ 5 kcal of energy (Frayn and Macdonald 1997), it 
is possible to further derive rate of energy expenditure in kcal.kg-1.min-1 Equations 5-3, 5-
7, 5-11 and 5-15 and in kcal.min-1 by further multiplying by body mass Equations 5-4, 5-
8, 5-12 and 5-16. 
ActivPAL Lower Thigh 
The linear regression equations from Figure 5-32 (a) was used to predict oxygen uptake for 
the ActivPAL in the lower thigh position as described below:  
Oxygen uptake (ml.kg-1.min-1) = 0.859* VM + 3.2063                               Equation 5-1 
 
METs can be obtained by dividing the oxygen uptake (ml.kg-1.min-1) by 3.5 as below: 
METs = VO2 (ml.kg-1.min-1) / 3.5 
METs = 1/3.5*(0.859* VM + 3.2063)                                                           Equation 5-2         
 
To calculate energy expenditure, each L/min of O2 consumed equalled 5 kcal/min. To 
convert ml/min to L/min (divide by 1000), and then (multiply by 5) to convert VO2L/min to 
kcals min (L/min*5) as described below: 
Energy expenditure (kcal.kg-1.min-1) = VO2 (L/min)*5 or VO2 (ml/kg/min)/1000*5.  
Energy expenditure (kcal.kg-1.min-1) = 5/1000*(0.859* VM + 3.2063)      Equation 5-3 
 
Total energy expenditure (kcal.min-1) = bodymass*VO2 (L/min)*5.  
Or VO2 (ml/kg/min)*bodymass » VO2 (ml.min)/1000*5. 
Total energy expenditure (kcal.min-1)= bodymass*(0.0043*VM+ 0.0160) Equation 5-4 
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ActivPAL Upper Thigh 
The linear regression equation from Figure 5-32 (b) was used to predict oxygen uptake for 
the ActivPAL in the upper thigh position are described below:  
Oxygen uptake (ml.kg-1.min-1) = 0.9037*VM +3.0674                          Equation 5-5 
METs = 1/3.5*(0.9037*VM +3.0674)                                                         Equation 5-6 
Energy expenditure (kcal.kg-1.min-1) = 5/1000*(0.9037*VM +3.0674)    Equation 5-7 
Energy expenditure (kg.min-1) = bodymass*(0.0045*VM + 0.0153)        Equation 5-8 
 
ActivPAL Hip 
The linear regression equation from Figure 5-32 (c) was used to predict oxygen uptake for 
the ActivPAL in the hip position are described below:  
Oxygen uptake (ml.kg-1.min-1) = 1.3551*VM + 4.6014                             Equation 5-9 
METs = 1/3.5*(1.3551*VM + 4.6014)                                                         Equation 5-10 
Energy expenditure (kcal.kg-1.min-1) = 5/1000*(1.3551*VM + 4.6014)   Equation 5-11 
Energy expenditure (kg.min-1) = bodymass*(0.0067*VM + 0.023)   Equation 5-12 
 
Actigraph Hip 
The linear regression equation from Figure 5-32 (d) was used to predict oxygen uptake for 
the Actigraph in the hip position are described below:  
Oxygen uptake (ml.kg-1.min-1) = 0.1475*VM + 4.9762                      Equation 5-13 
METs = 1/3.5*(0.1475*VM + 4.9762)                                                Equation 5-14 
Energy expenditure (kcal.kg-1.min-1) = 5/1000*(0.1475*VM + 4.9762) Equation 5-15 
Energy expenditure (kg.min-1) = bodymass*(0.00074*VM + 0.0248)    Equation 5-16 
 
Using equations 5-2, 5-6, 5-10 and 5-14, it is also possible to derive ranges of vector 
magnitude accelerations which correspond to light (1.5 – 2.9 METs), moderate (3.0 – 5.9 
METs) and vigorous (≥ 6.0 METs) physical activities; these values are shown in Table 5-2. 
By using these MET ranges, it would be possible to characterise the amount of time and 
number of steps taken in each intensity domain from vector magnitude acceleration putputs.  
Table 5-2: Vector magnitude values for light, moderate and vigorous activities. 
 
MET 
value 
VO2 
(ml.kg.min-1) 
VM acceleration values (g.s-1) 
Lower 
thigh 
Upper 
thigh 
Hip AG Hip 
Light 1.5-2.9 5.2 – 10.5 2.3 – 8.4 2.4 – 8.2 0.4 – 4.3 1.8 – 37.4 
Moderate 3.0-5.9 10.5 – 21.0 8.4  ̶  20.7 8.2  ̶  19.84 4.3 – 12.1 37.4  ̶  108.6 
Vigorous ≥6.0 ≥21.0 >20.71 >19.84 >12.10 >108.63 
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 Discussion 
The aim of this study was to develop novel algorithms using the raw acceleration outputs 
generated by ActivPAL and Actigraph accelerometers, to allow the accurate assessment of 
physical activity over a wide range of exercise intensities. This study has achieved the initial 
and crucial steps towards the development of these algorithms, establishing the steps 
required to organise raw acceleration counts generated by the accelerometers devices, and 
beginning the process of developing and validating these algorithms from regression models.  
The outcomes of this study indicate that there is a relatively consistent relationship between 
right and left side step counts during walking and running speeds. The equivalence of 
stepping rate outcomes between Right and Left accelerometer positions has been shown in 
Figure 5-11, 5-12, 5-13 and 5-14. The results of this study further illustrate the utility of the 
thigh as a highly accurate placement site for activity. The mean of Right and Left side steps 
was calculated for each position and compared with the actual steps Figures 5-15, 5-16, 5-
17 and 5-18. The equivalence of stepping rate outcomes between the accelerometer and 
actual steps demonstrated that thigh-based ActivPAL was capable of determining stepping 
activity well at and above 2 km.h-1, whereas hip-based ActivPAL accelerometer 
underestimated count steps below 4 km.h-1. Below 3 km.h-1, the ability of the Actigraph 
monitor to detect steps declined rapidly. Recent evidence suggests that the ActivPAL 
monitor does not have a high level of validity at slow speed of walking, the percentage of 
steps identified was over 90% for walking speeds at or ≥ 0.5 m/s and cadence at or ≥ 69 
steps/min. Although, below these speed, steps count reduced rapidly with zero steps detected 
at 0.1 m/s and at or below 24 steps/min (Stansfield et al. 2015). Given previous work 
showing high accuracy for measuring sedentary behavior and ambulatory activities with 
thigh-based accelerometers (Grant et al. 2006; Maddocks et al. 2010; Ryan et al. 2006; 
Skotte et al. 2014). Harrington et al (Harrington et al. 2011) also reported strong 
relationships between Actigraph, Activpal and step rate function. Both the ActivPAL and 
Actigraph step rate functions were accurate at moderate walking speeds compared to video 
recorded step rate, although the ActivPAL was more accurate at the slowest walking speed. 
It is likely that the ActivPAL provided better estimates due to the position on the thigh as 
opposed to the hip. The result was consistent with Oliver et al 2011 who assessed the validity 
of the step count function in ActivPal. The mean relative percentage differences between 
direct observation and ActivPAL step counts was -1.9%, ICC = 0.998, with high degree of 
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accuracy and reliability for all walking speed (Oliver  et al. 2011). Another study 
investigated the validity and reliability of the activPAL physical activity monitor in 
measuring steps. Participants walked on a treadmill at five different speeds and outdoors at 
three self-selected speeds (slow, normal, and fast). At all speeds, the activPAL was reliable 
and excellent for both step number and cadence (ICC (2, 1) ≥0.99). The absolute percentage 
error for the activPAL was < 1.11% for step number and cadence regardless of walking speed 
(Ryan et al. 2006). Testing the accuracy of the ActivPAL step record over a wide range of 
speeds is required. Recent evidence providing strong agreement over a narrow range of 
exercise activities (Dowd et al. 2012; Ryan et al. 2006), however,  the accuracy during fast 
walking and running speeds were less consistent (Aminian and Hinckson 2012). The finding 
of this study suggested that thigh-based accelerometer placement provides advantages over 
hip-based placement for quantification of stepping rate at slow speeds.  This may have 
implications for step counting during light incidental activities of daily living.  However, 
when using raw acceleration profiles to quantify speed and exercise intensity, hip and thigh 
accelerometer placement was comparable.   
There was a strong linear relationship between vector magnitude acceleration and speed in 
all positions, it has been noted that the equivalence of vector magnitude acceleration between 
Right and Left accelerometer was good, which determine there was no difference between 
both sides Figure 5-19, 5-20, 5-21 and 5-22.   The relationship between Upper and Lower 
thigh-based and oxygen uptake was very strong R2 = 0.90, R2 = 0.87 Figure 5-23 and 5-24, 
however, the value slightly lower with Actigraph hip-based compared to ActivPAL hip-
based. Hip-based placement had lower acceleration compared to thigh-based placement 
which will be expected due to the greater distance of axis rotation in the thigh Figure 5-25 
and 5-26.  
Montoye (Montoye A et al. 2016) compared the accuracy of accelerometers placed on the 
hip, thigh, and wrists, for measurement of Physical activity intensity, LTPA, MVPA and 
breaks in SB, using two Actigraph GT3X+ accelerometers were placed on the thigh and hip, 
and two GENEActiv accelerometers were placed on the wrist. Direct observation was 
utilized as a criterion measure of activities. They found that thigh-based was greater than 
wrist- or hip-based for estimating time spent in PA and breaks in SB, by sensitivities and 
specificities > 99%. Sensitivity and specificity were 87–95%, 93–97% for the hip- based 
respectively. Sensitivity and specificity for the left wrist-based were > 97% for estimating 
SB and LPA and 91–95% for MVPA. More recently, Florez-Pregonero et al assessed the 
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validity of ActiGraph GT3X+; activPAL, and SenseWear 2 in estimating energy expenditure 
during SB and LTPA, compared to indirect calorimetry (oxygen uptake, VO2).  The 
activPAL showed the lowest amount of percentage error compared with the other Wearable 
monitors 14.9%, and 9.3 % for SB and LPA, respectively. Thus, none of the wearable 
monitors in this study were comparable for assessing sedentary-to-light activities. Moreover, 
the ability of accelerometers in estimating EE during SB and LTPA, is less well known 
(Florez-Pregonero Alberto et al. 2016). For example, the estimated metabolic equivalent 
(MET) values from the activPAL at various speeds (2–4mph) are signiﬁcantly different (p < 
0.0001) from the criterion of oxygen uptake (Harrington et al. 2011). Recent result shown 
that hip and thigh accelerometer placement was comparable for measuring oxygen uptake 
when using raw acceleration profiles. 
It was not possible to determine oxygen uptake for the track-based measurement thus to 
ensure oxygen uptake value obtain from treadmill was likely to be relevant to free-iving 
conditions, a comparison between accelerometer and speed between treadmill and over 
ground was made this demonstrated that the relationship was similar and all the 
measurements were done in the treadmill-based probably reflected to free-based- living 
condition Figures 5-27, 5-28, 5-29 and 5-30. Based on relationships between acceleration 
outputs for treadmill and track were similar 
Half of the group were used as derivation set and equation tested on the other half of group 
Figure 5-31. The result indicated that the linear regression equation to obtain oxygen uptake 
from accelerometer was valid in all ActivPAL`s positions with SEE approximately between 
3.2 to 3.7 ml.kg-1.min-1 Figure 5-32, however, actigraph hip–based was somewhat less 
accurate with SEE = 4.8 ml.kg.min-1. Possible explanations for the measurement 
miscalculation observed in the current study are the difference between Actigraph and 
ActivPAL is likely due to the use Actigraph propriatory algorithms to determine acceleration 
count rather than use raw gravitation unit.  In addition, a small range of motion for the hip 
while walking at slow speeds on the treadmill may cause the ActiGraph to misclassify some 
activities. A study was done to examine the validity of published regression equations 
designed to predict energy expenditure from Actigraph accelerometer compared to indirect 
calorimetry, over a wide range of activities. Fifteen previously published equations were 
used to estimate energy expenditure. The result demonstrated that all equations significantly 
underestimated vigorous and most other activities (p < 0.05) and overestimated walking and 
sedentary activities. However, Freedson kcal equation was not significantly different from 
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actual time spent in light and moderate activities. Accurate regression equation is essential 
for the prediction of energy expenditure over a wide range of activities (Crouter et al. 2006). 
Another study was done to examine the validity of published regression equations to predict 
energy expenditure from Actigraph accelerometer compared to indirect calorimetry, in 
treadmill and activities of daily living. The researcher has demonstrated that the Freedson 
met equation under predicted energy expenditure for all daily living (bias -2.0 METs: 95% 
CI – 2.1, -1.9) and treadmill activities (bias -0.8 METs: 95% CI -0.8, -0.7). The freedson 
MET model appears to be most accurate for estimating EE for level treadmill activities (root 
mean squared error (RMSE) range 0.6 to 1.8 METs) and light intensity daily living that 
require minimal lower body movement (washing dishes, dusting and laundry) (RMSE range 
0.6-0.9 METs) (Lyden et al. 2011).  
Ward (Ward et al. 2005) explained that `one of the most challenging aspects of using 
accelerometers to measure physical activity behaviour is managing and understanding the 
vast amount of data collected`, while (Lee and Shiroma 2014) also recognised that 
procedures to reduce and process these data are not well developed. This study has overcome 
this challenge by establishing a process to organise the raw acceleration counts generated by 
the ActivPAL and Actigraph accelerometers into a compatible form will allow accurate and 
informative assessment of physical activity behaviour in future research. 
In this sutdy, the ActivPAL device is worn on Right and Left sides, however it would be 
expected there was no significant differences in acceleration records in both left and right 
positions. John et al agreed with that the mean activity counts obtained from the Actigraph 
in left and right sides were comparable (John et al. 2010) 
With this knowledge we were able to determine algorithms to calculate acceleration ranges 
equivalent to light, moderate and vigorous physical activity. This would enable  
determination of the amount of time and steps in each intensity domain. It also is possible to 
estimate energy expenditure from the vector magnitude acceleration values. Further work is 
needed to validate this estimation under free-living conditions, ideally in using doubly 
labelled water as a gold-standard comparison.  
It would be worth developing separate regression models to predict VO2 dependent on 
walking and running speed to understand if these produced more accurate results. Other 
aspects that may be worth including in this study to see if it improved the estimates would 
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be weight, height / leg length and / or BMI. Age would be another aspect considering since 
research such as by Ostrosky et al (Ostrosky et al. 1994) has shown that gait differs between 
adult and elderly people. Also worth developing would be separate regression models for 
males and female, since gait patterns can be different between genders (Senden et al. 2009). 
There were several strengths to this study. A key strength of study was used a wide range of 
low and high speed this enable determination accuracy of measurement at very low intensity 
reflect of everyday activity. Further advantage a treadmill and free-living activity was 
determined and both was comparable. In this study, we also able to compare between left 
and right sides in each position. It was clear that value from right and left were comparable 
indicating the steps counts and acceleration.  
This study does have some limitations. A walking and running linear relationship was only 
considered. However, light activity that people may undertake in free-living should be 
measured. However, as these activities generally include stepping and thigh-based has been 
shown as a good position for detecting stepping counts. It is likely that the data generated 
with thigh would be transferred to everyday activity. However, this require information in 
further study.  Thigh or hip-based placement will underestimate energy expenditure of 
activity which are using main body and to fully quantify activity from acceleration will be 
needed. For single accelerometer thigh-based is likely to be better position due to the 
sensitivity to pick activity and distinguish between sitting and upright activity.  
 Conclusion 
In conclusion, based on the results of this study, it appears that the use of accelerometer-
based data collected from the thigh and hip-based present unique challenges in classifying 
stepping counts and activities into type and intensity categories and estimating EE.  Thigh-
based was highly accurate placement site for determining activity and detecting stepping 
counts. This study has made the challenging and initial steps towards developing algorithms 
for ActivPAL to estimate oxygen uptake and energy expenditure from the acceleration 
output. While further research is needed to test the accuracy of these algorithms in a wide 
range of free-living activities, this work has made an important contribution which will 
facilitate the use of a single thigh-worn accelerometer for the accurate and detailed 
quantification of both sedentary behaviour and physical activity. 
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6. General Discussion 
 Summary 
As mentioned in the literature review, the implications of the detrimental effect on health of 
prolonged time sitting are well demonstrated (Biddle et al. 2016; Biswas et al. 2015; Same 
et al. 2016; Wilmot et al. 2012; Young et al. 2016). Thus, interventional research is urgently 
required to reverse the current trend towards lower physical activity levels and increased 
sitting time (Dunstan et al. 2011; Proper et al. 2011; Vandelanotte et al. 2013). Findings 
from this thesis describe the effects of different patterns of breaking up sedentary time on 
postprandial metabolic responses. In addition, novel indices were developed and validated 
for the estimation of intensity of physical activity and energy expenditure from acceleration 
outputs from a thigh-worn accelerometer, which may facilitate future use of a single thigh-
worn accelerometer for the comprehensive assessment of both sedentary behaviour and 
physical activity from a single device. Accelerometers provide the potential for accurate 
objective measurement of physical activity, which is important for epidemiological 
assessment of activity levels and the association with disease risk and for quantification of 
changes in activity behaviour in response to interventions.  The hip and thigh are commonly 
used locations for accelerometer placement.  However, it is unclear whether these two 
locations are comparable in terms of measurement of stepping rate, speed and exercise 
intensity. In long term trials as well as observational research it is essential to be able to 
measure sedentary behaviour and physical activity. Poor measurement led to 
misunderstanding the relationship of physical activity, sedentary behaviour and health 
outcome. Some accelerometers are usually worn on the hip or wrist which measure physical 
activity intensity. However, these monitors are not able to distinguish between sitting and 
standing. An accelerometer which able to measure sitting, standing, physical activity 
intensity, and low intensity steps count is needed to butter understand the differences and 
risk between sitting and upright activity and measure low intensity steps which is reflect to 
our normal daily activity.         
 The main findings of this thesis suggest that duration of bouts of sedentary behaviour 
appears to influence indices of metabolic health – principally energy expenditure – 
independent of total time spent or physical activity. Previous observational studies have 
reported associations between high volumes of sitting and a number of health outcomes, 
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such as metabolic syndrome  (Edwardson et al. 2012; Wijndaele et al. 2011) type 2 diabetes 
(Hu et al. 2003) (Ford et al. 2010; Hu et al. 2001; Zhang et al. 2006) cancer, CVD and all-
cause mortality (Katzmarzyk et al. 2009; Patel et al. 2010; Stamatakis et al. 2011). The 
findings presented in chapter 3 are supported by previous observational studies which 
demonstrate that interrupting periods of sitting by standing has featured a meaningful change 
in metabolic rate but not with glucose, insulin and TG regulation (Gupta et al. 2016). 
Moreover, the present findings in chapter 4 suggest that breaking up sedentary time with 
sit/stand activity might induce a number of positive effects on postprandial metabolism. 
There are important issues regarding the accurate measurement of sitting behaviour in 
observational studies which are currently unresolved (Celis-Morales et al. 2012). The 
research reported in Chapter 5 was, to the author’s knowledge, the first to evaluate the 
accuracy of acceleration for measuring step counts and physical activity intensity with thigh-
placed accelerometers across a range of walking and running speeds and to develop and 
validate algorithms to estimate energy expenditure from raw acceleration counts for a thigh-
placed accelerometer. 
 The first aim of this thesis was to compare the metabolic effects of breaking up sedentary 
time with prolonged periods of standing versus multiple shorter standing bouts with the same 
total duration to determine whether – in principle – altering the frequency of breaks in 
sedentary time, influences metabolic responses in 10 overweight/obese, over the course of 
the day. This aim was addressed in chapter three which determined that increasing the 
frequency of breaks in sedentary time by 10 1.5-minute bout of standing in every half-hour, 
while keeping total sedentary time constant, increased energy expenditure by 9%, p < 0.001, 
compared with 15 minutes of sitting and 15 minutes of standing over an 8-hour postprandial 
observation period. The present findings seem to be consistent with other research which 
found that breaking up prolonged sitting with standing increased energy expenditure by 2-
33% compared to sitting (Judice et al. 2015a; Levine et al. 2000; Reiff et al. 2012; Speck 
and Schmitz 2011).  However, there was no significant effects of either prolonged or 
intermittent standing breaks on postprandial incremental glucose, insulin or TG responses. 
This also accords with an earlier intervention study, which showed that breaking up sitting 
time with 2 minutes of standing every 20 minutes had no effect on postprandial glucose or 
TG responses over a 5-hour period (Bailey and Locke 2015). Although, these results differ 
from some published studies (Dunstan et al. 2012b;Larsen et al. 2015;Myashita et al. 
2008;Peddie et al. 2013) who demonstrated that breaking up prolonged sitting time with ≤3-
minute bouts of light or moderate intensity physical activity every 20-30 minutes can lower 
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postprandial glucose, insulin and TG concentrations.   Thus, these data provide proof-of-
principle that the number of transitions between sitting and standing influences energy 
expenditure and substrate utilisation, independent of total time spent sedentary.  This 
provides a potential explanation for the independent effect of frequency of sedentary breaks 
on indices of adiposity observed in large epidemiological studies (Cooper et al. 2012; Healy 
et al. 2008a; Healy et al. 2011). However, the intermittent protocol used is clearly not 
feasible to implement as a practical intervention. The aim of chapter four was to therefore 
investigate whether undertaking a large number of sit/stand transitions in a more practically 
feasible format – repeatedly standing and sitting 10 times over 30 seconds every 20 minutes 
– could induce similar metabolic benefits in inactive, overweight/obese adults.   
 
Epidemiological studies have shown that high level of sedentary behaviour is associated with 
increased risk of obesity (Thorp et al., 2011). It is conceivable that this may be mediated, at 
least in part, by the low energy expenditure associated with sitting.  A number of 
experimental studies have shown that replacing sitting with standing increases energy 
expenditure over the course of the day (Reiff et al., 2012; Speck & Schmitz, 2011).    
Building on this work, we recently observed that intermittently standing for 1.5 minutes 10 
times every 30 minutes led to 9% higher energy expenditure over an 8-hour postprandial 
period than standing continuously for 15 minutes every 30 minutes over the same time-frame 
(Hawari et al., 2016), indicating that the number of transitions between sitting and standing 
influenced energy expenditure independently of the overall amount of time spent sitting and 
standing.  In that study there were 144 additional sit-to-stand transitions in the intermittent 
standing condition and 296 kJ additional energy was expended: from this it was possible to 
calculate that a sit-to-stand transition expended ~2 kJ of energy.  The findings from the 
present study are consistent with this, energy expenditure was 410 kJ higher in the 
SIT/STAND compared with the SIT condition and 180 additional sit-to-stand transitions 
were undertaken in the former – equivalent to 2.3 kJ energy expenditure per transition.  Thus, 
the present data provide confirmation that previously observed differences in energy 
expenditure between continuous and intermittent standing (Hawari et al., 2016) can be fully 
accounted for by the energy expended in the transition from sitting to standing and taken 
together these independent observations provide a robust estimation of energy expended in 
a sit-to-stand transition cycle. 
Previous investigations of the effects of breaking up prolonged sitting with standing have 
had equivocal results in terms of alterations in glucose and insulin metabolic responses with 
6. General Discussion 
©Nabeha Hawari (2017)           136 
some (Thorp et al., 2014; Henson et al., 2016; Buckley et al., 2014), but not all (Bailey & 
Locke, 2015; Hawari et al., 2016) studies observing favourable changes when sitting is 
replaced by standing. In studies which have assessed postprandial TG responses, replacing 
sitting with standing has generally not resulted in significant changes (Henson et al., 2016; 
Hawari et al., 2016).  In the present study, we observed that breaking up prolonged sitting 
by with 10 chair-squats every 20 minutes reduced insulin concentrations in the post-
breakfast period, although this did not persist into the post-lunch period.  This could 
conceivably be mediated by the skeletal muscle contractions needed to move between sitting 
and standing stimulating contraction-mediated glucose uptake (Krook, Wallberg-
Henriksson, & Zierath, 2004), thereby reducing the requirement for insulin to maintain 
glucose homeostasis.  Indeed, the repeated sit-to-stand transitions over 30 seconds, in effect 
represents multiple sets of bodyweight squats over the course of the day.  However, the 
chair-squat intervention did not significantly affect postprandial glucose or TG 
concentrations.  Interestingly, Dempsey and colleagues recently reported that breaking up 
prolonged sitting with 3 minutes of bodyweight resistance exercises every 30 minutes over 
a 7-hour postprandial observation period reduced postprandial glucose, insulin and TG 
concentrations in adults with type 2 diabetes (Dempsey et al., 2016).  This more potent 
intervention effect in Dempsey’s study may reflect two things. First, the volume of resistance 
exercise undertaken in that study (6 vs 1.5 mins per hour) was substantially higher than in 
the present study.  It may well be that a larger volume of sit-to-stand transitions – for example 
60 seconds of ‘chair squats’, rather than 30 seconds, every 20 minutes – may elicit more 
substantial effects on postprandial insulin, glucose and TG responses.  Secondly, the 
participants in the present study were normoglycaemic, and it may be the case that the 
stimulus required to positively affect postprandial metabolic responses may be greater in 
healthy normoglyaemic individuals than those with metabolic dysfunction where there is 
greater capacity for improvement.  For example, lab-based interventions breaking up sitting 
with standing have been effective at reducing postprandial glucose and insulin 
concentrations in post-menopausal women with impaired glucose regulation (Henson et al., 
2016), but this effect has not been replicated in similar interventions in younger, 
normoglycaemic individuals (Bailey & Locke, 2015; Hawari et al., 2016; Miyashita et al., 
2013).  Thus, going forward, studies are needed i) to determine whether the present 
intervention is effective at reducing postprandial glucose, insulin and TG responses in 
individuals with impaired glucose regulation and ii) to determine whether the metabolic 
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benefits observed here would be enhanced in normoglycaemic individuals with an increased 
‘dose’ of ‘chair squats’. 
 The intervention undertaken in the present study is simple, requires no equipment and little 
space and only takes 1.5 minutes per hour.  The additional 410 kJ of energy expended over 
the course of the trial, would equate to 8.2 MJ over 4 weeks if the intervention was carried 
out on 5 days of the week, which is equivalent to over 1 kg weight loss.  This, together with 
the modest reductions in postprandial insulin concentrations, suggest that pragmatic, low 
volume, interventions of this nature may have the potential to elicit benefits to metabolic 
health.  Thus, the ‘chair squat’ approach used in the present study could potentially be 
developed into an alternative strategy which would be used as an alternative to, or in 
combination with, other interventions, such as standing desks, to break up periods of 
prolonged sitting in individuals, such as office workers, to who need to work at a desk 
throughout the day.  This would require substantial further development, and the present 
findings provide a rationale for undertaking longer-term randomised controlled trials to 
determine whether interventions of this nature are acceptable to individuals and sustainable 
in practice and whether they induce long-term benefits to metabolic health.   
Nevertheless, the data in chapter 4 suggests that this approach may be an effective way of 
reducing the adverse effects of sedentary time during working hours or leisure time, and this 
occurred without inducing a major reduction in total daily sitting time. Such findings add 
considerably to the existing literature and are important as they suggest that changing 
between sitting and standing postures more frequently in adults could be important for 
positive health outcomes. Targeting such facets of behaviour in obese adults, who are likely 
to be the most susceptible to the health risks associated with prolonged sitting (van Uffelen 
et al.2010). 
Chapter 3 and 4 have examined the effect of breaking prolonged sitting time with standing 
on metabolic health. Whilst the observational evidence supports the relationship between 
sedentary behaviour and health, intervention level evidence in humans is limited, particularly 
for the benefits standing without ambulation. More research is therefore required in order to 
establish the nature of the causal link between sedentary behaviour and metabolic health and 
the independent effects of standing and light ambulation. 
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Accurate monitoring for measuring physical activity and sedentary behaviour is needed to 
better assess the level of physical activities, sedentary behaviour and to quantify the dose 
response of activity, sedentary and health outcome. People spent relatively small proportion 
of day undertaking moderate or vigorous physical activity (Dunstan et al. 2012a; Loyen et 
al. 2016a). However, people spend most of the day in sedentary or low activity in daily 
activity level (Bennie et al. 2013; Loyen et al. 2016a; Loyen et al. 2016b; Milton et al. 2015; 
Owen et al. 2010b). Thus, accurate quantification of low intensity physical activity and 
sedentary behaviour is important. The ActivPAL is a gold standard for measuring sedentary 
and upright posture, and is widely used by researchers. However, the output of this device 
for physical activity intensity have been relatively limited with only stepping counts and 
rates being provided. Therefore it was very important to develop approaches to obtain better 
estimates of physical activity intensity using this device to facilitate the use of a single device 
to comprehensively monitor both sedentary time and physical activity.  
In Chapter 5 the new algorithms were developed and validated to quantify oxygen uptake, 
energy expenditure and step counts from accelerometer output of the ActivPAL devices 
worn on the thigh and on this hip. Participants undertook a wide range of walking and 
running activities, including walking at very low intensities, and validity was assessed under 
controlled conditions using direct observation as the criterion measure. The findings in 
Chapter 5 showed that the upper and lower thigh-worn ActivPAL accelerometer are accurate 
for detecting step counts during walking and running tasks (R2 = 0.86 for all). Hip-based 
ActivPAL and Actigraph underestimated steps count at speeds below ~ 3-4 km.h-1. Also, 
there was a strong linear relationship between vector magnitude acceleration and speed in 
all positions. The relationship between ActivPAL accelarations and oxygen uptake was very 
strong for both the thigh and hip positions (R2 ≈ 0.90), (R2 ≈ 0.88) respectively. 
An important finding in chapter 5 is that the data generated from treadmill-based walking 
was applicable with free-living walking, the finding detected that the relationships between 
mean vector magnitude and speed on the treadmill and on the track were very closely 
correlated. This means that the results observed during treadmill testing including VO2 
measurements, can be applied to free-living situation.   
This finding is of considerable potential interest to researchers who are interested in 
quantifying sedentary behaviour and physical activity intensity, and for researcher designing 
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interventions to address these behaviours, as it provides opportunity for comprehensive 
measurement of both sedentary behaviour and physical activity using a single device. 
 Conclusions 
Thus, overall this thesis has provided novel information show the frequency breaking 
sedentary has influences metabolic responses, independent of total time spent sitting or 
standing and showing that practically feasible intervention using, chair-squats to break 
sedentary time may be a promising approach.  Further study is needed to establish whether 
increasing the number of sit-to-stand transitions per cycle would augment the potential 
benefits and longer-term intervention studies are needed to determine whether this approach 
is feasible and effective in ‘real world’ settings. Targeting such facets of behaviour in adults, 
especially obese people, holds great potential for behaviour change strategies which could 
have a large impact on public health.  
In addition, this thesis has developed novel algorithms which will facilitate the use of a single 
thigh-worn accelerometer for comprehensive assessment of both sedentary behaviour and 
physical activity, which will be of use to researchers working in this domain.  Further 
validation work over a wide-range of free-living activities is now needed to confirm the 
utility of these new physical activity measurement tools. 
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8. Appendices 
Appendix A: Volunteer Information Sheet and concent forms – Chapter 3 
 
    
VOLUNTEER INFORMATION SHEET 
Title: Metabolic responses to breaking up sitting time 
 
You are being invited to take part in a research study. Before you decide it is important for 
you to understand why the research is being done and what it will involve.  Please take time 
to read the following information carefully and discuss it with others if you wish. Ask us if 
there is anything that is not clear or if you would like more information. Take time to decide 
whether or not you wish to take part. 
 
Thank you for reading this. 
What is the purpose of the study? 
Spending large amounts of time sitting down increases risk of heart disease, diabetes and 
obesity.  This risk may be reduced by breaking up periods of prolonged sitting with periods 
of standing up.  However, it is unclear whether different patterns of breaking up sitting time 
(i.e. with many short periods of standing, or a smaller number of longer periods of standing) 
have different influences on fat and sugar metabolism in the body.  This study will compare 
fat and sugar responses over the course of a day of prolonged sitting, a day when sitting is 
broken up by relatively long-periods of standing, and a day when sitting is broken up by 
more frequent shorter periods of standing.  
 
Why have I been chosen? 
You have been chosen because you are a healthy man or a postmenopausal women aged 
between 18-65 years, who is currently relatively physically inactive.  
 
Do I have to take part? 
It is up to you to decide whether or not to take part.  If you do decide to participate, you will 
be given this information sheet to keep and be asked to sign a consent form. If you do this 
you are still free to withdraw at any time and without giving a reason.   
 
What will happen to me if I take part? 
Screening procedures 
In the first instance you will be asked to attend for a screening visit in which we will: 
 discuss with you and complete confidential questionnaires regarding your health, 
family history and physical activity level 
Appendix A: Volunteer Information Sheet and Consent Forms 
©Nabeha Hawari (2017)           156 
 measure your blood pressure 
 take your height, weight and waist measurements 
 take a small blood samples to check the sugar level in your blood.   
 provide an opportunity for you to ask questions 
 
These preliminary procedures will enable us to determine whether you fall into the group of 
people we wish to study and will also ensure that it is perfectly safe for you to take part.  
 
Experimental procedures 
We will ask you to undergo 3 main experimental trials. Each trial will run approximately 1-
2 weeks apart, in random order.   
 
a) Sitting all day 
We will ask you to come to the University after an overnight fast (i.e. having eaten nothing 
for 12 hours) and spend the day with us (~8 hours).  We will then take a breath sample to 
measure how many calories and how much fat you are burning, ask you to answer some 
questions to determine your memory and problem solving capacity, and take a small blood 
sample from a tiny plastic tube called a ‘cannula’ placed in a vein in your forearm.  This is 
no more painful than a simple blood test. We will then ask you to sit comfortably for about 
8 hours (comfort breaks to go to the toilet are allowed), during which time you can read, 
watch TV or use a computer. We will provide you with a test breakfast and test lunch over 
the course of the day and throughout the day we will take further small blood samples and 
breath samples and ask memory and problem solving questions.  A total of about 120 ml 
(about a quarter of a blood donation) of blood will be taken over the course of the day. 
 
b) Prolonged standing 
This trial will be identical to the Sitting all day trial, except that we will ask you to stand up 
continuously for 15 minutes out of each 30 minutes throughout the 8-hour observation 
period. 
 
c) Intermittent standing 
This trial will be identical to the Sitting all day trial, except that we will ask you to repeatedly 
stand 2 minutes and sit for 2 minutes throughout the 8-hour observation period. 
  
What do I have to do? 
Other than the specific tasks described above, we ask you to maintain your usual lifestyle 
(i.e. don’t change your diet or exercise habits) for the duration of this study.  We also ask 
you to weigh and record everything that you eat and drink for the two days before your first 
main experimental trial (we will provide you with scales and record sheets to do this) and 
not to undertake any planned exercise or drink alcohol on these days.  We will ask you to 
wear a small matchbox-sized device called an accelerometer during these days, and during 
the days of the trials themselves, so we can monitor your level or physical activity and sitting.  
We will ask you to repeat your diet and activity pattern for the two days before your second 
and third experimental trials. 
What are the possible disadvantages and risks of taking part? 
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 Blood sampling via the cannula may cause minor bruising or an inflammation of the vein. 
Good practice, however, minimises this risk.  Some people may feel faint when they give 
blood. 
 There is a small possibility that taking part in this study will reveal a health problem that 
you already have such as high cholesterol or high blood pressure. If such a problem is 
revealed, we will ask your permission to inform your GP to ensure that you receive 
appropriate treatment. 
 
What are the possible benefits of taking part? 
There may be no immediate benefits to you personally, but as a result of being involved in 
this study you will receive health information about yourself including a dietary assessment 
and information about your cholesterol and blood sugar levels.  You will also receive £100 
as a token of thanks for participating. This study will help us to determine how reducing time 
spent sitting down can improve risk factors for heart disease, diabetes and obesity. The 
findings of this study will be published in scientific journals so that understanding about how 
reducing sitting can help people to improve their cardiovascular health and better control of 
their weight. This information may contribute towards improving physical activity 
guidelines. 
 
 
We will provide you with feedback about the main study findings and also about your own 
results and would be delighted to explain results and discuss the implications with you. 
 
What if something goes wrong? 
The chances of something going wrong are extremely small. We have conducted several 
similar projects over the past 15 years, with many hundreds of participants, and have never 
had any problems. All of the procedures involved in this study are low risk and our screening 
tests are designed to ensure that you will only participate if it is safe for you to do so. In the 
unlikely event that you are harmed due to someone's negligence, then you may have grounds 
for a legal action but you may have to pay the costs of such action.  
 
Will my taking part in this study be kept confidential? 
All information which is collected about you during the course of the research will be kept 
strictly confidential. Any information about you which leaves the University or hospital will 
have your name and address removed so that you cannot be recognised from it. In addition, 
your records, samples and results will be identified by a number and not your name.  
 
What will happen to the results of the research study? 
The results from this study will be presented at scientific meetings and published in scientific 
journals. The results will also form part of Mrs Nabeha Hawari’s PhD thesis.  A copy of the 
published results will be sent to you upon request. You will not be identifiable in any of the 
data presented or published from this study. 
 
What will happen to my samples after the study has finished? 
The blood samples that you provide for this study may be useful for future research into the 
prevention and treatment of diabetes and heart disease; this may involve investigating new 
biochemical markers that are not yet identified. Samples will be analysed anonymously and 
will require a new ethics application before they would be used for future research. If you 
do not wish your samples to be used for future research, please indicate this on the consent 
form. 
Who has reviewed the study? 
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This study has been reviewed and approved by the College of Medial Veterinary and Life 
Sciences Ethics Committee at the University of Glasgow.  
 
Contact for Further Information 
Any questions about the procedures used in this study are encouraged. If you have any 
doubts or questions, please ask for further explanations by contacting one of the investigators 
below: 
 
Mrs Nabeha Hawari    
E-mail: n.hawari.1@research.gla.ac.uk 
Tel: 0141 3303475 (office) or  (mobile) 07919182743 
 
 
Dr Iqbal AlShayji 
E-mail: Iqbal.alshayji@glasgow.ac.uk 
Tel: 07799353689     
 
Dr Jason Gill 
E-mail: jason.gill@glasgow.ac.uk 
Tel: 0141 3302916     
 
You will be given a copy of this information sheet and a signed consent form to keep 
for your records. 
 
 
Appendix A: Volunteer Information Sheet and Consent Forms 
©Nabeha Hawari (2017)           159 
 
 
 
Volunteer Identification Number for this trial: ___________ 
 
 
CONSENT FORM 
 
Title: Metabolic responses to breaking up sitting time 
 
Name of Researcher: ____________________________________________ 
                                                                                                Please initial box 
 
1. I confirm that I have read and understand the information sheet 
dated 01.10.2014 for the above study and have had the 
opportunity to ask questions. 
 
2. I understand that my participation is voluntary and that  
I am free to withdraw at any time, without giving any reason, 
without my medical care or legal rights being affected. 
 
3. I agree to take part in the above study. 
 
 
4. I agree for my samples to be used for future research into the 
prevention and treatment of diabetes and heart disease.  This may 
involve analysis of new biochemical markers not yet identified. 
     
              
 Name of Subject                                   Date                        Signature 
 
    
Name of Person taking consent  Date                   Signature 
(if different from researcher) 
 
   
Researcher                                                Date                  Signature 
 
 
Copy for participant 
Copy for researcher 
 
 
Yes  
  
 No 
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Appendix B: Health Screen – Chapter 3, 4 & 5 
 
HEALTH SCREEN FOR STUDY VOLUNTEERS 
 
Name: ……………………………………………………….  
 
It is important that volunteers participating in research studies are currently in good health and have 
had no significant medical problems in the past.  This is to ensure (i) their own continuing well-being 
and (ii) to avoid the possibility of individual health issues confounding study outcomes. 
 
Please complete this brief questionnaire to confirm fitness to participate: 
 
1. At present, do you have any health problem for which you are: 
(a) on medication, prescribed or otherwise  yes [ ] no [ ] 
(b) attending your general practitioner    yes [ ] no [ ] 
(c) on a hospital waiting list    yes [ ] no [ ] 
2. In the past two years, have you had any illness which required you to: 
(a) consult your GP     yes [ ] no [ ] 
(b) attend a hospital outpatient department   yes [ ] no [ ] 
(c) be admitted to hospital      yes [ ] no [ ] 
 
3. Have you ever had any of the following: 
(a) Convulsions/epilepsy     yes [ ] no [ ] 
(b) Asthma       yes [ ] no [ ] 
(c)  Eczema       yes [ ] no [ ] 
(d)  Diabetes      yes [ ] no [ ] 
(e) A blood disorder     yes [ ] no [ ] 
(f) Head injury      yes [ ] no [ ] 
(g)  Digestive problems     yes [ ] no [ ] 
(h) Hearing problems     yes [ ] no [ ] 
(i) Problems with bones or joints    yes [ ] no [ ] 
(j) Disturbance of balance/co-ordination   yes [ ] no [ ] 
(k) Numbness in hands or feet    yes [ ] no [ ] 
(l) Disturbance of vision     yes [ ] no [ ] 
(m) Thyroid problems     yes [ ] no [ ] 
(n) Kidney or liver problems    yes [ ] no [ ] 
(o) Chest pain or heart problems    yes [ ] no [ ] 
(p) Any other health problems    yes [ ] no [ ] 
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4.  Have any of your family (parents, grandparents, brothers, sisters, children, aunts, uncles, 
cousins) ever had any of the following: (if yes please give details including age of first diagnosis) 
(a) Any heart problems     yes [ ] no [ ] 
(b) Diabetes      yes [ ] no [ ] 
(c)  Stroke       yes [ ] no [ ] 
(d)  Any other family illnesses    yes [ ] no [ ] 
4. For females only – Are you postmenopausal?*   yes [ ] no [ ] 
(*at least 2 years since last menstrual bleeding) 
 
6. Do you currently smoke     yes [ ] no [ ] 
 Have you ever smoked     yes [ ] no [ ] 
  
 If so, for how long did you smoke and when did you stop? …………………… 
 
7. How many units of alcohol do you typically drink in a week? …………………. 
 
If YES to any question, please describe briefly if you wish (e.g. to confirm whether problem 
was short-lived, insignificant or well controlled.) (Use a separate sheet if necessary) 
………………………………………………………………………………………………………
………………………………………………………………………………………………………
……………………….….…………………………………………………………… 
 
Name and address of GP 
………………………………………………………………………………… 
………………………………………………………………………………… 
      
Blood pressure measured at screening:     mm Hg  
 
Fasting plasma glucose measured at screening:  mmol/l 
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Appendix C: Volunteer`s Information – Chapter 3 
 
Date  
Subject No. & 
Trial 
 
Name  M    F 
Address  
Telephone  
Email  
Date of Birth  Age  
Ethnicity  
 
Height (cm)  Body Mass (kg)  
Waist (cm)   Hip (cm)   
BMI (kg/m2)  WHR  
BP    Glucose (mmol/l)  
ActivPAL*  
 
* ActivPAL will be fixed on the lower right thigh 
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Appendix D: Food Instructions – Chapter 3 & 4 
 
 
Preparation for the Study Day   
1. For three days before each trial, please refrain from planned or strenuous 
exercise, other than for personal transportation. 
 
2. Weigh and record your food and drink for two days before your first test. 
You will have to repeat this EXACTLY prior to the second test, so it is 
advisable to eat meals that you will easily be able to repeat.  You will be 
provided with kitchen weighing scales and record sheets.  No alcohol should 
be consumed on these days. 
 
3. If possible, please try to have the same amount of sleep prior to each test 
and wake at the same time on the morning of each test. 
 
4. For second day of the trial, please arrive at the laboratory after a 12-hour 
fast, i.e. if your test is at 8 am then your last food and drink should be taken 
by 8 pm the evening before.  Ensure that you drink plenty of water during 
the evening to prevent dehydration. 
 
5. Please come to the laboratory warm.  This will help with blood collection.  
Wear warm clothing with loose sleeves that can easily be pulled up. 
 
6. Please come to the West Medical Building by car.  If this is a problem, 
please contact us beforehand and we will arrange transport for you. 
 
7. Remember to bring CDs, videos, books, work etc to keep you occupied 
during the day. 
 
If you have any queries or worries concerning the experiment, 
please contact 
 Nabeha Hawari n.hawari.1@research.gla.ac.uk (e-mail). 
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Food Inventory Instructions 
It is important that you weigh and record everything that you eat and drink for the two days 
prior to experiment. Please do not take any alcohol on these days.  Your last food and drink 
should be taken 12 hours before your trial day.   
 
Please (i) start a separate page for each day. 
 (ii) start a separate line for each item. 
 
Column 1 
Record meal and time and place of eating. 
 
Column 2 
Describe each item as accurately as possible, stating where relevant: 
i. type and brand 
ii. whether food is fresh, dried, canned, frozen, salted, smoked, etc. 
iii. whether food is cooked, if so give method of cooking e.g. fried, baked, etc. 
 
Column 3 
Record the weight of each item after cooking: 
i. place scales on a level surface 
ii. place plate or container on top of scales 
iii. press ‘ON/Reset’ button to turn on scales 
iv. once zero appears, add first item of food 
v. record weight displayed 
vi. press reset button before weighing next item 
 
Wherever possible, record weights in grams.  If this is not possible, record weights in 
household measures (e.g. sugar or jam in teaspoons, stating whether level, rounded, or 
heaped). 
 
Column 4 
Record the weight of any leftovers, such as food remaining on plate, weight of container in 
which food has been weighed, apple cores, etc. 
 
Columns 5 
Please leave blank. 
 
If food consists of several items, please list each on a separate line i.e. instead of writing 
‘one cheese sandwich’, record separately the weights of bread margarine, cheese, etc. 
 
Please remember to record all drinks, as well as food, giving weights where possible, or 
volumes if these are known.  Record separately the weights of added milk and sugar. 
 
An example is shown overleaf. 
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Food Inventory - Example 
 
Name_____________________________________    Date ________________ 
 
1. 2. 3. Weight of 4. Weight of Leave 
Time/Place Description of food/drink food/drink container/ Blank 
  (g) leftovers (g)  
Breakfast Cornflakes (Kelloggs) 28    
8:30am Milk (Sainsbury’s virtually fat-free) 48    
Home Bread (Mothers Pride, large white  76    
 sliced, toasted)     
 Flora margarine 7    
 Robinsons lemon marmalade 12    
 Coffee (instant) 2    
 Milk (whole pasteurised) 10    
      
Lunch Cheese (Cheddar) 55    
1:00pm Bread (white, crusty) 76    
Pub Butter 4    
 Chutney (2 teaspoons)     
      
Snack Coffee (instant) 2    
3:30pm Coffee-mate 6    
Office Mars Bar 35    
 Apple 76 8 (core)   
      
Dinner Turkey Fillet (frozen, grilled) 102    
6:30pm Potatoes, old, boiled 320 74   
Home   (leftover)   
 Peas (Birds Eye, frozen, boiled) 50    
 Heinz tomato ketchup 14    
 Yoghurt (Ski strawberry thick and  162 10   
 creamy)  (carton)   
 Coffee, filter 148    
 Milk (Sainsbury’s virtually fat-free)  8    
      
Snack Banana 107    
7:45pm Orange Tango (can) 330    
Home      
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Food Inventory 
 
Name_____________________________________    Date ________________ 
 
1. 2. 3. Weight of 4. Weight of Leave 
Time/Place Description of food/drink food/drink container/ Blank 
  (g) leftovers (g)  
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Appendix E: Accelerometers Instructions – Chapter 3 & 4 
 
 
Accelerometers Instructions 
 
1. You will be fitted with two accelerometers (one on your right hip and one 
on your lower right thigh).  Please KEEP THE ACCELEROMETERS ON YOUR 
PERSON AT ALL TIMES, EVEN DURING SLEEPING. 
 
2. The ActivPAL (on your right thigh) will flash green when it is activated. 
 
3. You will be provided with extra stickers and adhesives in case you needed 
to refit ActivPAL.  
 
4. Please take off the Actigraph (the belt around your hip) before you shower 
as it is NOT waterproof.  Kindly fit it back on your RIGHT side afterwards. 
 
5. Please use the attached sheet to record the days and times whenever you 
take off the Actigraph and when you put it back on. 
 
 ActivPAL Actigraph 
Position 
Right thigh  
(10 cm from the middle of the 
knee) 
Right side of the hip 
Accessories Additional stickers belt 
 
If any of the accelerometers is flashing RED, please contact 
Nabeha Hawari  
n.hawari.1@research.gla.ac.uk (mobile: 07919182743). 
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Sedentary Time Study: accelerometers 7-Day Record 
Volunteer Name:  
Actigraph 
(Belt) 
Day Date Time OFF Time ON 
    
    
    
    
    
 
Volunteer Name:  
ActivPAL 
(Knee) 
Day Date Time OFF Time ON 
    
    
    
    
    
 
Notes 
………………………………………………………………………………… 
………………………………………………………………………………… 
………………………………………………………………………………… 
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Appendix F: Check List Form – Chapter 3 & 4 
Sedentary Study Check List 
ALWAYS REMEMBER TO BOOK THE MET SUITE & EXERCISE LAB 
A Week Pre-Trial 
For subject 
 ActivPAL  Accelerometers sheet 
 Actigraph  Copy food diary to repeat 
 
A Day Pre-Trial 
 Protocol  
 Charge and initiate an Actigraph and an ActivPAL  for Trial Day 
 Charge and initiate an Actigraph and an ActivPAL  for Next Trial Week 
 Accelerometers sheet 
 Adhesives 
 Self-sealed bags x3  previous week + trial day + next week accelerometers 
Met Suite: 
  Label blood tubes  1 EDTA + 1 Serum for each time point (x11 timepoints) 
 Saline 
 Blood collection sets 
o 2-ml & 5-ml syringes + connector + luer adaptor + tissue/gauze  + tray + gloves 
 Cannulation set  
o green cannula + swabs + 3-way stopcock + tourniquet + tape 
 Test tube rack 
 Ice box 
 Sharps bin 
 Seating + Douglas bag rack 
 Douglas bags  x2 
 Mouth piece/Valves x2 
 Stopwatches x4  Blood + Expired Air + Protocol + Backup 
 
Molecular Lab: 
  Label Apex tubes (0.5 ml)  6 EDTA + 4 Serum for each time point 
 Plastic Boxes for Apex tubes 
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Trial Day 
 Evacuate Douglas bags, if necessary.  
 Ice 
 Tissues for subject (after expired air collection) 
Molecular Lab: 
 Turn on centrifuge 
 Change YSI mode to RUN 
 Run controls on YSI 
When the subject arrives: 
 WEIGH SUBJECT 
 BAROMETRIC PRESSURE 
 Calculate test meal 
 Weigh test meal food and store in fridge (do not toast the bagel) 
 Take food diary and copy for subject to repeat. 
 Replace accelerometers 
Post-Trial 
 Clean Expired air equipment:  
o Rinse and soak valves/mouthpieces/nose clips in Trigene (for 3 hours) 
o Wash tube with trigene and leave to dry 
o Blow up Douglas bags 
o Turn off analyser pump at the end of the day 
o  Sign sheet behind the door 
 Clean Met Suite 
o Sign sheet behind the door 
 Clean Kitchen 
o Sign sheet behind the door 
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Appendix G: Sitting, prlonged standing and Intermittent Standing 
Protocols-Chapter 3 
SITTING PROTOCOL 
Date  Time  
Weight 
(kg) 
 Subject  
 
Protocol Time Position Notes 
Weigh Subject On arrival   
Remove accelerometers   Download data and charge 
Place new accelerometers   
- ActivPAL: lower right thigh 
- Actigraph: right hip 
Rest for 10 mins  Sit  
4-min Resting air sample 1  Sit  
Analyse  Sit  OK      Repeat 
4-min Resting air sample 2  Sit  
Analyse  Sit  OK      Repeat 
Cannulation -10 min Sit Rest for 10 min 
Fasting blood sample 0 min Sit  
Breakfast 00:00 Sit Within 5-10 min 
Start Stopwatch 00:00  GO TO NEXT PAGE 
 
Half-hourly Protocol 
 
4-min Air 
Blood 
30 15 0 
| | | 
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Date  1 – 2 HOURS Subject  
 
Protocol Time Position Notes 
Breakfast 00:00 Sit  
Mouthpiece & nose clip 13:00 
Sit 
 
4-min air collection 15:00  
Stop air collection 19:00  
Mouthpiece & Nose clip 28:00  
4-min air collection  30:00 
Sit 
Blood Sample (30 min) 
Stop air collection 34:00  
Mouthpiece & nose clip 43:00  
4-min air collection 45:00  
Stop air collection 49:00  
Mouthpiece & nose clip 58:00  
4-min air collection 1:00:00 
Sit 
Blood sample (60 min) 
Stop air collection 1:04:00  
Mouthpiece & nose clip 1:13:00  
4-min air collection 1:15:00  
Stop air collection 1:19:00  
Mouthpiece & nose clip 1:28:00  
4-min air collection 1:30:00 
Sit 
 
Stop air collection 1:34:00  
Mouthpiece & nose clip 1:43:00  
4-min air collection 1:45:00  
Stop air collection 1:49:00  
Mouthpiece & nose clip 1:58:00  
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Date  2 – 4 HOURS Subject  
 
Protocol Time Position Notes 
4-min air collection 2:00:00 
Sit 
Blood sample (120 min) 
Stop air collection 2:04:00  
Mouthpiece & nose clip 2:13:00  
4-min air collection 2:15:00  
Stop air collection 2:19:00  
Mouthpiece & nose clip 2:28:00  
4-min air collection 2:30:00 
Sit 
 
Stop air collection 2:34:00  
Mouthpiece & nose clip 2:43:00  
4-min air collection 2:45:00  
Stop air collection 2:49:00  
Mouthpiece & nose clip 2:58:00  
4-min air collection 3:00:00 
Sit 
Blood sample (180 min) 
Stop air collection 3:04:00  
Mouthpiece & nose clip 3:13:00  
4-min air collection 3:15:00  
Stop air collection 3:19:00  
Mouthpiece & nose clip 3:28:00  
4-min air collection 3:30:00 
Sit 
 
Stop air collection 3:34:00  
Mouthpiece & nose clip 3:43:00  
4-min air collection 3:45:00  
Stop air collection 3:49:00  
Blood 4:00:00 Blood sample (240 min) 
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Date  4 – 6 HOURS Subject  
 
Protocol Time Position Notes 
Lunch 4:00:00 Sit  
Mouthpiece & nose clip 4:13:00 
Sit 
 
4-min air collection 4:15:00  
Stop air collection 4:19:00  
Mouthpiece & Nose clip 4:28:00  
4-min air collection  4:30:00 
Sit 
Blood Sample (270 min) 
Stop air collection 4:34:00  
Mouthpiece & nose clip 4:43:00  
4-min air collection 4:45:00  
Stop air collection 4:49:00  
Mouthpiece & nose clip 4:58:00  
4-min air collection 5:00:00 
Sit 
Blood sample (300 min) 
Stop air collection 5:04:00  
Mouthpiece & nose clip 5:13:00  
4-min air collection 5:15:00  
Stop air collection 5:19:00  
Mouthpiece & nose clip 5:28:00  
4-min air collection 5:30:00 
Sit 
 
Stop air collection 5:34:00  
Mouthpiece & nose clip 5:43:00  
4-min air collection 5:45:00  
Stop air collection 5:49:00  
Mouthpiece & nose clip 5:58:00  
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Date  6 – 8 HOURS Subject  
 
Protocol Time Position Notes 
4-min air collection 6:00:00 
Sit 
Blood sample (360 min) 
Stop air collection 6:04:00  
Mouthpiece & nose clip 6:13:00  
4-min air collection 6:15:00  
Stop air collection 6:19:00  
Mouthpiece & nose clip 6:28:00  
4-min air collection 6:30:00 
Sit 
 
Stop air collection 6:34:00  
Mouthpiece & nose clip 6:43:00  
4-min air collection 6:45:00  
Stop air collection 6:49:00  
Mouthpiece & nose clip 6:58:00  
4-min air collection 7:00:00 
Sit 
Blood sample (420 min) 
Stop air collection 7:04:00  
Mouthpiece & nose clip 7:13:00  
4-min air collection 7:15:00  
Stop air collection 7:19:00  
Mouthpiece & nose clip 7:28:00  
4-min air collection 7:30:00 
Sit 
 
Stop air collection 7:34:00  
Mouthpiece & nose clip 7:43:00  
4-min air collection 7:45:00  
Stop air collection 7:49:00  
Mouthpiece & nose clip 7:58:00  
4-min air collection 8:00:00 Blood sample (480 min) 
Stop air collection 8:04:00  
Remove ActivPAL and Actigraph Download data 
Fit ActivPAL and Actigraph for next week  
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Sedentary Behaviour Study 
Expired Air Samples (1) 
Date 
Weight 
(kg) 
Lab Temp 
(oC) 
Bar Press 
(mmHg) 
Flow Rate 
(ml/min) 
Subject 
      S 
Bag 
Time 
(min) 
Time 
(0:00) 
Sampling 
Time (sec)* 
FECO2% FEO2% 
Volume 
(L) 
Temp 
(oC) 
  Resting 1      
  Resting 2      
  Resting 3      
Breakfast 
 15 0:15      
 30 0:30      
 45 0:45      
 60 1:00      
 75 1:15      
 90 1:30      
 105 1:45      
 120 2:00      
 135 2:15      
 150 2:30      
 165 2:45      
 180 3:00      
 195 3:15      
 210 3:30      
 225 3:45      
 
*Sampling time: 4 mins (240 sec) 
Researcher: ______________________________ 
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Sedentary Behaviour Study 
Expired Air Samples (2) 
Date 
Weight 
(kg) 
Lab Temp 
(oC) 
Bar Press 
(mmHg) 
Flow Rate 
(ml/min) 
Subject 
      S 
Bag 
Time 
(min) 
Time 
(0:00) 
Sampling 
Time (sec)* 
FECO2% FEO2% 
Volume 
(L) 
Temp 
(oC) 
Lunch 
 255 4:15      
 270 4:30      
 285 4:45      
 300 5:00      
 315 5:15      
 330 5:30      
 345 5:45      
 360 6:00      
 375 6:15      
 390 6:30      
 405 6:45      
 420 7:00      
 435 7:15      
 450 7:30      
 465 7:45      
 480 8:00      
        
 
*Sampling time: 4 mins (240 sec) 
Researcher: ______________________________ 
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Sedentary Behaviour Study 
Blood Sampling and Glucose Measurements 
Date    Subject 
     S 
Time (0:00) 
Timepoint 
(min) 
 Protocol 
Glucose 
(mmol/l) 
Notes 
0:00 0  Fasting    
0:30 30      
1:00 60      
2:00 120      
3:00 180      
4:00 240  Lunch    
4:30 270      
5:00 300      
6:00 360      
7:00 420      
8:00 480      
 
Controls Lot No:  
High value 
(mmol/l): 
 
Low value 
(mmol/l): 
 
Control (Start) L L H H mmol/l 
Control (Middle) L L H H mmol/l 
Control (End) L L H H mmol/l 
 
Important notes: 
 TWO blood samples Serum + EDTA 
 EDTA samples should be placed on ice immediately. 
 EDTA samples should be spun and aliquoted within 5-10 min (6 aliquots) 
o Centrifuge should be set at 4000 rpm for 15 mins (programme #4) 
 SERUM samples should be left to clot for ~1h before separating and aliquoting (4 aliquots) 
 All aliquots should be at least 0.5 ml. 
 
Researcher: ___________________ Glucose Analysis: ______________________ 
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PROLONGED STANDING PROTOCOL 
Date  Time  
Weight 
(kg) 
 Subject  
 
Protocol Time Position Notes 
Weigh Subject  On arrival   
Remove accelerometers  On arrival  Download data and charge 
Place new accelerometers   
- ActivPAL: lower right thigh 
- Actigraph: right hip 
Rest for 10 mins    
4-min Resting air sample 1  Sit  
Analyse  Sit  OK      Repeat 
4-min Resting air sample 2  Sit  
Analyse  Sit  OK      Repeat 
Cannulation -10 min Sit Rest for 10 min 
Fasting blood sample 0 min Sit  
Breakfast 00:00 Sit Within 5-10 min 
Start Stopwatch 00:00  GO TO NEXT PAGE 
 
Half-hourly Protocol 
 
 
 
 
|              7.5 min             | 
15 min 
4-min Air 
Blood 
 
30 15 0 
|              7.5 min             | 
7.5 22.5 
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Date  PART 1 Subject  
 
Protocol Time Position Notes 
Breakfast 00:00 Sit  
Mouthpiece & nose clip 13:00 
Sit 
 
4-min air collection 15:00  
Stop air collection 19:00  
Mouthpiece & Nose clip 28:00  
4-min air collection  30:00 
Sit 
Blood Sample (30 min) 
Stop air collection 34:00  
 37:30 
STAND 
 
Mouthpiece & nose clip 43:00  
4-min air collection 45:00 
STAND 
 
Stop air collection 49:00  
 52:30 
Sit 
 
Mouthpiece & nose clip 58:00  
4-min air collection 1:00:00 
Sit 
Blood sample (60 min) 
Stop air collection 1:04:00  
 1:07:30 
STAND 
 
Mouthpiece & nose clip 1:13:00  
4-min air collection 1:15:00 
STAND 
 
Stop air collection 1:19:00  
 1:22:30 
Sit 
 
Mouthpiece & nose clip 1:28:00  
4-min air collection 1:30:00 
Sit 
 
Stop air collection 1:34:00  
 1:37:30 
STAND 
 
Mouthpiece & nose clip 1:43:00  
4-min air collection 1:45:00 
STAND 
 
Stop air collection 1:49:00  
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Date  PART 2 Subject  
 
Protocol Time Position Notes 
 1:52:30 
Sit 
 
Mouthpiece & nose clip 1:58:00  
4-min air collection 2:00:00 
Sit 
Blood sample (120 min) 
Stop air collection 2:04:00  
 2:07:30 
STAND 
 
Mouthpiece & nose clip 2:13:00  
4-min air collection 2:15:00 
STAND 
 
Stop air collection 2:19:00  
 2:22:30 
Sit 
 
Mouthpiece & nose clip 2:28:00  
4-min air collection 2:30:00 
Sit 
 
Stop air collection 2:34:00  
 2:37:30 
STAND 
 
Mouthpiece & nose clip 2:43:00  
4-min air collection 2:45:00 
STAND 
 
Stop air collection 2:49:00  
 2:52:30 Sit  
Mouthpiece & nose clip 2:58:00   
4-min air collection 3:00:00 
Sit 
Blood sample (180 min) 
Stop air collection 3:04:00  
 3:07:30 
STAND 
 
Mouthpiece & nose clip 3:13:00  
4-min air collection 3:15:00 
STAND 
 
Stop air collection 3:19:00  
 3:22:30 
Sit 
 
Mouthpiece & nose clip 3:28:00  
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Date  PART 3 Subject  
 
Protocol Time Position Notes 
4-min air collection 3:30:00 
Sit 
 
Stop air collection 3:34:00  
 3:37:30 
STAND 
 
Mouthpiece & nose clip 3:43:00  
4-min air collection 3:45:00 
STAND 
 
Stop air collection 3:49:00  
 3:52:30 
Sit 
 
 3:58:00  
Blood sample then 
Lunch 
4:00:00 Sit Blood sample (240 min) 
Mouthpiece & nose clip 4:13:00 
Sit 
 
4-min air collection 4:15:00  
Stop air collection 4:19:00  
Mouthpiece & Nose clip 4:28:00  
4-min air collection  4:30:00 
Sit 
Blood Sample (270 min) 
Stop air collection 4:34:00  
 4:37:30 
STAND 
 
Mouthpiece & nose clip 4:43:00  
4-min air collection 4:45:00 
STAND 
 
Stop air collection 4:49:00  
 4:52:30 
Sit 
 
Mouthpiece & nose clip 4:58:00  
4-min air collection 5:00:00 
Sit 
Blood sample (300 min) 
Stop air collection 5:04:00  
 5:07:30 
STAND 
 
Mouthpiece & nose clip 5:13:00  
4-min air collection 5:15:00 
STAND 
 
Stop air collection 5:19:00  
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Date  PART 4 Subject  
 
Protocol Time Position Notes 
 5:22:30 
Sit 
 
Mouthpiece & nose clip 5:28:00  
4-min air collection 5:30:00 
Sit 
 
Stop air collection 5:34:00  
 5:37:30 
STAND 
 
Mouthpiece & nose clip 5:43:00  
4-min air collection 5:45:00 
STAND 
 
Stop air collection 5:49:00  
 5:52:30 
Sit 
 
Mouthpiece & nose clip 5:58:00  
4-min air collection 6:00:00 
Sit 
Blood sample (360 min) 
Stop air collection 6:04:00  
 6:07:30 
STAND 
 
Mouthpiece & nose clip 6:13:00  
4-min air collection 6:15:00 
STAND 
 
Stop air collection 6:19:00  
 6:22:30 
Sit 
 
Mouthpiece & nose clip 6:28:00  
4-min air collection 6:30:00 
Sit 
 
Stop air collection 6:34:00  
 6:37:30 
STAND 
 
Mouthpiece & nose clip 6:43:00  
4-min air collection 6:45:00 
STAND 
 
Stop air collection 6:49:00  
 6:52:30 
Sit 
 
Mouthpiece & nose clip 6:58:00  
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Date  PART 5 Subject  
 
Protocol Time Position Notes 
4-min air collection 7:00:00 
Sit 
Blood sample (420 min) 
Stop air collection 7:04:00  
 7:07:30 
STAND 
 
Mouthpiece & nose clip 7:13:00  
4-min air collection 7:15:00 
STAND 
 
Stop air collection 7:19:00  
 7:22:30 
Sit 
 
Mouthpiece & nose clip 7:28:00  
4-min air collection 7:30:00 
Sit 
 
Stop air collection 7:34:00  
 7:37:30 
STAND 
 
Mouthpiece & nose clip 7:43:00  
4-min air collection 7:45:00 
STAND 
 
Stop air collection 7:49:00  
 7:52:30 
Sit 
 
Mouthpiece & nose clip 7:58:00  
4-min air collection 8:00:00 Blood sample (480 min) 
Stop air collection 8:04:00  
Remove ActivPAL and Actigraph Download data 
Fit ActivPAL and Actigraph for next week  
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Sedentary Behaviour Study 
Expired Air Samples (1) 
Date 
Weight 
(kg) 
Lab Temp 
(oC) 
Bar Press 
(mmHg) 
Flow Rate 
(ml/min) 
Subject 
      P 
Bag 
Time 
(min) 
Time 
(0:00) 
Sampling 
Time 
(sec)* 
FECO2% FEO2% Volume (L) 
Temp 
(oC) 
  Resting 1      
  Resting 2      
  Resting 3      
Breakfast 
 15 0:15      
 30 0:30      
 45 0:45      
 60 1:00      
 75 1:15      
 90 1:30      
 105 1:45      
 120 2:00      
 135 2:15      
 150 2:30      
 165 2:45      
 180 3:00      
 195 3:15      
 210 3:30      
 225 3:45      
 
*Sampling time: 4 mins (240 sec)           Researcher: ______________________________ 
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Sedentary Behaviour Study 
Expired Air Samples (2) 
Date 
Weight 
(kg) 
Lab 
Temp 
(oC) 
Bar Press 
(mmHg) 
Flow 
Rate 
(ml/min) 
Subject 
      P 
Bag 
Time 
(min) 
Time 
(0:00) 
Sampling 
Time 
(sec)* 
FECO2% FEO2% Volume (L) 
Temp 
(oC) 
Lunch 
 255 4:15      
 270 4:30      
 285 4:45      
 300 5:00      
 315 5:15      
 330 5:30      
 345 5:45      
 360 6:00      
 375 6:15      
 390 6:30      
 405 6:45      
 420 7:00      
 435 7:15      
 450 7:30      
 465 7:45      
 480 8:00      
        
 
*Sampling time: 4 mins (240 sec)          Researcher: _______________________ 
 
Appendix G: Sitting, prlonged standing and Intermittent Standing Protocols 
©Nabeha Hawari (2017)           187 
Sedentary Behaviour Study 
Blood Sampling and Glucose Measurements 
Date    Subject 
     P 
Time (0:00) 
Timepoint 
(min) 
 Protocol 
Glucose 
(mmol/l) 
Notes 
0:00 0  Fasting    
0:30 30      
1:00 60      
2:00 120      
3:00 180      
4:00 240  Lunch    
4:30 270      
5:00 300      
6:00 360      
7:00 420      
8:00 480      
 
Controls Lot No:  
High value 
(mmol/l): 
 
Low value 
(mmol/l): 
 
Control (Start) L L H H mmol/l 
Control (Middle) L L H H mmol/l 
Control (End) L L H H mmol/l 
 
Important notes: 
 TWO blood samples Serum + EDTA 
 EDTA samples should be placed on ice immediately. 
 EDTA samples should be spun and aliquoted within 5-10 min (6 aliquots) 
o Centrifuge should be set at 4000 rpm for 15 mins (programme #4) 
 SERUM samples should be left to clot for ~1h before separating and aliquoting (4 aliquots) 
 All aliquots should be at least 0.5 ml. 
 
Researcher: __________________________ Glucose Analysis:_____________ 
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INTERMITTENT STANDING PROTOCOL 
Date  Time  
Weight 
(kg) 
 Subject  
 
Protocol Time Position Notes 
Weigh Subject On arrival   
Remove accelerometers    Download data and charge 
Place new accelerometers   
- ActivPAL: lower right thigh 
- Actigraph: right hip 
Rest for 10 mins  Sit  
4-min Resting air sample 1  Sit  
Analyse  Sit  OK      Repeat 
4-min Resting air sample 2  Sit  
Analyse  Sit  OK      Repeat 
Cannulation -10 min Sit Rest for 10 min 
Fasting blood sample 0 min Sit  
Breakfast 00:00 Sit Within 5-10 min 
Start Stopwatch 00:00  GO TO NEXT PAGE 
 
Half-hourly Protocol 
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Date  FIRST HOUR Subject 
 
 
Protocol Time Position Notes 
Breakfast 00:00 Sit  
Mouthpiece & nose clip 13:00 
Sit 
 
4-min air collection 15:00  
Stop air collection 19:00  
Mouthpiece & Nose clip 28:00  
4-min air collection  30:00 
Sit 
Blood Sample (30 min) 
Stop air collection 34:00  
 35:00 STAND  
 36:30 Sit  
 37:00 STAND  
 38:30 Sit  
 39:00 STAND  
 40:30 Sit  
 41:00 STAND  
 42:30 Sit  
Mouthpiece & nose clip 43:00 STAND  
 44:30 Sit  
4-min air collection 45:00 STAND  
 46:30 Sit  
 47:00 STAND  
 48:30 Sit  
Stop air collection 49:00 STAND  
 50:30 Sit  
 51:00 STAND  
 52:30 Sit  
 53:00 STAND  
 54:30 Sit  
Mouthpiece & nose clip 58:00 Sit  
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Date  1 – 1.5 HOUR Subject  
 
Protocol Time Position Notes 
4-min air collection 1:00:00 
Sit 
Blood Sample (60 min) 
Stop air collection 1:04:00  
 1:05:00 STAND  
 1:06:30 Sit  
 1:07:00 STAND  
 1:08:30 Sit  
 1:09:00 STAND  
 1:10:30 Sit  
 1:11:00 STAND  
 1:12:30 Sit  
Mouthpiece & nose clip 1:13:00 STAND  
 1:14:30 Sit  
4-min air collection 1:15:00 STAND  
 1:16:30 Sit  
 1:17:00 STAND  
 1:18:30 Sit  
Stop air collection 1:19:00 STAND  
 1:20:30 Sit  
 1:21:00 STAND  
 1:22:30 Sit  
 1:23:00 STAND  
 1:24:30 Sit  
Mouthpiece & nose clip 1:28:00 Sit  
4-min air collection 1:30:00 Sit  
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Date  1.5 – 2 HOUR Subject  
 
Protocol Time Position Notes 
Stop air collection 1:34:00 Sit  
 1:35:00 STAND  
 1:36:30 Sit  
 1:37:00 STAND  
 1:38:30 Sit  
 1:39:00 STAND  
 1:40:30 Sit  
 1:41:00 STAND  
 1:42:30 Sit  
Mouthpiece & nose clip 1:43:00 STAND  
 1:44:30 Sit  
4-min air collection 1:45:00 STAND  
 1:46:30 Sit  
 1:47:00 STAND  
 1:48:30 Sit  
Stop air collection 1:49:00 STAND  
 1:50:30 Sit  
 1:51:00 STAND  
 1:52:30 Sit  
 1:53:00 STAND  
 1:54:30 Sit  
Mouthpiece & nose clip 1:58:00 Sit  
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Date  2 – 2.5 HOUR Subject  
 
Protocol Time Position Notes 
4-min air collection 2:00:00 
Sit 
Blood Sample (120 min) 
Stop air collection 2:04:00  
 2:05:00 STAND  
 2:06:30 Sit  
 2:07:00 STAND  
 2:08:30 Sit  
 2:09:00 STAND  
 2:10:30 Sit  
 2:11:00 STAND  
 2:12:30 Sit  
Mouthpiece & nose clip 2:13:00 STAND  
 2:14:30 Sit  
4-min air collection 2:15:00 STAND  
 2:16:30 Sit  
 2:17:00 STAND  
 2:18:30 Sit  
Stop air collection 2:19:00 STAND  
 2:20:30 Sit  
 2:21:00 STAND  
 2:22:30 Sit  
 2:23:00 STAND  
 2:24:30 Sit  
Mouthpiece & nose clip 2:28:00 Sit  
4-min air collection 2:30:00 Sit  
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Date  2.5 - 3 HOUR Subject  
 
Protocol Time Position Notes 
Stop air collection 2:34:00 Sit  
 2:35:00 STAND  
 2:36:30 Sit  
 2:37:00 STAND  
 2:38:30 Sit  
 2:39:00 STAND  
 2:40:30 Sit  
 2:41:00 STAND  
 2:42:30 Sit  
Mouthpiece & nose clip 2:43:00 STAND  
 2:44:30 Sit  
4-min air collection 2:45:00 STAND  
 2:46:30 Sit  
 2:47:00 STAND  
 2:48:30 Sit  
Stop air collection 2:49:00 STAND  
 2:50:30 Sit  
 2:51:00 STAND  
 2:52:30 Sit  
 2:53:00 STAND  
 2:54:30 Sit  
Mouthpiece & nose clip 2:58:00 Sit  
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Date  3 – 3.5 HOUR Subject  
 
Protocol Time Position Notes 
4-min air collection 3:00:00 
Sit 
Blood Sample (180 min) 
Stop air collection 3:04:00  
 3:05:00 STAND  
 3:06:30 Sit  
 3:07:00 STAND  
 3:08:30 Sit  
 3:09:00 STAND  
 3:10:30 Sit  
 3:11:00 STAND  
 3:12:30 Sit  
Mouthpiece & nose clip 3:13:00 STAND  
 3:14:30 Sit  
4-min air collection 3:15:00 STAND  
 3:16:30 Sit  
 3:17:00 STAND  
 3:18:30 Sit  
Stop air collection 3:19:00 STAND  
 3:20:30 Sit  
 3:21:00 STAND  
 3:22:30 Sit  
 3:23:00 STAND  
 3:24:30 Sit  
Mouthpiece & nose clip 3:28:00 
Sit 
 
4-min air collection 3:30:00  
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Date  3.5 - 4 HOUR Subject  
 
Protocol Time Position Notes 
Stop air collection 3:34:00 Sit  
 3:35:00 STAND  
 3:36:30 Sit  
 3:37:00 STAND  
 3:38:30 Sit  
 3:39:00 STAND  
 3:40:30 Sit  
 3:41:00 STAND  
 3:42:30 Sit  
Mouthpiece & nose clip 3:43:00 STAND  
 3:44:30 Sit  
4-min air collection 3:45:00 STAND  
 3:46:30 Sit  
 3:47:00 STAND  
 3:48:30 Sit  
Stop air collection 3:49:00 STAND  
 3:50:30 Sit  
 3:51:00 STAND  
 3:52:30 Sit  
 3:53:00 STAND  
 3:54:30 Sit  
Blood Sample & Lunch 4:00:00  Blood Sample (240 min) 
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Date  FIFTH HOUR Subject  
 
Protocol Time Position Notes 
Lunch 4:00:00 Sit  
Mouthpiece & nose clip 4:13:00 
Sit 
 
4-min air collection 4:15:00  
Stop air collection 4:19:00  
Mouthpiece & Nose clip 4:28:00  
4-min air collection  4:30:00 
Sit 
Blood Sample (270 min) 
Stop air collection 4:34:00  
 4:35:00 STAND  
 4:36:30 Sit  
 4:37:00 STAND  
 4:38:30 Sit  
 4:39:00 STAND  
 4:40:30 Sit  
 4:41:00 STAND  
 4:42:30 Sit  
Mouthpiece & nose clip 4:43:00 STAND  
 4:44:30 Sit  
4-min air collection 4:45:00 STAND  
 4:46:30 Sit  
 4:47:00 STAND  
 4:48:30 Sit  
Stop air collection 4:49:00 STAND  
 4:50:30 Sit  
 4:51:00 STAND  
 4:52:30 Sit  
 4:53:00 STAND  
 4:54:30 Sit  
Mouthpiece & nose clip 4:58:00 Sit  
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Date  5 – 5.5 HOUR Subject  
 
Protocol Time Position Notes 
4-min air collection 5:00:00 
Sit 
Blood Sample (300 min) 
Stop air collection 5:04:00  
 5:05:00 STAND  
 5:06:30 Sit  
 5:07:00 STAND  
 5:08:30 Sit  
 5:09:00 STAND  
 5:10:30 Sit  
 5:11:00 STAND  
 5:12:30 Sit  
Mouthpiece & nose clip 5:13:00 STAND  
 5:14:30 Sit  
4-min air collection 5:15:00 STAND  
 5:16:30 Sit  
 5:17:00 STAND  
 5:18:30 Sit  
Stop air collection 5:19:00 STAND  
 5:20:30 Sit  
 5:21:00 STAND  
 5:22:30 Sit  
 5:23:00 STAND  
 5:24:30 Sit  
Mouthpiece & nose clip 5:28:00 Sit  
4-min air collection 5:30:00 Sit  
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Date  5.5 – 6 HOUR Subject  
 
Protocol Time Position Notes 
Stop air collection 5:34:00 Sit  
 5:35:00 STAND  
 5:36:30 Sit  
 5:37:00 STAND  
 5:38:30 Sit  
 5:39:00 STAND  
 5:40:30 Sit  
 5:41:00 STAND  
 5:42:30 Sit  
Mouthpiece & nose clip 5:43:00 STAND  
 5:44:30 Sit  
4-min air collection 5:45:00 STAND  
 5:46:30 Sit  
 5:47:00 STAND  
 5:48:30 Sit  
Stop air collection 5:49:00 STAND  
 5:50:30 Sit  
 5:51:00 STAND  
 5:52:30 Sit  
 5:53:00 STAND  
 5:54:30 Sit  
Mouthpiece & nose clip 5:58:00 Sit  
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Date  6 – 6.5 HOUR Subject  
 
Protocol Time Position Notes 
4-min air collection 6:00:00 
Sit 
Blood Sample (360 min) 
Stop air collection 6:04:00  
 6:05:00 STAND  
 6:06:30 Sit  
 6:07:00 STAND  
 6:08:30 Sit  
 6:09:00 STAND  
 6:10:30 Sit  
 6:11:00 STAND  
 6:12:30 Sit  
Mouthpiece & nose clip 6:13:00 STAND  
 6:14:30 Sit  
4-min air collection 6:15:00 STAND  
 6:16:30 Sit  
 6:17:00 STAND  
 6:18:30 Sit  
Stop air collection 6:19:00 STAND  
 6:20:30 Sit  
 6:21:00 STAND  
 6:22:30 Sit  
 6:23:00 STAND  
 6:24:30 Sit  
Mouthpiece & nose clip 6:28:00 Sit  
4-min air collection 6:30:00 Sit  
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Date  6.5 – 7 HOUR Subject  
 
Protocol Time Position Notes 
Stop air collection 6:34:00 Sit  
 6:35:00 STAND  
 6:36:30 Sit  
 6:37:00 STAND  
 6:38:30 Sit  
 6:39:00 STAND  
 6:40:30 Sit  
 6:41:00 STAND  
 6:42:30 Sit  
Mouthpiece & nose clip 6:43:00 STAND  
 6:44:30 Sit  
4-min air collection 6:45:00 STAND  
 6:46:30 Sit  
 6:47:00 STAND  
 6:48:30 Sit  
Stop air collection 6:49:00 STAND  
 6:50:30 Sit  
 6:51:00 STAND  
 6:52:30 Sit  
 6:53:00 STAND  
 6:54:30 Sit  
Mouthpiece & nose clip 6:58:00 Sit  
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Date  7 – 7.5 HOUR Subject  
 
Protocol Time Position Notes 
4-min air collection 7:00:00 
Sit 
Blood Sample (420 min) 
Stop air collection 7:04:00  
 7:05:00 STAND  
 7:06:30 Sit  
 7:07:00 STAND  
 7:08:30 Sit  
 7:09:00 STAND  
 7:10:30 Sit  
 7:11:00 STAND  
 7:12:30 Sit  
Mouthpiece & nose clip 7:13:00 STAND  
 7:14:30 Sit  
4-min air collection 7:15:00 STAND  
 7:16:30 Sit  
 7:17:00 STAND  
 7:18:30 Sit  
Stop air collection 7:19:00 STAND  
 7:20:30 Sit  
 7:21:00 STAND  
 7:22:30 Sit  
 7:23:00 STAND  
 7:24:30 Sit  
Mouthpiece & nose clip 7:28:00 
Sit 
 
4-min air collection 7:30:00  
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Date  7.5 – 8 HOUR Subject  
 
Protocol Time Position Notes 
Stop air collection 7:34:00 Sit  
 7:35:00 STAND  
 7:36:30 Sit  
 7:37:00 STAND  
 7:38:30 Sit  
 7:39:00 STAND  
 7:40:30 Sit  
 7:41:00 STAND  
 7:42:30 Sit  
Mouthpiece & nose clip 7:43:00 STAND  
 7:44:30 Sit  
4-min air collection 7:45:00 STAND  
 7:46:30 Sit  
 7:47:00 STAND  
 7:48:30 Sit  
Stop air collection 7:49:00 STAND  
 7:50:30 Sit  
 7:51:00 STAND  
 7:52:30 Sit  
 7:53:00 STAND  
 7:54:30 Sit  
Mouthpiece & nose clip 7:58:00 Sit  
4-min air collection 8:00:00 
Sit 
Blood sample (480 min) 
Stop air collection 8:04:00 END 
Remove ActivPAL and Actigraph Download data 
Fit ActivPAL and Actigraph for next week  
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Sedentary Behaviour Study 
Expired Air Samples (1) 
Date 
Weight 
(kg) 
Lab 
Temp 
(oC) 
Bar Press 
(mmHg) 
Flow Rate 
(ml/min) 
Subject 
      I 
Bag 
Time 
(min) 
Time 
(0:00) 
Sampling 
Time 
(sec)* 
FECO2% FEO2% 
Volume 
(L) 
Temp 
(oC) 
  Resting 1      
  Resting 2      
  Resting 3      
Breakfast 
 15 0:15      
 30 0:30      
 45 0:45      
 60 1:00      
 75 1:15      
 90 1:30      
 105 1:45      
 120 2:00      
 135 2:15      
 150 2:30      
 165 2:45      
 180 3:00      
 195 3:15      
 210 3:30      
 225 3:45      
*Sampling time: 4 mins (240 sec)                        Researcher: ______________________ 
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Sedentary Behaviour Study 
Expired Air Samples (2) 
Date 
Weight 
(kg) 
Lab 
Temp 
(oC) 
Bar Press 
(mmHg) 
Flow Rate 
(ml/min) 
Subject 
      I 
Bag 
Time 
(min) 
Time 
(0:00) 
Sampling 
Time 
(sec)* 
FECO2% FEO2% 
Volume 
(L) 
Temp 
(oC) 
Lunch 
 255 4:15      
 270 4:30      
 285 4:45      
 300 5:00      
 315 5:15      
 330 5:30      
 345 5:45      
 360 6:00      
 375 6:15      
 390 6:30      
 405 6:45      
 420 7:00      
 435 7:15      
 450 7:30      
 465 7:45      
 480 8:00      
        
 
*Sampling time: 4 mins (240 sec)          Researcher: ______________________ 
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Sedentary Behaviour Study 
Blood Sampling and Glucose Measurements 
Date    Subject 
     I 
Time 
(0:00) 
Timepoint 
(min) 
 Protocol 
Glucose 
(mmol/l) 
Notes 
0:00 0  Fasting    
0:30 30      
1:00 60      
2:00 120      
3:00 180      
4:00 240  Lunch    
4:30 270      
5:00 300      
6:00 360      
7:00 420      
8:00 480      
 
Controls Lot No:  
High value 
(mmol/l): 
 
Low value 
(mmol/l): 
 
Control (Start) L L H H mmol/l 
Control (Middle) L L H H mmol/l 
Control (End) L L H H mmol/l 
 
Important notes: 
 TWO blood samples Serum + EDTA 
 EDTA samples should be placed on ice immediately. 
 EDTA samples should be spun and aliquoted within 5-10 min (6 aliquots) 
o Centrifuge should be set at 4000 rpm for 15 mins (programme #4) 
 SERUM samples should be left to clot for ~1h before separating and aliquoting (4 aliquots) 
 All aliquots should be at least 0.5 ml. 
 
Researcher: __________________________ Glucose Analysis: ____________ 
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Appendix H: Appointments Sheet – Chapter 3 & 4 
Name:       
 
Date Time Test Place Duration Instructions 
2/11/14      No exercise 
3/11/14     
 No exercise 
 No alcohol 
 Weigh and record dietary intake 
 
 
 
4/11/14     
 No exercise 
 No alcohol 
 Weigh and record dietary intake 
 NOTHING TO EAT OR DRINK (EXCEPT WATER) AFTER  
________________________ 
 Sleep well 
5/11/14 08:30 am Sitting  
University of 
Glasgow 
8 hours 
 Fasting for 12 hours 
 Wear warm clothes (loose sleeves) 
 Bring a DVD, CD, work or a book to read 
8:30 pm 
NH01 
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Name:       
Date Time Test Place Duration Instructions 
9/11/14      No exercise 
10/11/14     
 No exercise 
 No alcohol 
 Repeat diet EXACTLY as consumed on ________________ 
11/11/14     
 No exercise 
 No alcohol 
 Repeat diet EXACTLY as consumed on ________________ 
 NOTHING TO EAT OR DRINK (EXCEPT WATER) AFTER  
________________________ 
 Sleep well 
12/11/14 08:30 am 
Prolonged 
Standing 
University of 
Glasgow 
8 hours 
 Fasting for 12 hours 
 Wear warm clothes (loose sleeves) 
 Bring a DVD, CD, work or a book to read 
  
NH01 
3/11/14 
4/11/14 
8:30 pm 
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Name:       
 
Date Time Test Place Duration Instructions 
16/11/14      No exercise 
17/11/14     
 No exercise 
 No alcohol 
 Repeat diet EXACTLY as consumed on ________________ 
18/11/14     
 No exercise 
 No alcohol 
 Repeat diet EXACTLY as consumed on ________________ 
 NOTHING TO EAT OR DRINK (EXCEPT WATER) AFTER  
________________________ 
 Sleep well 
19/11/14 08:30 am 
Intermittent 
Standing 
University of 
Glasgow 
8 hours 
 Fasting for 12 hours 
 Wear warm clothes (loose sleeves) 
 Bring a DVD, CD, work or a book to read 
 
 
NH01 
3/11/14 
4/11/14 
8:30 pm 
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Appendix I: Volunteer Information Sheet and Consent Form - Chapter 4 
VOLUNTEER INFORMATION SHEET 
Title: Effects of breaking prolonged sitting with intermittent ‘chair 
squats’ on day-long metabolic responses. 
You are being invited to take part in a research study. Before you decide it is important for 
you to understand why the research is being done and what it will involve.  Please take time 
to read the following information carefully and discuss it with others if you wish. Ask us if 
there is anything that is not clear or if you would like more information. Take time to decide 
whether or not you wish to take part. 
Thank you for reading this. 
What is the purpose of the study? 
Spending large amounts of time sitting down increases risk of heart disease, diabetes and 
obesity.  This risk may be reduced by breaking up periods of prolonged sitting with periods 
of standing up.  We have recently shown that increasing the number of times a person moves 
from sitting to standing during the day increases metabolic rate and the amount of fat the 
body burns.  This study will investigate the effects of breaking up prolonged sitting with 10 
‘chair squats’ (repeatedly standing up and sitting down 10 times over 30 seconds) performed 
every 20 minutes over the course of a day on fat and sugar metabolism in the body.    
 
Why have I been chosen? 
You have been chosen because you are a healthy man or a postmenopausal women aged 
between 18-65 years, who is currently relatively physically inactive.  We are planning to 
include 20 people in this study. 
 
Do I have to take part? 
It is up to you to decide whether or not to take part.  If you do decide to participate, you will 
be given this information sheet to keep and be asked to sign a consent form. If you do this 
you are still free to withdraw at any time and without giving a reason.  A decision to 
withdraw at any time, or a decision not to take part, will not affect the standard of care you 
receive. 
What will happen to me if I take part? 
Screening procedures 
In the first instance you will be asked to attend for a screening visit in which we will: 
 discuss with you and complete confidential questionnaires regarding your health, 
family history and physical activity level 
 measure your blood pressure 
 take your height, weight and waist measurements 
 take a small blood samples to check the sugar level in your blood.   
 provide an opportunity for you to ask questions 
 
These preliminary procedures will enable us to determine whether you fall into the group of 
people we wish to study and will also ensure that it is perfectly safe for you to take part.  
 
Experimental procedures 
We will ask you to undergo 2 main experimental trials. Each trial will run approximately 1-
2 weeks apart, in random order.   
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a) Sitting all day 
We will ask you to come to the University after an overnight fast (i.e. having eaten nothing 
for 12 hours) and spend the day with us (~7 hours).  We will then take a breath sample to 
measure how many calories and how much fat you are burning, and take a small blood 
sample from a tiny plastic tube called a ‘cannula’ placed in a vein in your forearm.  This is 
no more painful than a simple blood test. We will then ask you to sit comfortably for about 
6.5 hours (comfort breaks to go to the toilet are allowed), during which time you can read, 
watch TV or use a computer. We will provide you with a test breakfast and test lunch over 
the course of the day and throughout the day we will take further small blood samples and 
breath samples and ask memory and problem solving questions.  A total of about 120 ml 
(about a quarter of a blood donation) of blood will be taken over the course of the day. 
d) Sit/stand 
This trial will be identical to the Sitting trial, except that participants will be asked to 
repeatedly sit and stand 10 times over 30 seconds (chair squats), every 20 minutes, 
throughout the 6.5-hour observation period. 
 
Recording diet and physical activity 
We will ask you to weigh and record everything you eat and drink for two days before your 
first main trial and to repeat this diet before your second main trial.  We will provide you 
with weighing scales and diet sheets to do this.  We will also ask you to wear a small 
matchbox-sized device called an accelerometer during these days, and during the days of the 
trials themselves, so we can monitor your level or physical activity and sitting. 
  
What do I have to do? 
Other than the specific tasks described above, we ask you to maintain your usual lifestyle 
(i.e. don’t change your diet or exercise habits) for the duration of this study.  We also ask 
you to weigh and record everything that you eat and drink for the two days before your first 
main experimental trial (we will provide you with scales and record sheets to do this) and 
not to undertake any planned exercise or drink alcohol on these days.  We will ask you to 
wear a small matchbox-sized device called an accelerometer during these days, and during 
the days of the trials themselves, so we can monitor your level or physical activity and sitting.  
We will ask you to repeat your diet and activity pattern for the two days before your second 
and third experimental trials. 
 
What are the possible disadvantages and risks of taking part? 
 Blood sampling via the cannula may cause minor bruising or an inflammation of the vein. 
Good practice, however, minimises this risk.  Some people may feel faint when they give 
blood. 
 There is a small possibility that taking part in this study will reveal a health problem that 
you already have such as high cholesterol or high blood pressure. If such a problem is 
revealed, we will ask your permission to inform your GP to ensure that you receive 
appropriate treatment. 
 
What are the possible benefits of taking part? 
There may be no immediate benefits to you personally, but as a result of being involved in 
this study you will receive health about yourself including a dietary assessment and 
information about your cholesterol and blood sugar levels.  Please let us know if you would 
prefer not to receive any of this information.  You will also receive £100 as a token of thanks 
for participating. This study will help us to determine how reducing time spent sitting down 
can improve risk factors for heart disease, diabetes and obesity. The findings of this study 
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will be published in scientific journals so that understanding about how reducing sitting can 
help people to improve their cardiovascular health and better control of their weight. This 
information may contribute towards improving physical activity guidelines. 
 
 
We will provide you with feedback about the main study findings and also about your own 
results and would be delighted to explain results and discuss the implications with you. 
 
What if something goes wrong? 
The chances of something going wrong are extremely small. We have conducted several 
similar projects over the past 15 years, with many hundreds of participants, and have never 
had any problems. All of the procedures involved in this study are low risk and our screening 
tests are designed to ensure that you will only participate if it is safe for you to do so. In the 
unlikely event that you are harmed due to someone's negligence, then you may have grounds 
for a legal action but you may have to pay for it.  
 
Will my taking part in this study be kept confidential? 
All information which is collected about you during the course of the research will be kept 
strictly confidential. Any information about you which leaves the University or hospital will 
have your name and address removed so that you cannot be recognised from it. In addition, 
your records, samples and results will be identified by a number and not your name.  
 
 
What will happen to the results of the research study? 
The results from this study will be presented at scientific meetings and published in 
scientific journals. The results will also form part of Mrs Nabeha Hawari’s PhD thesis.  
A copy of the published results will be sent to you upon request. You will not be identifiable 
in any of the data presented or published from this study. 
 
What will happen to my samples after the study has finished? 
The blood samples that you provide for this study may be useful for future research into the 
prevention and treatment of diabetes and heart disease; this may involve investigating new 
substances in the blood that are not yet identified. Samples will be analysed anonymously 
and will require a new ethics application before they would be used for future research. If 
you do not wish your samples to be used for future research, please indicate this on the 
consent form. 
Who has reviewed the study? 
This study has been reviewed and approved by the College of Medial Veterinary and Life 
Sciences Ethics Committee at the University of Glasgow.  
 
Contact for Further Information 
Any questions about the procedures used in this study are encouraged. If you have any 
doubts or questions, please ask for further explanations by contacting one of the investigators 
below: 
Mrs Nabeha Hawari    
E-mail: n.hawari.1@research.gla.ac.uk 
Tel: 0141 3303475 (office) or (mobile) 07919182743 
 
Dr Jason Gill 
E-mail: jason.gill@glasgow.ac.uk 
Tel: 0141 3302916     
 
You will be given a copy of this information sheet and a signed consent form to keep for 
your records. 
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 Volunteer Identification Number for this trial: ___________ 
CONSENT FORM 
 
Title: Effects of breaking prolonged sitting with intermittent ‘chair 
squats’ on day-long metabolic responses. 
 
Name of Researcher: ____________________________________________ 
 
                                                                                                     Please initial box 
 
1. I confirm that I have read and understand the information sheet 
Version 2 dated 22.10.15 for the above study and have had the 
opportunity to ask questions. 
 
5. I understand that my participation is voluntary and that  
I am free to withdraw at any time, without giving any reason, 
without my medical care or legal rights being affected. 
 
6. I agree to take part in the above study. 
 
 
7. I agree for my samples to be used for future research into the 
prevention and treatment of diabetes and heart disease.  This may 
involve analysis of new biochemical markers not yet identified. 
 
 
      
           
Name of Subject                                    Date                  Signature 
   
Name of Person taking consent  Date                   Signature 
(if different from researcher) 
 
   
Researcher                                                 Date                     Signature 
 
Copy for participant 
Copy for researcher 
 
 
Yes  
  
 No 
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Appendix J: Announcement 3 - Chapter 4 
 
 
  
We will investigate the effects of breaking up prolonged sitting 
with 10 ‘chair squats’ over the course of a day on fat and 
sugar metabolism in the body. 
If you are a healthy man (18 – 65 years) or postmenopausal woman, who is 
heavier than your ideal weight, you may be able to help us. 
Exclusion criteria will include uncontrolled hypertension, diabetes or a previous history of 
heart disease. 
Participation will involve 3 visits to our lab (including 30-min screening visit) 
over a period of 3 weeks. All participants will receive detailed feedback on their 
blood Pressure, blood glucose, energy expenditure, and your weekly activity. 
Participants will also receive payment to compensate for the 
inconvenience of taking part 
 If you are interested, please contact                   
Mrs Nabeha Hawari    n.hawari.1@research.gla.ac.uk
 
                                     Thank You      
Would you like to help out with a research looking 
into how breaking up sitting time can affect your 
metabolism? 
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Appendix K: Sit & Sit/Stand Protocols-Chapter 4 
Sit/Stand Protocol 
Date  Time  
Weight 
(kg) 
 Subject  
 
Protocol Time Position Notes 
Change accelerometers  
On 
arrival 
 Download data and charge 
Place new accelerometers   
- ActivPAL on lower right 
thigh 
 
4-min Resting air sample 1  Sit  
Analyse  Sit  OK      Repeat 
4-min Resting air sample 2  Sit  
Analyse  Sit  OK      Repeat 
Cannulation -10 min Sit Rest for 10 min 
Fasting blood sample 0 min Sit  
Breakfast 00:00 Sit Within 5-10 min 
Start Stopwatch 00:00  GO TO NEXT PAGE 
 
 Protocol 
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Date  PART 1 Subject  
 
Protocol Time Position Notes 
Breakfast 00:00 Sit  
Mouthpiece & nose clip 10:00 
Sit 
 
 
Open bag 1  (B1)  12:00 Sit  
Stop air collection in B1  (3-min collection) 
switch on to bag (B2)  
15:00 
Sit/stand 
10 times 
 
Stop air collection in (B2)  (30sec) 
switch on to bag (B3) 
15:30 Sit  
Stop air collection in (B3) (60-sec collection ) 
switch on to bag (B4) 
16:30 Sit  
Stop air collection in (B4) (60 sec air collection)  
switch on to bag (B5) 
17:30 
Sit 
 
Stop air collection in (B5) (60 sec air collection) 
switch on to bag (B6) 
18:30 
Sit 
 
Stop air collection in  (B6) (90 sec air collection)  
20:00 
Sit 
 
Mouthpiece & nose clip 30:00 
Sit 
 
Blood Sample (30 
min) 
Open bag 1  (B1)   32:00 Sit 3-min collection 
Stop air collection in B1   
switch on to bag (B2)  
35:00 
Sit/stand 
10 times 
 
Stop air collection in (B2)   
switch on to bag (B3) 
35:30 Sit Gas collection 
Stop air collection in (B3)  
switch on to bag (B4) 
36:30 Sit  
Stop air collection in (B4)  
switch on to bag (B5) 
37:30 
Sit 
 
Stop air collection in (B5)  
switch on to bag (B6) 
38:30 
Sit 
 
Stop air collection in  (B6)   40:00 Sit  
Mouthpiece & nose clip 50:00 
Sit 
 
 
Open bag 1  (B1)   52:00 Sit  
Stop air collection in B1   
switch on to bag (B2)  
55:00 
Sit/stand 
10 times 
 
Stop air collection in (B2)   
switch on to bag (B3) 
55:30 Sit  Gas collection 
Stop air collection in (B3)  
switch on to bag (B4) 
56:30 Sit  
Stop air collection in (B4)  
switch on to bag (B5) 
57:30   
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Date  
PART 2 
Subject  
 
Protocol Time Position Notes 
Stop air collection in (B5)  
switch on to bag (B6) 
   58:30 
Sit 
 
Stop air collection in  (B6)  01:00:00 Sit Blood Sample (60 min) 
Mouthpiece & nose clip 01:10:00 
Sit 
 
 
 Open bag 1 (B1) 01:12:00 Sit  
Stop air collection in B1   
switch on to bag (B2)  
01:15:00 
Sit/stand 
10 times 
 
Stop air collection in (B2)   
switch on to bag (B3) 
01:15:30 Sit Gas collection 
Stop air collection in (B3)  
switch on to bag (B4) 
01:16:30 Sit  
Stop air collection in (B4)  
switch on to bag (B5) 
01:17:30 
Sit 
 
Stop air collection in (B5)  
switch on to bag (B6) 
01:18:30 
Sit 
 
Stop air collection in  (B6)  01:20:00 Sit  
Mouthpiece & nose clip 01:30:00 
Sit 
 
 
 Open bag 1 (B1) 01:32:00 Sit  
Stop air collection in B1   
switch on to bag (B2)  
   
01:35:00 
Sit/stand 
10 times 
 
Stop air collection in (B2)   
switch on to bag (B3) 
01:35:30 Sit Gas collection 
Stop air collection in (B3)  
switch on to bag (B4) 
01:36:30 Sit  
Stop air collection in (B4)  
switch on to bag (B5) 
01:37:30 
Sit 
 
Stop air collection in (B5)  
switch on to bag (B 6) 
01:38:30 
Sit 
 
Stop air collection in  (B6)  01:40:00 Sit  
Mouthpiece & nose clip 01:50:00 
Sit 
 
 
 Open bag 1 (B1) 01:52:00 Sit  
Stop air collection in B1   
switch on to bag (B2)  
 01:55:00 
Sit/stand 
10 times 
 
Stop air collection in (B2)   
switch on to bag (B3) 
01:55:30 Sit Gas collection 
Stop air collection in (B3)  
switch on to bag (B4) 
 01:56:30 Sit  
Stop air collection in (B4)  
switch on to bag (B5) 
 01:57:30 Sit  
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Date  PART 3 Subject  
 
Protocol Time Position Notes 
Stop air collection in (B5)  
switch on to bag (B 6) 
01:58:30 Sit  
Stop air collection in  (B6)  02:00:00 Sit Blood Sample (120 min) 
Mouthpiece & nose clip 02:10:00 
Sit 
 
 
 Open bag 1 (B1) 02:12:00 Sit  
Stop air collection in B1   
switch on to bag (B2)  
02:15:00 
Sit/stand 
10 times 
 
Stop air collection in (B2)   
switch on to bag (B3) 
02:15:30 Sit Gas collection 
Stop air collection in (B3)  
switch on to bag (B4) 
02:16:30 Sit  
Stop air collection in (B4)  
switch on to bag (B5) 
02:17:30 
Sit 
 
Stop air collection in (B5)  
switch on to bag (B 6) 
02:18:30 
Sit 
 
Stop air collection in  (B6)  02:20:00 Sit  
Mouthpiece & nose clip 02:30:00 
Sit 
 
 
 Open bag 1 (B1) 02:32:00 Sit  
Stop air collection in B1   
switch on to bag (B2)  
02:35:00 
Sit/stand 
10 times 
 
Stop air collection in (B2)   
switch on to bag (B3) 
02:35:30 Sit Gas collection 
Stop air collection in (B3)  
switch on to bag (B4) 
02:36:30 Sit  
Stop air collection in (B4)  
switch on to bag (B5) 
02:37:30 
Sit 
 
Stop air collection in (B5)  
switch on to bag (B 6) 
02:38:30 
Sit 
 
Stop air collection in  (B6)  02:40:00 Sit  
Mouthpiece & nose clip 02:50:00 
Sit 
 
 
 Open bag 1 (B1) 02:52:00 Sit  
Stop air collection in B1   
switch on to bag (B2)  
02:55:00 Sit  
Stop air collection in (B2)   
switch on to bag (B3) 
02:55:30 
Sit/stand 
10 times 
Gas collection 
Stop air collection in (B3)  
switch on to bag (B4) 
02:56:30 Sit  
Stop air collection in (B4)  
switch on to bag (B5) 
02:57:30 
Sit 
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Date  PART 4 Subject  
 
Protocol Time Position Notes 
Stop air collection in (B5)  
switch on to bag (B 6) 
02:58:30 
Sit 
 
Stop air collection in  (B6) 
03:00:00 
Sit 
 Blood Sample (180 min) 
LUNCH (210min) 03:30:00 Sit 
Blood Sample (210min) 
 
Mouthpiece & nose clip 
03:40:00 
 
  
 Open bag 1 (B1) 
03:42:00 
 
  
Stop air collection in B1   
switch on to bag (B2)  
03:45:00 
Sit/stand 
10 times 
 
Stop air collection in (B2)   
switch on to bag (B3) 
03:45:30 Sit Gas collection 
Stop air collection in (B3)  
switch on to bag (B4) 
03:46:30 Sit  
Stop air collection in (B4)  
switch on to bag (B5) 
03:47:30 
Sit 
 
Stop air collection in (B5)  
switch on to bag (B 6) 
03:48:30 
Sit 
 
Stop air collection in  (B6) 
03:50:00 
Sit 
 
Mouthpiece & nose clip 04:00:00 
Sit 
 
Blood Sample (240 min) 
 Open bag 1 (B1) 04:02:00 Sit  
Stop air collection in B1   
switch on to bag (B2)  
04:05:00 
Sit/stand 
10 times 
 
Stop air collection in (B2)   
switch on to bag (B3) 
04:05:30 Sit Gas collection 
Stop air collection in (B3)  
switch on to bag (B4) 
04:06:30 
Sit 
 
Stop air collection in (B4)  
switch on to bag (B5) 
04:07:30 Sit  
Stop air collection in (B5)  
switch on to bag (B 6) 
04:08:30 Sit  
Stop air collection in  (B6) 04:10:00 Sit  
Mouthpiece & nose clip 04:20:00   
 Open bag 1 (B1) 04:22:00 Sit  
Stop air collection in B1   
switch on to bag (B2)  
04:25:00 
Sit/stand 
10 times 
 
Stop air collection in (B2)   
switch on to bag (B3) 
04:25:30 Sit Gas collection 
Stop air collection in (B3)  
switch on to bag (B4) 
04:26:30 Sit  
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Date  PART 5 Subject  
 
Protocol Time Position Notes 
Stop air collection in (B4)  
switch on to bag (B5) 
04:27:30 Sit  
Stop air collection in (B5)  
switch on to bag (B 6) 
:04 28:30 Sit  
Stop air collection in  (B6) 04:30:00 Sit Blood sample (270 min) 
Mouthpiece & nose clip 04:40:00 Sit  
 Open bag 1 (B1) 04:42:00 Sit  
Stop air collection in B1   
switch on to bag (B2)  
04:45:00 
Sit/stand 
10 times 
 
Stop air collection in (B2)   
switch on to bag (B3) 
04:45:30 Sit Gas collection 
Stop air collection in (B3)  
switch on to bag (B4) 
04:46:30 Sit  
Stop air collection in (B4)  
switch on to bag (B5) 
04:47:30 
Sit 
 
Stop air collection in (B5)  
switch on to bag (B 6) 
04:48:30 
Sit 
 
Stop air collection in  (B6) 04:50:00 Sit  
Mouthpiece & nose clip 05:00:00 
Sit 
 
 
 Open bag 1 (B1) 05:02:00 Sit  
Stop air collection in B1   
switch on to bag (B2)  
05:05:00 
Sit/stand 
10 times 
 
Stop air collection in (B2)   
switch on to bag (B3) 
05:05:30 Sit Gas collection 
Stop air collection in (B3)  
switch on to bag (B4) 
05:06:30 Sit  
Stop air collection in (B4)  
switch on to bag (B5) 
05:07:30 
Sit 
 
Stop air collection in (B5)  
switch on to bag (B 6) 
04:08:30 
Sit 
 
Stop air collection in  (B6) 05:10:00 Sit  
Mouthpiece & nose clip 05:20:00 Sit  
 Open bag 1 (B1) 05:22:00 Sit  
Stop air collection in B1   
switch on to bag (B2)  
05:25:00 
Sit/stand 
10 times 
 
Stop air collection in (B2)   
switch on to bag (B3) 
05:25:30 Sit Gas collection 
Stop air collection in (B3)  
switch on to bag (B4) 
05:26:30 Sit  
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Date  PART 6 Subject  
 
Stop air collection in (B4)  
switch on to bag (B5) 05:27:30 Sit  
Stop air collection in (B5)  
switch on to bag (B 6) 05:28:30 Sit  
Stop air collection in  (B6) 
05:30:00 Sit Blood sample (330 min) 
Mouthpiece & nose clip 05:40:00 
Sit 
 
 
 Open bag 1 (B1) 05:42:00 
Sit 
 
 
Stop air collection in B1   
switch on to bag (B2)  
05:45:00 
Sit/stand 10 
times 
 
Stop air collection in (B2)   
switch on to bag (B3) 
05:45:30 Sit Gas collection 
Stop air collection in (B3)  
switch on to bag (B4) 
05:46:30 Sit  
Stop air collection in (B4)  
switch on to bag (B5) 
05:47:30 
Sit 
 
Stop air collection in (B5)  
switch on to bag (B 6) 
05:48:30 
Sit 
 
Stop air collection in  (B6) 05:50:00 Sit  
Mouthpiece & nose clip 06:00:00 
Sit 
 
 
 Open bag 1 (B1) 06:02:00 Sit  
Stop air collection in B1   
switch on to bag (B2)  
06:05:00 
Sit/stand 10 
times 
 
Stop air collection in (B2)   
switch on to bag (B3) 
06:05:30 Sit Gas collection 
Stop air collection in (B3)  
switch on to bag (B4) 
06:06:30 Sit  
Stop air collection in (B4)  
switch on to bag (B5) 
06:07:30 
Sit 
 
Stop air collection in (B5)  
switch on to bag (B 6) 
06:08:30 Sit 
 
Stop air collection in  (B6) 06:10:00 Sit  
Mouthpiece & nose clip 06:20:00 Sit  
 Open bag 1 (B1) 06:22:00 Sit  
Stop air collection in B1   
switch on to bag (B2)  
06:25:00 
Sit/stand 10 
times 
 
Stop air collection in (B2)   
switch on to bag (B3) 
06:25:30 Sit Gas collection 
  
 
 
 
 
Appendix K: Sit & Sit/Stand Protocols 
©Nabeeha Hawari (2017)           221 
  
Date  PART 7 Subject  
 
 
Stop air collection in (B3)  
switch on to bag (B4) 
06:26:30   
Stop air collection in (B4)  
switch on to bag (B5) 
06:27:30 Sit  
Stop air collection in (B5)  
switch on to bag (B 6) 
06:28:30 Sit  
Stop air collection in  (B6) 
06:30:00 Sit Blood sample (390 min) 
Fit ActivPAL for next week   Download data 
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Chair Squats Study 
Expired Air Samples (1) 
Date 
Weight 
(kg) 
Lab Temp 
(oC) 
Bar Press 
(mmHg) 
Flow Rate 
(ml/min) 
Subject 
       
Bag Protocol 
Time 
(00:00:00) 
Sampling 
Time 
(sec)* 
FECO2% FEO2% 
Volume 
(L) 
Temp (oC) 
  Resting 1      
  Resting 2      
  Resting 3      
Breakfast 
B1 15 15:00      
B2 15.5 15:30      
B3 16.5 16:30      
B4 17.5 17:30      
B5 18.5 18:30      
B6 20 20:00      
B1 35 35:00      
B2 35.5 35:30      
B3 36.5 36:30      
B4 37.5 37:30      
B5 38.5 38:30      
B6 40 40:00      
B1 55 55:00      
B2 55.5 55:30      
B3 56.5 56:30      
B4 57.5 57:30      
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B5 58.5 58:30      
B6 60 01:00:00      
B1 75 01:15:00      
B2 75.5 01:15:30      
B3 76.5 01:16:30      
B4 77.5 01:17:30      
B5 78.5 01:18:30      
B6 80 01:20:00      
B1 95 01:35:00      
B2 95.5 01:35:30      
B3 96.5 01:36:30      
B4 97.5 01:37:30      
B5 98.5 01:38:30      
B6 100 01:40:00      
B1 115 01:55:00      
B2 115.5 01:55:30      
B3 116.5 01:56:30      
B4 117.5 01:57:30      
B5 118.5 01:58:30      
B6 120 02:00:00      
B1 135 02:15:00      
B2 135.5 02:15:30      
B3 136.5 02:16:30      
B4 137.5 02:17:30      
B5 138.5 02:18:30      
B6 140 02:20:00      
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B1 155 02:35:00      
B2 155.5 02:35:30      
B3 156.5 02:36:30      
B4 157.5 02:37:30      
B5 158.5 02:38:30      
B6 160 02:40:00      
B1 175 02:55:00      
B2 175.5 02:55:30      
B3 176.5 02:56:30      
B4 177.5 02:57:30      
B5 178.5 02:58:30      
B6 180 03:00:00      
 
Researcher: ______________________________ 
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Sit/Stand Study 
Expired Air Samples (2) 
Date 
Weight 
(kg) 
Lab Temp 
(oC) 
Bar Press 
(mmHg) 
Flow Rate 
(ml/min) 
Subject 
       
Bag 
Time 
(min) 
Time 
(0:00) 
Sampling 
Time 
(sec)* 
FECO2% FEO2% 
Volume 
(L) 
Temp (oC) 
Lunch 
B1 225 03:45:00      
B2 225.5 03:45:30      
B3 226.5 03:46:30      
B4 227.5 03:47:30      
B5 228.5 03:48:30      
B6 230 03:50:00      
B1 245 04:05:00      
B2 245.5 04:05:30      
B3 246.5 04:06:30      
B4 247.5 04:07:30      
B5 248.5 04:08:30      
B6 250 04:10:00      
B1 265 04:25:00      
B2 265.5 04:25:30      
B3 266.5 04:26:30      
B4 267.5 04:27:30      
B5 268.5 04:28:30      
B6 270 04:30:00      
B1 285 04:45:00      
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B2 285.5 04:45:30      
B3 286.5 04:46:30      
B4 287.5 04:47:30      
B5 288.5 04:48:30      
B6 290 04:50:00      
B1 305 05:05:00      
B2 305.5 05:05:30      
B3 306.5 05:06:30      
B4 307.5 05:07:30      
B5 308.5 05:08:30      
B6 310 05:10:00      
B1 325 05:25:00      
B2 325.5 05:25:30      
B3 326.5 05:26:30      
B4 327.5 05:27:30      
B5 328.5 05:28:30      
B6 330 05:30:00      
B1 345 05:45:00      
B2 345.5 05:45:30      
B3 346.5 05:46:30      
B4 347.5 05:47:30      
B5 348.5 05:48:30      
B6 350 05:50:00      
B1 365 06:05:00      
B2 365.5 06:05:30      
B3 366.5 06:06:30      
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B4 367.5 06:07:30      
B5 368.5 06:08:30      
B6 370 06:10:00      
B1 385 06:25:00      
B2 385.5 06:25:30      
B3 386.5 06:26:30      
B4 387.5 06:27:30      
B5 388.5 06:28:30      
B6 390 06:30:00      
 
 
Researcher: ______________________________ 
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Sit/Stand Study 
Blood Sampling and Glucose Measurements 
Date    Subject 
     Sit/Stand 
Time 
(0:00) 
Time point 
(min) 
 Protocol 
Glucose 
(mmol/l) 
Notes 
0:00 0  Fasting    
0:30 30      
1:00 60      
2:00 120      
3:00 180      
3:30 210  Lunch    
4:00 240      
4:30 270      
5:30 330      
6:30 390      
 
Controls Lot No:  
High value 
(mmol/l): 
 
Low value 
(mmol/l): 
 
Control (Start) L L H H mmol/l 
Control (Middle) L L H H mmol/l 
Control (End) L L H H mmol/l 
 
Important notes: 
 TWO blood samples Serum + EDTA 
 EDTA samples should be placed on ice immediately. 
 EDTA samples should be spun and aliquoted within 5-10 min (6 aliquots) 
o Centrifuge should be set at 4000 rpm for 15 mins (programme #4) 
 SERUM samples should be left to clot for ~1h before separating and aliquoting (4 aliquots) 
 All aliquots should be at least 0.5 ml. 
Researcher: __________________________ Glucose Analysis: _______________ 
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SIT PROTOCOL 
Date  Time  
Weight 
(kg) 
 Subject  
 
Protocol Time Position Notes 
Change accelerometers  
On 
arrival 
 Download data and charge 
Place new accelerometers   
- ActivPAL on lower right 
thigh 
 
4-min Resting air sample 1  Sit  
Analyse  Sit  OK      Repeat 
4-min Resting air sample 2  Sit  
Analyse  Sit  OK      Repeat 
Cannulation -10 min Sit Rest for 10 min 
Fasting blood sample 0 min Sit  
Breakfast 00:00 Sit Within 5-10 min 
Start Stopwatch 00:00  GO TO NEXT PAGE 
 
Protocol
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Date  PART 1 Subject  
 
Protocol Time Position Notes 
Breakfast 00:00 Sit  
Mouthpiece & nose clip 10:00 
Sit 
 
 
8-min air collection in (B1) 12:00 Sit 
Gas collection 
Stop air collection  20:00 Sit 
Mouthpiece & nose clip 30:00 
Sit 
 
Blood Sample (30 min) 
8-min air collection in (B2) 32:00 Sit 
Gas collection 
Stop air collection  40:00 Sit 
Mouthpiece & nose clip 50:00 
Sit 
 
 
8-min air collection in  (B1) 52:00 Sit  
Stop air collection  01:00:00 Sit 
Gas collection & Blood 
Sample (60 min) 
Mouthpiece & nose clip 01:10:00 
Sit 
 
 
8-min air collection in (B2) 01:12:00 Sit 
Gas collection 
Stop air collection  01:20:00 Sit 
Mouthpiece & nose clip 01:30:00 
Sit 
 
 
8-min air collection in (B1) 01:32:00 Sit 
Gas collection 
Stop air collection  01:40:00 Sit 
Mouthpiece & nose clip 01:50:00 
Sit 
 
 
8-min air collection in (B2) 01:52:00 Sit  
Stop air collection  02:00:00 Sit 
Gas collection & Blood 
Sample (120 min) 
Mouthpiece & nose clip 02:10:00 
Sit 
 
 
8-min air collection in (B1) 02:12:00 Sit 
Gas collection 
Stop air collection  02:20:00 Sit 
Mouthpiece & nose clip 02:30:00 
Sit 
 
 
8-min air collection in (B2) 02:32:00 Sit 
Gas collection 
Stop air collection  02:40:00 Sit 
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Date  PART 2 Subject  
 
Protocol Time Position Notes 
Mouthpiece & nose clip 02:50:00 
Sit 
 
 
8-min air collection in (B1) 02:52:00 Sit  
Stop air collection  03:00:00 Sit 
Gas collection & Blood 
Sample (180 min) 
LUNCH (210min) 03:30:00 Sit 
Blood Sample (210 
min) 
Mouthpiece & nose clip 03:40:00   
8-min air collection in (B2) 03:42:00  
Gas collection 
Stop air collection  03:50:00 Sit 
Mouthpiece & nose clip 04:00:00 
Sit 
 
Blood Sample (240 
min) 
8-min air collection in (B1) 04:02:00 Sit 
Gas collection 
Stop air collection  04:10:00 Sit 
Mouthpiece & nose clip 04:20:00 Sit  
8-min air collection in (B2) 04:22:00 Sit  
Stop air collection  
04:30:00  
Gas collection &Blood 
sample (270 min) 
Mouthpiece & nose clip 04:40:00 Sit  
8-min air collection in (B1) 04:42:00 Sit 
Gas collection 
Stop air collection  04:50:00 Sit 
Mouthpiece & nose clip 05:00:00 
Sit 
 
 
8-min air collection in (B2) 05:02:00 Sit 
Gas collection 
Stop air collection 05:10:00 Sit 
Mouthpiece & nose clip 05:20:00 Sit  
8-min air collection in (B1) 05:22:00 Sit  
Stop air collection   05:30:00 Sit 
Gas collection & Blood 
sample (330 min) 
Mouthpiece & nose clip 05:40:00 
Sit 
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Date  PART 3 Subject  
 
8-min air collection in (B2) 05:42:00 Sit 
Gas collection  
Stop air collection  05:50:00 Sit 
Mouthpiece & nose clip 06:00:00 
Sit 
 
 
8-min air collection in (B1) 06:02:00 Sit 
Gas collection 
Stop air collection  06:10:00 Sit 
Mouthpiece & nose clip 06:20:00 Sit  
8-min air collection 06:22:00 Sit  
Stop air collection in (B2) 06:30:00  Sit 
Gas collection & Blood 
sample (390 min) 
Fit ActivPAL for next week   Download data 
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Chair squats Study 
Expired Air Samples (1) 
Date 
Weight 
(kg) 
Lab Temp 
(oC) 
Bar Press 
(mmHg) 
Flow Rate 
(ml/min) 
Subject 
       
Bag 
Time 
(min) 
Time 
(00:00:00) 
Sampling 
Time 
(sec)* 
FECO2% FEO2% 
Volume 
(L) 
Temp 
(oC) 
  Resting 1      
  Resting 2      
  Resting 3      
Breakfast 
B1 20 20:00      
B2 40 40:00      
B1 60 01:00:00      
B2 80 01:20:00      
B1 100 01:40:00      
B2 120 02:00:00      
B1 140 02:20:00      
B2 160 02:40:00      
B1 180 03:00:00      
 
Researcher: ______________________________ 
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Chair squats Study 
Expired Air Samples (2) 
Date 
Weight 
(kg) 
Lab Temp 
(oC) 
Bar Press 
(mmHg) 
Flow Rate 
(ml/min) 
Subject 
       
Bag 
Time 
(min) 
Time 
(0:00) 
Sampling 
Time 
(sec)* 
FECO2% FEO2% 
Volume 
(L) 
Temp (oC) 
Lunch 
B1 230 03:50:00      
B2 250 04:10:00      
B1 270 04:30:00      
B2 290 04:50:00      
B1 310 05:10:00      
B2 330 05:30:00      
B1 350 05:50:00      
B2 370 06:10:00      
B1 390 06:30:00      
 
 
Researcher: ______________________________ 
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Chair squats Study 
Blood Sampling and Glucose Measurements 
Date    Subject 
     Sitting 
Time 
(0:00) 
Time point 
(min) 
 Protocol 
Glucose 
(mmol/l) 
Notes 
0:00 0  Fasting    
0:30 30      
1:00 60      
2:00 120      
3:00 180      
3:30 210  Lunch    
4:00 240      
4:30 270      
5:30 330      
6:30 390      
 
Controls Lot No:  
High value 
(mmol/l): 
 
Low value 
(mmol/l): 
 
Control (Start) L L H H mmol/l 
Control (Middle) L L H H mmol/l 
Control (End) L L H H mmol/l 
 
Important notes: 
 TWO blood samples Serum + EDTA 
 EDTA samples should be placed on ice immediately. 
 EDTA samples should be spun and aliquoted within 5-10 min (6 aliquots) 
o Centrifuge should be set at 4000 rpm for 15 mins (programme #4) 
 SERUM samples should be left to clot for ~1h before separating and aliquoting (4 aliquots) 
 All aliquots should be at least 0.5 ml. 
Researcher: __________________________ Glucose Analysis: _________________ 
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Appendix L: Participants Feedback – Chapter 3 & 4 
 
 
 
Metabolic responses to breaking up sitting time 
RESULTS FEEDBACK 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
 
Name: First and Last names 
DOB:  dd/mm/yyy 
Address: Address1 
  Address2 
  City and Postcode 
 
Study Start Date: dd/mm/yyyy 
Study End Date: dd/mm/yyyy 
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Body Composition Measurements 
 
 
1. Height and Weight  
Height and body mass are widely used to measure body fatness.  An index called the ‘Body 
mass index’ or ‘BMI’ can be used to determine whether somebody is the correct weight for 
his or her height.  Usually, a BMI value of 20 to 25 is normal, 25 to 30 is overweight, and 
30+ is classed as obese (BMI is calculated by dividing body mass in kg by height in metres 
squared, i.e. kg/m2).  However, this index is of limited value, as it does not take into account 
an individual’s build and does not distinguish between fat and muscle mass.  (In fact a 
number of athletes would be classed as overweight by this index, due to their large muscle 
mass.)  
Your height: xx.x m  (x’ xx”) 
Your weight: xxx kg  (xx stn xx lbs) 
Your body mass index (BMI):  xxx  kg/m2 
 
The following graph shows the ideal body mass for adults (18 years and older) based on their 
height. According to your height, your body mass should be between about xx.x – xx.x 
kg (xx.x – xx.x stones).  
 
 
Appendix L: Partcipants Feedback 
©Nabeeha Hawari (2017)           238 
2. Waist Circumference  
The waist circumference (or girth) is perhaps of greater importance than BMI in determining 
risk of metabolic disorders such as diabetes and heart disease.  This is because abdominal 
fat is thought to be in a position anatomically (i.e. near to the liver and other internal organs) 
where it could potentially cause a lot of harm.  The risk for certain metabolic 
complications is higher when the waist circumference is greater than 99 cm (39 in) for 
men and 88.9 cm (35 in) for women.  
Your Waist Circumference (WC): xxx  cm  (xx.x in) 
 
3. Waist-to-Hip Ratio (WHR) 
The pattern of body fat distribution is recognised as an important indicator of heath and 
prognosis. The more fat on the trunk (also called abdominal fat), the higher the risk of 
hypertension, diabetes and other metabolic complications. The wait-to-hip ratio (WHR) is 
the circumference of the waist divided by the circumference of the hip (buttocks/hips).  It 
has traditionally been used as a simple method for assessing body fat distribution and 
identifying individuals with higher amounts of abdominal fat.  Health risk increases as WHR 
increases and the standards for risk vary with age and sex.  The WHR should be below 0.95 
for young men and 0.86 for young women.  For individuals aged 60-69 years, the cutoff 
values are less than 1.03 for men and less than 0.90 for women.  
Your Waist-to-Hip Ratio (WHR): xxx 
                        
Health Screening Results 
 
1. Blood Pressure 
Your Blood Pressure:  xxx/xx  mm Hg 
The target for the general population is to have a blood pressure below 140/90 mmHg. The 
systolic pressure (xxx mm Hg) indicates how hard the heart is working and the force that is 
blood exerts when blood is pumped from the heart.  The diastolic pressure (xx mm Hg) tells 
us what resistance there is to blood flow and therefore how easily blood flows through the 
blood vessels. 
 
2. Fasting Glucose  
Fasting glucose level is used to determine whether you have diabetes or not. The normal 
range of fasting glucose is 3.5-5.5 mmol/l and a value of greater than 7 mmol/l suggests 
diabetes.  
 
Your Fasting Glucose:  x.x  mmol/l  (normal) 
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Physical Activity 
 
 
1. Weekly Analysis 
During the three weeks you have participated in the study, you were asked to wear two 
accelerometers to measure your physical activity. One of these accelerometers is called the 
activPAL, which was fitted on the right thigh.  It moved as you moved, generating totals for 
the periods spent sitting, standing and stepping.  The result of your weekly activity is 
presented by week, day and hour (see next figure), and the following parameters were 
calculated: 
 Time sitting/lying (hours) 
 Time quiet standing (hours)  
 Time stepping (hours)  
 Step count (steps)  
 Sit to stand transfers (number of)  
 Energy expenditure (MET.h)  
 Walking frequency (cadence) (number of steps taken at 10steps/minute intervals)  
Your weekly results are attached at the back of this report. 
 
Sample of the Weekly Activity Analysis – Explained. 
 
Summary by Week 
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Summary by Day 
 
 
 
 
 Please note that this is not your result.  Your weekly analyses for the 
three weeks are attached at the back. 
 
 
2. Energy Expenditure  
The body requires energy for every physical activity which is dependent on the duration and 
type of activity and the body’s age and gender. Energy is measured in calories (cal) and is 
obtained from the body stores or the food we eat, namely carbohydrates, fat and protein. The 
longer and harder the exercise is, the more calories you burn in order to sustain it. In order 
to lose 1 pound of fat, you need to burn 3500 kcal (7700 kcal for 1 kg).  Your energy 
expenditure for the three trials are as follows: 
Your Energy Expenditure:  
Sitting trial: xxxx kcal 
Prolonged Standing trial: xxxx kcal 
Intermittent Standing trial: xxxx kcal 
  
 
 
 
Appendix L: Partcipants Feedback 
©Nabeeha Hawari (2017)           241 
3. Exercise Recommendations 
 
The UK Physical Activity guidelines recommend that you perform a total of 150 minutes of 
moderate-intensity activity or 75 minutes of vigorous-intensity activity per week.  This 
physical activity should be spread across the week.  For example, you can do at least 30 
minutes of moderate-intensity activity on 5 or more days of the week.  This 30-minutes 
period does not need to be continuous - you could split it up into a number of shorter exercise 
periods (each of at least 10 minutes).  This amount of exercise is the ideal, but taking any 
exercise at all will be beneficial.  In addition, everyday activities such as walking to the shops 
can all count towards your daily exercise.  It is important to note that for adults who are 
already overweight or obese and achieving the recommended weekly amount of activity (30 
minutes x 5 times a week or 150 minutes per week) will gain multiple health benefits even 
if they did not lose weight.  
 
Type of activity Examples 
Moderate intensity Brisk walking, bike riding, 
dancing, swimming, active travel 
Vigorous intensity Running, playing sport, taking 
part in aerobic exercise classes, 
using cardiovascular gym 
equipment. 
 
 
 
 Thank you for your time and participation  
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Appendix M: Participant Information Sheet and Consent Form - Chapter 5 
 
 
PARTICIPANT INFORMATION SHEET 
Development and testing of methods to measure human movement using a 
movement sensor positioned on the thigh or in a pocket. 
You are being invited to take part in a research study. Before you decide it is important for 
you to understand why the research is being done and what it will involve. Please take time 
to read the following information carefully and discuss it with others if you wish. Ask us if 
there is anything that is not clear or if you would like more information. Take time to decide 
whether or not you wish to take part. 
What is the purpose of the study? 
The purpose of this study is to develop and test new methods of measuring human 
movement using a movement sensor device positioned on the thigh or in your pocket.  This 
information will help us to better understand how people move throughout the day which 
will help research into understanding of how movement influences risk of diseases such as 
heart disease and diabetes and help us to understand how we can get people to move 
more.  
Why have I been chosen? 
You have been chosen because you are a healthy adult aged between 18-60 years. 
Do I have to take part? 
It is up to you to decide whether or not to take part. If you do decide to take part, you will be 
given this information sheet to keep and be asked to sign a consent form. If you decide to 
take part, you are still free to withdraw at any time and without giving a reason. A decision 
to withdraw at any time, or a decision not to take part, will not affect the standard of care 
you receive. 
What will happen to me if I take part? 
Before enrolling in the study we will ask you to attend for a screening visit in which we will 
ask you to complete a confidential questionnaire about your health, measure your blood 
pressure, measure your height and weight and provide an opportunity for you to ask 
questions. 
 
These screening procedures will enable us to determine whether you fall into the group of 
people we wish to study and will also ensure that it is perfectly safe for you to participate in 
this study. 
 
We will then ask you to perform two trials, on different days, involving walking and running 
at different speeds from very slow walking (1 km/h) to fairly fast running (12 km/h).  In one 
trial, we will ask you to walk and run on a treadmill.  In the other trial we will ask you to walk 
and run around an athletics track. In both trials, we will ask you to wear a number of motion 
detection devices, called accelerometers, under your clothes on the fronts of both of your 
thighs (stuck on using a special double-sided adhesive gel), in your trouser or short pockets, 
and attached to your hips.   
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The photographs below show the placement of the accelerometer devices.  During the 
treadmill session, we will ask you to breathe through a mouthpiece while you are walking 
and running to enable us to collect the air that you breathe out to measure the amount of 
oxygen your body is using.  We will also videotape you while you are walking and running 
during these trials to enable us to count how many steps that you took and compare this to 
the values recorded on the accelerometer devices.  For each trial we will ask you to walk at 
up to 8 different speeds, and run at up to 6 different speeds in total.  You will have the 
chance to rest between the different walking and running speeds if you need to.  Each trial 
will take about 90-120 minutes in total and we can schedule them at your convenience.  
What do I have to do? 
We will ask you to perform the trials described above.  No special preparation is needed for 
these trials. 
 
What are the possible disadvantages and risks of taking part? 
The walking and running that we are asking you to do will not be at a maximal level but the 
possibility exists that, very seldom, certain changes may occur during or shortly after the 
tests. They include abnormal blood pressure, fainting or a change in the normal rhythm of 
the heartbeat. We will monitor your heart rate throughout the exercise session and will stop 
the test if your heart rate reaches 85% of your maximum heart rate. 
What are the possible benefits of taking part? 
There may be no direct benefits to you but the findings will help research into how we can 
measure human movement better.  The findings of this study will be presented at scientific 
conferences and published in scientific journals and will help us to better understand how 
movement influences risk of diseases such as heart disease and diabetes and how we can 
get people to move more. We will also be delighted to explain our findings and discuss their 
implications with you. 
Will my taking part in this study be kept confidential? 
All information which is collected about you during the course of the research will be kept 
strictly confidential. You will be identified by an ID number, and any information about you 
will have your name and address removed so that you cannot be recognised from it. 
What will happen to the results of the research study? 
The findings of this study will be presented at scientific conferences and published in 
scientific journals and will help us to better understand how movement influences risk of 
Accelerometers 
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diseases such as heart disease and diabetes and how we can get people to move more.  
You will not be identified in any publication or presentation of this work.   
Who is organising and funding the research? 
This work forms part of Nabeha Hawari’s PhD.  She is funded by a scholarship from the 
Government of Saudi Arabia. 
Who has reviewed the study? 
This study has been reviewed and approved by the College of Medical, Veterinary and Life 
Sciences Ethics committee at the University of Glasgow. 
Contact for Further Information 
Any questions about the procedures used in this study are encouraged. You will be given a 
copy of this information sheet and a signed consent form to keep for your records. If you 
have any doubts or questions, please ask for further explanations by contacting either:  
Nabeha Hawari on 07919182743 (email : n.hawari.1@research.gla.ac.uk ) 
Dr Jason Gill on 0141 3302916 (email : Jason.Gill@glasgow.ac.uk ) 
Thank you for your interest in this study! 
14 May 2013  (Version 1) 
College of MVLS,  Ethics Committee 
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Participant Identification Number for this trial: 
                                                           CONSENT FORM 
 
Title of Project: Development and testing of methods to measure human movement 
using a movement sensor positioned on the thigh or in a pocket. 
Name of Researcher(s): Dr Jason Gill, Mrs Nabeha Hawari 
                                                    Please initial box 
 
I confirm that I have read and understand the information sheet dated 14 May 2013 
(version 1) for the above study and have had the opportunity to ask questions. 
 
I understand that my participation is voluntary and that I am free to withdraw at 
any time, without giving any reason, without my legal rights being affected. 
 
I agree to take part in the above study.       
 
           
Name of subject                                    Date                 Signature 
 
 
    
Name of Person taking consent  Date                   Signature 
(if different from researcher) 
 
 
   
Researcher                                                Date                    Signature 
 
(1 copy for subject; 1 copy for researcher) 
 
14 May 2013  (Version 1) 
College of MVLS  
Ethics Committee 
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Appendix N: Announcement - Chapter 5 
 
 
Would you like to help us to better understand how people move throughout the day 
which will help research into understanding of how movement influences risk of diseases 
such as heart disease and diabetes and help us to understand how we can get people to 
move more? 
                                                               
 
We are testing and development methods to measure human movement 
using a movement sensor positioned on the thigh or in a pocket 
 
If you are a healthy (man or women), aged between 18 – 60 years.  Exclusion criteria will include 
uncontrolled hypertension, a previous history of established CHD, or conditions such as arthritis 
or injuries that alter gait and/or limit ability to walk or run on a treadmill, you may be able to 
help us. 
 Participants will perform two experimental trials – one involving walking and running on 
a treadmill and one involving walking and running on an athletics track.  For each trial, 
participants will wear ActivPAL devices in a number of locations on the body (lower thigh, 
upper thigh, hip and pocket, on the left and right sides), and Actigraph accelerometers 
on the right and left hips, to record body accelerations and posture changes. The treadmill and track 
trials will be undertaken in random order. 
Nabeha Saleh Hawari 
07919182743(Mobile) 
(Email)  
n.hawari.12@research.gla.a
c.uk 
 
Dr Jason Gill 
Tel. 01413302916 
Jason.Gill@glasgow.ac.uk 
Nabeha Saleh Hawari 
07919182743(Mobile) 
(Email)  
n.hawari.12@research.gla.a
c.uk 
 
Dr Jason Gill 
Tel. 01413302916 
Jason.Gill@glasgow.ac.uk 
Nabeha Saleh Hawari 
07919182743(Mobile) 
(Email)  
n.hawari.12@research.gla.a
c.uk 
 
Dr Jason Gill 
Tel. 01413302916 
Jason.Gill@glasgow.ac.uk 
Nabeha Saleh Hawari 
07919182743(Mobile) 
(Email)  
n.hawari.12@research.gla.a
c.uk 
 
Dr Jason Gill 
Tel. 01413302916 
Jason.Gill@glasgow.ac.uk 
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Appendix O: Subject`s Information - Chapter 5 
 
General information                                         
 
Subject Number : 
 
 
Date of screening: 
 
Time: 
 
Name: 
 
Address: 
 
 
 
Date of Birth: 
 
Email: 
Age: 
 
Telephone number: 
Height: 
 
Weight: 
BMI: 
 
Blood Pressure: 
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Appendix P: Gas Collection Duration - Chapter 5 
Gas Collection Duration 
 
Condition Duration (min) Sampling Time (min) 
 
Sitting 0 - 8 3 – 8 
 
Standing 8 - 13 8 – 13 
 
1 km/h 13 - 18 16 – 18 
 
2 km/h 18 - 23 21 – 23 
 
3 km/h 23 - 28 26 – 28 
 
4 km/h 28 - 33 31 – 33 
 
5 km/h 
 
33 - 38 36 - 38 
6 km/h 
 
38 - 43 41 - 43 
7 km/h (walking) 
 
43 - 48 46 - 48 
7 km/h (running) 
 
48 - 53 51 - 53 
8 km/h (walking) 
 
53 - 58 56 - 58 
8 km/h (running) 
 
58 - 63 61 - 63 
9 km/h (running) 
 
63 - 68 66 - 68 
10 km/h (running) 
 
68 - 73 71 - 73 
11 km/h (running) 
 
73 - 78 76 - 78 
12 km/h (running) 
 
78 - 83 81 - 83 
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Gas Collection on Treadmill 
 
Date Name 
Weight 
(kg) 
Height 
(cm) 
Lab Temp 
( ̊C) 
Bar Press. 
(mmHg) 
 
 
     
 
Bag Sample time FECO2 % FEO2 % Volume (L) Temp (̊C) 
Sitting 
 
     
Standing 
 
     
1km/h 
 
     
2km/h 
 
     
3km/h 
 
     
4km/h 
 
     
5km/h 
 
     
6km/h 
 
     
7km/h Walking 
 
     
7km/h Running 
 
     
8km/h Walking  
 
     
8km/h Running 
 
     
9km/h 
 
     
10km/h 
 
     
11km/h 
 
     
12km/h 
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Treadmill Based Running Tests 
Subject No: _________________  Start Time: ____________ 
 Date:____________ 
 
Initial Sitting Rest Duration:  ____________________ 
 
nitial Standing Rest Duration:  ____________________ 
 
PB = _________ mmHg 
 
Walking 
 
Speed 
(km/h) 
Time 
of Day 
(24hr) 
Average 
Heart 
Rate 
(bpm) 
Video 
File 
Name 
Douglas Bag Data Collection 
Collection 
Time (min) 
Initial 
Reading 
(L) 
Final 
Reading 
(L) 
Expired 
Air 
Temp.   
(̊C) 
FEO2 
(%) 
FECO2 
(%) 
1 
 
         
2 
 
         
3 
 
         
4 
 
         
5 
 
         
6 
 
         
7 
 
         
8 
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Running 
Speed 
(km/h) 
Time 
of Day 
(24hr) 
Averag
e Heart 
Rate 
(bpm) 
Video 
File 
Name 
Douglas Bag Data Collection 
Collection 
Time 
(min) 
Initial 
Reading 
(L) 
Final 
Reading 
(L) 
Expired 
Air 
Temp.   
(̊C) 
FEO2 
(%) 
FECO2 
(%) 
7 
 
         
8 
 
         
9 
 
         
10 
 
         
11 
 
         
 
Rest Period Recordings 
 
       Note: 
 
Speed before rest 
(km/h) 
Duration of Rest 
(mins & secs) 
Time of Day 
(am/pm) 
Additional Notes 
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Track Protocol 
Field Based Walking Tests 
Subject No:      Start Time:   Date 
Target 
Speed 
(km/h) 
Target Time 
(secs) 
Attempt no. 
Distance 
(m) 
Actual 
time 
(seconds) 
Time of 
Day 
(am/pm) 
Average 
Heart Rate 
(bpm) 
Video File 
Name 
     1       144 
1 
  
Sitting  -  
 
-  
Standing -  -  
Walking 40    
2 
Sitting  -  -  
Standing -  -  
Walking 40    
3 
Sitting  -  -  
Standing -  -  
Walking 40    
     2 72.0 
1 
  
Sitting  -  
 
-  
Standing -  -  
Walking 40    
2 
Sitting  -  -  
Standing -  -  
Walking 40    
3 
Sitting  -  -  
Standing -  -  
Walking 40    
     3       48.0 
1 
  
Sitting  -  
 
-  
Standing -  -  
Walking 40    
2 
Sitting  -  -  
Standing -  -  
Walking 40    
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3 
Sitting  -  -  
Standing -  -  
Walking 40    
     4 36.0 
1 
  
Sitting  -  
 
-  
Standing -  -  
Walking 40    
2 
Sitting  -  -  
Standing -  -  
Walking 40    
3 
Sitting  -  -  
Standing -  -  
Walking 40    
     5       28.8 
1 
  
Sitting  -  
 
-  
Standing -  -  
Walking 40    
2 
Sitting  -  -  
Standing -  -  
Walking 40    
3 
Sitting  -  -  
Standing -  -  
Walking 40    
6 24.0 
1 
  
Sitting  -  
 
-  
Standing -  -  
Walking 40    
2 
Sitting  -  -  
Standing -  -  
Walking 40    
3 
Sitting  -  -  
Standing -  -  
Walking 40    
7 46.3 
1 
  
Sitting  -  
 
-  
Standing -  -  
Walking 90    
2 Sitting  -  -  
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Standing -  -  
Walking 90    
3 
Sitting  -  -  
Standing -  -  
Walking 90    
8 40.5 
1 
  
Sitting  -  
 
-  
Standing -  -  
Walking 90    
2 
Sitting  -  -  
Standing -  -  
Walking 90    
3 Sitting  -  -  
 Standing -    
 Walking 90    
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Field Based Running Tests 
Subject No:       Start Time:   Date 
Target 
Speed 
(km/h) 
Target Time 
(secs) 
Attempt no. 
Distance 
(m) 
Actual 
time 
(seconds) 
Time of 
Day 
(24hr) 
Average 
Heart Rate 
(bpm) 
Video File 
Name 
       7      46.3 
1 
  
Sitting -  
 
-  
Standing -  -  
Running 90    
2 
Sitting -  -  
Standing -  -  
Running 90    
3 
Sitting -  -  
Standing -  -  
Running 90    
8 40.5 
1 
  
Sitting -  
 
-  
Standing -  -  
Running 90    
2 
Sitting -  -  
Standing -  -  
Running 90    
3 
Sitting -  -  
Standing -  -  
Running 90    
       9        36.0 
1 
  
Sitting -  
 
-  
Standing -  -  
Running 90    
2 
Sitting -  -  
Standing -  -  
Running 90    
3 
Sitting -  -  
Standing -  -  
Running 90    
     10 32.4 
1 
  
Sitting -  
 
-  
Standing -  -  
Running 90    
2 Sitting -  -  
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Standing -  -  
Running 90    
3 
Sitting -  -  
Standing -  -  
Running 90    
      11       29.5 
1 
  
Sitting -  
 
-  
Standing -  -  
Running 90    
2 
Sitting -  -  
Standing -  -  
Running 90    
3 
Sitting -  -  
Standing -  -  
Running 90    
 
 
 ©Nabeha Hawari (2017)   257 
Appendix S: Conference Posters - Chapter 5 
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